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PREFACE
The Health Systems in Transition (HiT) series consists of country-based 
reviews that provide a detailed description of a health system and of reform 
and policy initiatives in progress or under development in a specific coun-
try. Each review is produced by country experts in collaboration with the 
Observatory’s staff. In order to facilitate comparisons between countries, 
reviews are based on a template, which is revised periodically. The template 
provides detailed guidelines and specific questions, definitions and examples 
needed to compile a report.
HiTs seek to provide relevant information to support policy-makers and 
analysts in the development of health systems in Europe. They are building 
blocks that can be used:
  to learn in detail about different approaches to the organization, 
financing and delivery of health services and the role of the main 
actors in health systems;
  to describe the institutional framework, the process, content and 
implementation of health care reform programmes;
  to highlight challenges and areas that require more in-depth 
analysis;
  to provide a tool for the dissemination of information on health sys-
tems and the exchange of experiences of reform strategies between 
policy-makers and analysts in different countries; and
  to assist other researchers in more in-depth comparative health 
policy analysis.
Compiling the reviews poses a number of methodological problems. In 
many countries there is relatively little information available on the health 
system and the impact of reforms. Due to the lack of a uniform data source, 
quantitative data on health services are based on a number of different 
sources, including the World Health Organization (WHO) Regional Office 
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for Europe Health for All database, national statistical offices, Eurostat, 
the Organisation for Economic Co-operation and Development (OECD) 
Health Data, the International Monetary Fund (IMF), the World Bank, and 
any other relevant sources considered useful by the authors. Data collection 
methods and definitions sometimes vary, but typically are consistent within 
each separate series.
A standardized review has certain disadvantages because the financing 
and delivery of health care differ across countries. However, it also offers 
advantages, because it raises similar issues and questions. The HiTs can be 
used to inform policy-makers about experiences in other countries that may 
be relevant to their own national situation. They can also be used to inform 
comparative analysis of health systems. This series is an ongoing initiative 
and material is updated at regular intervals.
Comments and suggestions for the further development and improve-
ment of the HiT series are most welcome and can be sent to contact@obs.
who.int.
HiTs and HiT summaries are available on the Observatory’s website: 
www.healthobservatory.eu.
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ABSTRACT
This analysis of the Norwegian health system reviews recent developments in 
organization and governance, health financing, health care provision, health 
reforms and health system performance. Norway is among the wealthiest 
nations in the world, with low levels of income inequality. Norwegians enjoy 
long and healthy lives, with substantial improvement made due to effective 
and high-quality medical care and the impact of broader public health pol-
icies. However, this comes at a high cost, as the Norwegian health system 
is among the most expensive in Europe, with most financing coming from 
public funds. Yet there are several areas requiring substantial co-payments, 
such as adult dental care, outpatient pharmaceuticals, and institutional care 
for older or disabled people.
Recent and ongoing reforms have focused on aligning provision of care 
to changing population health needs, including adapting medical education, 
strengthening primary care and improving coordination between primary 
and specialist care sectors. There has been an increasing use of e-health 
solutions, and information and communication technologies. Improvements 
in measuring performance and a more effective use of indicators is expected 
to play a larger role in informing policy and planning of health services.

EXECUTIVE SUMMARY
Norwegians enjoy high levels of wealth and long and healthy 
lives
Norway is a member of the European Economic Area (EEA) with a pop-
ulation of 5.3 million. The country is sparsely populated, with the majority 
of the population living along the coast, mainly in the south-eastern and the 
south-western parts of Norway.
Norway is a parliamentary democracy with three different adminis-
trative levels: state, counties and municipalities. An administrative reform 
is currently under way. The goal is to improve administrative efficiency by 
reducing the number of municipalities and replacing counties with (fewer) 
regions. This administrative reorganization impacts on health care organi-
zation and governance.
Per capita gross domestic product (GDP) in Norway is one of the 
highest in the world, with oil trade fuelling economic growth since 1960s. 
Income inequality is one of the lowest among the EEA countries, although 
rising; Norway is also highly rated with respect to gender equality and 
female participation rates are high in education, the labour market and 
political life.
Life expectancy has continued to increase and reached 82.7 years in 
2017 – among the highest in Europe. Like in other high-income countries, 
cardiovascular diseases and cancers are the main causes of death. However, 
self-harm and substance use disorders are the key causes of death among 
younger adults. Cancers, circulatory diseases and musculoskeletal disorders 
had the largest contribution to the burden of disease in Norway as measured 
by disability-adjusted life years (DALYs).
Norway is no exception to the impact of major risk factors, such as 
increasing rates of overweight and obesity, as well as unbalanced diet. There 
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are also persistent socioeconomic inequalities in health, driven by a higher 
prevalence of risk factors, smoking in particular, among people with lower 
income and education. Nevertheless, there are also positive trends such as a 
decreasing share of smokers. Norway is also among the countries with the 
highest share of adult population who exercise regularly.
Norway’s health system is relatively decentralized, and there 
are ongoing efforts to improve coordination between primary 
and specialist care
Norway has a semi-decentralized health system, with four Regional Health 
Authorities (RHAs) being responsible for specialist care and municipalities 
responsible for primary care and social services. The 2012 Coordination 
Reform established a mandatory network of governance structures, encom-
passing health trusts and the municipalities to improve the coordination 
of specialist and primary care. In addition, counties play a role, including 
in provision of dental care (until 2023), safeguarding access to services and 
serving as an appeal body to municipal decisions, and, increasingly, in coor-
dination of care and provision of public health services.
The Ministry of Health and Care Services, with the help from its sub-
ordinate agencies, is responsible for the regulation and supervision of the 
system and ensures that health and social services are provided in accordance 
with national legislation and regulations. In 2016 central health governance 
structures were reorganised, resulting in the merging of agencies, and the 
establishment of new ones, including the Directorate for e-Health and the 
Norwegian Healthcare Investigation Board to investigate adverse medical 
events.
Historically, there were no direct mechanisms to ensure that health 
is taken into account by ministries other than the Ministry of Health 
and Care Services, but this changed with the introduction of the Public 
Health Act in 2011, in which the ‘Health in All Policies’ approach fea-
tured centrally.
In 2013 the National System for Managed Introduction of New Health 
Technologies within the Specialist Health Service in Norway was introduced 
to facilitate evidence-based decision-making within specialist health services. 
The system of health technology assessment has been in place since 1998 
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and over the years its application has expanded from clinicians to national 
policy-making.
Empowering of patients and next of kin continues to be a policy priority 
through comprehensive patients’ rights legislation that regulates issues such 
as patient choice and complaint procedures. Most recently, children and 
young people have gained a legal right to be heard as a patient, as well as 
the right to confidentiality.
Norway spends more on health than other countries and most of 
it comes from public funds, yet there are several areas requiring 
substantial co-payments
Health care expenditure accounted for 10.4% of GDP in 2017 – the fifth 
highest in the WHO European Region. With Norway’s per capita GDP 
being one of the highest in the world, the country’s per capita health 
expenditure is also much higher than in most countries – over US$6500 
PPP, second only to Switzerland. Public sources account for 85.5% of current 
health expenditure, which is the highest share in Europe, and comprise 
financing from central and local governments and the National Insurance 
Scheme.
All residents of Norway are entitled to essential medical care. Most 
private health financing comes from households’ out-of-pocket payments, 
of which most is spent on pharmaceuticals, dental care and long-term 
care. There are annual cost-sharing ceilings to protect the population from 
excessive health care spending. Municipal services, such as home care for 
the elderly and disabled people (except for nursing, which is fully covered), 
and inpatient care for the elderly in nursing homes are among the services 
that are not included in the cost-sharing ceiling.
Norway has well-established formal arrangements in place for its older 
and disabled populations and has traditionally spent more on long-term 
care (LTC) as a share of current spending on health compared to any other 
OECD country. The share of current expenditure spent on LTC is equal 
to the share spent on inpatient care and amounts to over a quarter of total 
spending on health.
Integrated purchaser–provider relations had been the dominant feature 
of the Norwegian health care system. However, in the last two decades 
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attempts have been made to introduce a more clear-cut purchaser–provider 
split. Hospital care, as well as outpatient psychiatry and treatment of drug 
and alcohol abuse, is financed, in equal parts, through block grants and 
case-based financing from the central government to the RHAs. Other 
types of specialist care are mainly financed through global budgets, with 
elements of case-based funding. Quality-based funding is being rolled out 
at the national level.
Primary care is financed from municipal taxes, block grants from the 
central government and earmarked grants for specific purposes; a major 
funding source for primary care is also the National Insurance Scheme, 
as well as patient co-payments. The financing structure is aimed at both 
containing costs and giving providers sufficient flexibility to ensure the best 
mix of services for patients.
There is limited spare capacity in the hospital sector and, 
despite a relatively high number of nurses, shortages are pre-
dicted in the years to come
There are twenty hospital trusts in Norway. The number of hospital beds 
has been declining over the years and reflects the government’s efforts to 
improve resource allocation by shifting inpatients to outpatient settings in 
the community and to day surgery. In 2017 there were 3.2 acute beds per 
1000 inhabitants in Norway, which is higher than in the other Scandinavian 
countries. However, the average bed occupancy rate is over 80%, above the 
OECD-average of 75.7%, suggesting that spare capacity in the inpatient 
sector is fairly limited.
Public beds account for 96% of all hospital beds. There are regional 
variations in the age and condition of hospitals across the country. In 
general, a greater need for upgrading is observed in the Northern and 
Western RHAs. In 2015 the RHAs established the Agency for Hospital 
Construction to provide expertise on hospital planning and construction 
to all hospital trusts.
The use of e-tools has increased in recent years. In 2017, 96% of munici-
palities sent electronic referrals to hospitals and nearly all patient information 
sent from hospitals to municipalities was sent electronically. By the end of 
2018 more than 92% of all prescriptions were e-prescriptions. Telemedicine 
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is used to improve access to care and to provide continuous education to 
health personnel in remote areas.
The number of doctors (4.7 per 1000 inhabitants) and nurses (17.7 
per 1000) in Norway is among the highest in Europe, and so is the ratio of 
nurses to doctors. Yet shortages of nurses are predicted in the next decades 
and there are already shortages of nurses in the LTC sector. Nearly 40% of 
physicians in 2015 were foreign-trained; half of them were Norwegian-born 
but educated outside Norway. A new system of competency training was 
introduced in March 2017 to align education with changing population 
needs.
The provision of services is changing following efforts to 
strengthen primary care and shift more care to the community
While counties increasingly play an important coordinating role, the munic-
ipalities are responsible for implementing cross-sectoral public health inter-
ventions locally. Various governmental and non-governmental actors are 
involved in public health activities. The 2012 Public Health Act improved 
horizontal and vertical coordination of public health work. In 2015 the gov-
ernment presented a white paper with a comprehensive overview of public 
health initiatives, including incorporation of mental health as an integral 
part of public health.
Primary care is provided at the municipal level, mostly by self-employed 
physicians and as part of municipal services (in nursing homes and as 
part of home-based services). Team-based delivery of primary care is cur-
rently being piloted alongside new primary care financing models. General 
Practitioners (GPs) act as gatekeepers, referring patients to more complex 
care. Inpatient care is mainly provided by hospital trusts owned by the 
RHAs. Hospitals also provide outpatient specialist care in their outpatient 
departments. Policy efforts since the 1980s have sought to replace relatively 
expensive inpatient care with less costly outpatient and day surgery and to 
bring care closer to patients’ homes. A range of treatments are now provided 
as day care, including somatic and psychiatric care and treatment of drug 
and alcohol addiction.
A number of clinical pathways exist within specialist care for certain 
conditions, for example cancer, and describe anticipated care/treatment needs. 
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The care coordination reform of 2012 put more emphasis on municipalities’ 
responsibility for 24-hour care and services after hospital discharge, includ-
ing obligating the municipalities to establish individual treatment plans for 
patients with chronic diseases. In 2017 the Directorate of Health published 
national guidelines to support municipalities in developing comprehensive 
patient pathways for patients with multi-morbidities with a high level of 
care needs.
Access to pharmaceuticals, including innovative therapies, is compara-
tively good in Norway. Patient co-payments for outpatient pharmaceuticals 
are capped and certain population groups are exempt from cost-sharing. 
Prescription pharmaceuticals account for over 90% of pharmaceutical con-
sumption and generics make up over 50% of total pharmaceutical sales. 
Norwegian doctors are among those prescribing the fewest broad spectrum 
antibiotics, in an attempt to reduce the emergence of antibiotic-resistant 
bacteria.
At the primary care level, emergency or acute primary care services are 
in most municipalities provided by GPs (within office hours) and emergency 
medical centres (after hours) supported by telephone services. Hospitals 
receive emergency cases in Accident and Emergency (A&E) departments. 
A special feature of the Norwegian system is that patients are not allowed 
to seek treatment at an A&E directly, but have to be either referred by a 
physician or brought in by ambulance.
Rehabilitation is provided at both primary (physiotherapy, occupational 
therapy, etc.) and secondary (specialized rehabilitation) levels. Municipalities 
as well as the RHAs are responsible for the coordination of rehabilitation 
services and all RHAs and most municipalities have established designated 
coordination units. Nevertheless, ensuring sufficient cross-sectoral cooper-
ation and coordination across administrative levels and professional groups 
is seen as an ongoing challenge.
Long-term care is provided in three types of setting: patients’ homes, 
nursing homes or sheltered homes run by municipalities. In nursing homes, 
there has been a deliberate shift towards increasing the number of single-
occupancy rooms to make it more home-like. Palliative care services are 
provided at all levels of care, but the availability of palliative care does not 
always meet the demand. In the area of mental health care there has been 
a long-term shift towards de-institutionalization, and, more recently, an 
increase in financing for such services.
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The Coordination Reform of 2012 paved the way for multi-
disciplinary primary care teams
Key policy initiatives in recent years have included improving the coor-
dination of care between municipalities and hospitals (the ‘Coordination 
Reform’); strengthening primary care and public health; extending patient 
choice; reorganizing hospital care; and adapting education and training of 
health professionals to future health needs.
Evaluation of the Coordination Reform has shown mixed results so 
far. However, overall, it was found to have supported delivery of care at the 
lowest, effective level of care and it paved the foundation for the primary 
care and public health reforms of 2015. Primary care teams are currently 
(2018–2021) being piloted with the goal of instituting multidisciplinary 
environments. Related to this and in line with the Health and Hospital Plan 
2020-2023, a new action plan sets out plans for adapting competencies of 
health professionals to future health needs. Ongoing reform efforts focus 
on the following areas: public health (focus on children and youth and pre-
vention of loneliness); primary care (evaluation of the regular GP scheme); 
substance abuse (more emphasis on prevention and harm reduction); and 
long-term care (creating an age-friendly society).
Quality and effectiveness of health care services are among the 
best in Europe, but this comes at high cost
Transparency in the health care system has been a political priority over the 
past few decades. Public monitoring of performance indicators in policy 
processes has both improved and been used more widely over the past three 
decades. It is used to systematically measure performance at the national as 
well as the international level and it has a clear influence on national health 
policy goals. The country scores well on health indicators, such as amenable 
and preventable mortality, which can be attributed to high effectiveness of 
health care and broader public health policies.
The distribution of hospitals in Norway reflects the distribution of the 
population, with the majority of hospitals located in the South-Eastern 
Region and the longest distances to the nearest hospital being in the 
Northern region. Despite the high density of health care personnel, Norway 
xxvi Health Systems in Transition
still struggles to ensure equal access to health care across its entire territory, 
particularly in rural and sparsely populated areas.
The Norwegian health system offers a high level of social and financial 
protection. Population coverage is universal and public financing accounts 
for the vast majority (85%) of health expenditure. Various mechanisms, such 
as exemptions and ceilings on OOP payments, limit the financial burden 
of care on individuals. However, the level of protection is poor for certain 
types of care, such as home-based services and institutional care for older or 
disabled people and adult dental care. Nevertheless, unmet need for medical 
examination is relatively small in Norway (1.1% of the population, with 0.4% 
reporting unmet need due to cost).
Comparative price levels in the health and hospital sectors are higher in 
Norway than in most other countries. When adjusting for countries’ economic 
development, Norway’s health spending is in line with other high-income 
countries, although the debates persist on whether the cost of health care 
justifies the level of outcomes. Much attention has been paid to improving 
care quality and patient safety and Norway scores well on most indicators. A 
shift to care outside the hospital setting, coordination reform and expansion 
of generic medicines and biosimilars contributed to improved efficiency 




  Norway is the northernmost European country located in the 
Scandinavian Peninsula, with a population of 5.3 million, largely 
concentrated in the southern part of Norway.
  Macroeconomic management of Norway’s oil-generated wealth, 
via the sovereign wealth fund and the associated fiscal rule, has 
helped achieve very high standards of living across society over 
the past several decades. However, substantial falls in the oil price 
in recent years have resulted in lower economic growth (1.4% in 
2018). Nevertheless, in 2018 the GDP per capita (adjusted for 
purchasing power parity) in Norway was $65 600 – among the 
highest in the world.
  Norway is a parliamentary democracy with three different admin-
istrative levels: state, counties and municipalities. An ongoing 
administrative reform aims to improve administrative efficiency 
by replacing counties with (fewer) regions and reducing the number 
of municipalities.
  The health of Norwegians is generally good and life expectancy 
continues to rise. In 2017 the average life expectancy was 82.7 
years, and the gender gap is slowly closing. As in other European 
countries, cardiovascular diseases and cancers are the main causes 
of death, although external causes are the second-largest cause of 
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deaths in people aged under 65, with suicide accounting for almost 
half of these.
  Norway faces a number of health challenges, such as increasing 
rates of overweight and obesity, low intake of fruit and vegetables, 
as well as inequalities in health and prevalence of risk factors, with 
vulnerable groups being affected the most.
1.1 Geography and sociodemography
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Norway is located in the northwestern part of the Scandinavian Peninsula 
and has land borders with Sweden, Finland and Russia and coastal borders 
with the North Sea and the North Atlantic Ocean (Fig. 1.1). It consists of 
the mainland, the archipelago of Svalbard and the island of Jan Mayen. Table 
1 shows the main demographic indicators. Norway’s 5.3 million inhabitants 
(2018) live in a total land area of 324 000 km2 (mainland), which averages at 
15 people per km2 and places Norway amongst the most sparsely populated 
countries in Europe. The majority of the population lives along the coast, 
mainly in the south and south-west.
More than 80% of the population lives in urban areas; more than 40% 
lives around the Oslofjord in the south-eastern part where the capital, Oslo, is 
located and less than 10% of the population lives in the northern part of Norway.
In 2018 the population grew by 0.7%, down from the peak of over 1.3% 
per year in 2009–2012. Oslo and surrounding areas continue to experience 
the fastest population growth. Compared to two decades ago, when natural 
change (births minus deaths) accounted for 60% of population growth and 
net migration for 40%, this proportion more than reversed in 2007–2014, 
when about 70% of the population growth was explained by net migration. 
Net migration has since fallen from the peak levels and in 2018 births 
accounted for 46% of population growth. Between 2004 and 2015 migration 
was predominantly economic. In 2016 political refugees accounted for the 
highest share of immigrants (30%; with more than 60% of them coming from 
Syria) but in the following year the number of refugees decreased by more 
than half. In 2017 the main reasons for immigrating to Norway included 
to be reunited with a family member (38% of immigrants), work (33%) and 
political refuge (19%). At the beginning of 2019 the immigrant population 
accounted for 14.4% of the total population and Norwegian-born children of 
immigrants accounted for 3.4%. The majority of immigrants (48%) originate 
from countries in the European Economic Area (EEA), followed by Asian 
(34%) and African countries (14%) (Statistics Norway, 2019a).
Apart from the decrease in net migration, the decline in natural popu-
lation change is another factor explaining lower population growth in recent 
years. In 2018, at 1.6, the fertility rate was the lowest ever and well below the 
replacement level (2.1). The mean age at which women give birth to their 
first child increased to 29.5 years old in 2018, compared to 25.2 years old in 
1988 (Statistics Norway, 2019a).
In 2017 the median age in Norway was 39.3 years old, which is relatively 
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young compared to 42.8 in the European Union (EU28) (European 
Commission, 2019). However, the share of people aged 65 and older has 
been increasing (Table 1.1). Conversely, the proportion of 0–14-year-olds has 
fallen in the past decade. As a result of these trends, the old-age dependency 
ratio (the proportion of people aged 65+ to those aged 15–64) rose from 22% 
in 2008 to 26% in 2018 and is expected to reach 40% by 2050. In the EU 
this ratio stood at 31% in 2018 and is forecast to increase to 50% by 2050.
The average household size has decreased slightly, from an average of 
2.3 members in 2006 to 2.2 in 2018 (which has been unchanged at this 
level since 2010). Over a third of the population (38%) lives in a household 
with children. Approximately one in five people (22%) lives in a two-person 
household and 17% of the population (38% of households) live alone. One-
person households are more frequent in the larger urban centres compared 
to more sparsely populated areas. While among younger people, more men 
live alone compared to women, this is reversed among older people due to 
higher average life expectancy among women (Statistics Norway, 2019a).
In 2000 the proportions of females and males with tertiary education 
(graduate and postgraduate university degrees) were equal and stood at 22%. 
Since then, this proportion has increased more among women than among 
men and in 2016 reached, respectively, 38.3% and 30.8%. Overall, 35% of 
the population had tertiary education in 2017 (Statistics Norway, 2019a).
The vast majority of the population (over 90%) speaks Norwegian. Just 
over 70% of the population had a declared membership in the Church of 
Norway in 2016 and 12% belonged to other religious organizations (Statistics 
Norway, 2019a).
TABLE 1.1 Trends in demographic indicators, 1995–2018, selected years
1995 2000 2005 2010 2015 2018
Total population (millions) 4.4 4.5 4.6 4.9 5.2 5.3
Population aged 0–14 (% of total) 19.5 20.0 19.6 18.8 18.0 17.5
Population aged 65 and above (% of total) 16.0 15.3 14.8 14.9 16.3 17.0
Population growth (% annual growth rate) 0.5 0.6 0.7 1.2 1.0 0.7
Fertility rate, total (births per woman) 1.9 1.9 1.8 2.0 1.7 1.6
Population density (people per sq. km) 11.9 12.3 12.7 13.4 14.2 14.6
Distribution of population (% rural) 26.2 24.0 22.3 20.9 18.9 17.8
Source: World Bank (2019)
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1.2 Economic context
The Norwegian economy is generally characterized as a mixed economy – a 
capitalist market economy with a large component of state influence. The 
discovery of offshore oil and gas fields in the late 1960s gave rise to the 
considerable increase in GDP per capita over the following decades (Table 
1.2). Oil exports allowed Norway to build up an export surplus, amounting to 
NKr288 billion or €31.5 billion in 2018. Good macroeconomic management 
of the oil-generated wealth, via a sovereign wealth fund and an associated fiscal 
rule, has helped achieve very high standards of living across society. Inflows of 
labour from other countries have also supported the economic activity. However, 
substantial falls in the oil price in recent years have resulted in lower economic 
growth (1.4% in 2018). In 2018 GDP per capita (adjusted for differences in 
purchasing power) in Norway was $65 600, which is notably higher than the 
EU average, as well as higher than other Scandinavian countries.
Despite some fluctuations in recent years, unemployment remains rela-
tively low – at 3.8% of the labour force in 2018 (Table 1.2). The majority of 
the labour force (78%) is employed in the services sector. This figure includes 
public sector employees, who represent 30% of the labour force. In 2018 
the health and social work sector accounted for 20.7% of the total share of 
employment in Norway, making the health and social care sector one of the 
largest employers. Overall, the services sector accounts for 27% of export 
revenues in Norway. About 20% of the labour force works in secondary 
industries, including the petroleum industry, which accounts for 2% of the 
total labour force and 39% of export revenues (Statistics Norway, 2019a).
Norway is highly rated with respect to gender equality. Female partic-
ipation rates are high in education, the labour market and political life. In 
2017 the United Nations (UN) ranked Norway as the most gender-equal 
nation based on the Gender-related Development Index (GDI) (UNDP, 
2018). Income inequality in Norway is one of the lowest in Europe, albeit 
it is growing. In 2018 Norway had a Gini coefficient of equalized dispos-
able income of 25%, compared to 31% in the EU (European Commission, 
2019). Norway also had one of the lowest at-risk-of-poverty rates among 
the EU/EEA countries – 13% in 2018, which is similar to Denmark, but 
higher than in Finland (12%). There are, however, reasons for concern as the 
unemployment rate among young adults is particularly high among those 
with the lowest level of education (OECD, 2018b).
6 Health Systems in Transition
TABLE 1.2 Macroeconomic indicators, 1995–2018, selected years
1995 2000 2005 2010 2015 2018
GDP per capita (current NKr)  220 941  335 759  430 200  530 498  600 954  665 297 
GDP per capita, PPP  
(current international $)  24 322  36 956  47 772  57 965  60 519  65 598 
GDP growth (annual %) 4.2 3.2 2.6 0.7 2.0 1.4
Total government spending (% of GDP)1 50.3 42.0 42.1 44.9 48.8 48.7
Net lending/borrowing (% of GDP)1 3.2 15.4 14.8 11.9 6.4 5.5
Public debt (% of GDP)2 37.3 32.3 46.9 48.4 38.6 45.6
Unemployment, total (% of labour force) 6.3 3.5 4.4 3.5 4.3 3.8
At-risk-of-poverty rate (60% of median 
equivalised income), EU-SILC1 11.0 11.4 11.2 11.9 12.9
Income inequality  
(Gini coefficient), EU-SILC1 28.2 23.6 23.9 24.8
Sources: World Bank (2019) unless stated otherwise; 1 European Commission (2019); 2 OECD (2019)
1.3 Political context
Norway is a constitutional monarchy with a parliamentary system. The 
Constitution is founded on the pillars of the sovereignty of the people, 
separation of powers and human rights. The head of state is a hereditary 
monarch, while the head of the government is the prime minister. The country 
is governed by a three-tier parliamentary system, with each tier governed 
by a popularly elected body: the national parliament (Stortinget), the county 
councils (fylke) and the municipal councils (kommuner). Municipalities and 
counties govern local politics and are responsible for primary education and 
primary health care. The 169 members of the Stortinget are elected every 
four years with proportional representation from the 19 counties. In 2020 
the 19 counties will be replaced by 11 regions (region) and the number of 
municipalities will be reduced from 429 to 354.
Politically, for the past 50 years a Labour (or Labour-led) government 
alternated with various non-socialist coalition governments. Since the last 
parliamentary election in September 2017 the two-party coalition between 
the Conservative Party (Høyre) and the Progress party (Framskrittspartiet) 
was re-elected (it was first elected in 2013). It was joined by the Liberal 
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Party (Venstre) in 2018 and then by the Christian Democratic Party (Kristelig 
Folkeparti) in January 2019, which ensured it a majority in parliament.
Norway has ratified several bilateral social security agreements with other 
Nordic countries, as well as the EEA Agreement, which came into force in 
1994. There is a long tradition of close cooperation with the other Nordic 
countries (Denmark, Sweden, Finland and Iceland). In 1982 an agreement 
on a common labour market was signed between the five countries and since 
1992 there has been a social security convention among them (extended to 
social assistance and social services in 1994).
Norway is a member of the UN, the World Trade Organization (WTO), 
the North Atlantic Treaty Organization (NATO), the Council of Europe, 
the European Economic Area (EEA) and the Nordic Council. Norway has, 
among others, signed the following international treaties and documents: 
the General Agreement on Trade in Services (GATS), the Convention on 
the Rights of the Child, the European Convention on Human Rights, the 
International Bill of Rights, the Barents Health Programme (with Sweden, 
Finland and Russia) and the WHO Framework Convention on Tobacco 
Control.
1.4 Health status
The health of Norwegians has improved considerably over the last few dec-
ades and life expectancy continues to rise. In 2017 the average life expectancy 
was 82.7 years, 81.0 years for men and 84.3 years for women, with the gender 
gap slowly closing (Table 1.3).
Non-communicable diseases are the key cause of deaths in Norway. 
Circulatory diseases, followed by cancers, are the most common causes of 
mortality, accounting for, respectively, 28% and 27% of deaths (Table 1.3). 
Deaths from external causes are the second-largest cause of deaths in people 
aged under 65, with suicide accounting for almost half of deaths from external 
causes in this age group.
According to the Global Burden of Disease study (Institute for Health 
Metrics and Evaluation, 2019), malignant neoplasms, circulatory diseases 
and musculoskeletal diseases made the largest contribution to the burden of 
disease in Norway (measured by disability-adjusted life years, DALYs). In 
2017 they accounted for, respectively, 17%, 13% and 12% of the total number 
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of DALYs. In terms of years lived with disability (YLDs), musculoskeletal 
disorders accounted for 21% of the total, followed by mental disorders (15%) 
(Table 1.4).
Musculoskeletal disorders continue to account for the highest share 
of work absences: 46% in 2017 (Norwegian Directorate of Health, 2017a). 
Around 18% of work absences were attributed to mental health problems, 
with this share remaining stable over recent years. Since 2011 mental health 
problems have replaced musculoskeletal disorders as the main reason for 
claiming disability pension in Norway (more than 30% of claimants in 
2017) (NAV, 2019). Whereas musculoskeletal disorders are more frequent 
reasons for claiming disability pensions among older people and women, 
mental health problems are the main reason among younger people and 
men.
In 2018, 5.8% of full-time employees, on average, were on sick leave at 
any given time in Norway (Statistics Norway, 2019a). This figure has been 
stable over the past six years and international comparisons show that it is 
almost twice as high as in other countries in Northern Europe (Denmark, 
Finland, Iceland, Sweden, Netherlands and Great Britain). Regulations on 
sick leave, sick leave benefits and dismissal contribute to this comparatively 
high rate of work absence – Norwegian employees with long-term sickness 
absence continue to be formally employed, whereas long-term sickness 
absence may lead to unemployment in other countries (Lien, 2019; PROBA 
Samfunnsanalyse, 2014).
Prevalence of diabetes types 1 and 2, at 5.4% in 2017, is similar to 
other Nordic countries and the OECD average (OECD, 2018a). However, 
prevalence of type 1 diabetes in Norwegian children (<14yrs), at 2.6 cases 
per 1000, is among the highest in the world (according to the latest data 
from OECD, 2017). According to a long-term study, between 2004 and 
2012 the incidence of new diabetes type 1 cases in children has been stable 
at around 300 new cases per year (Norwegian Institute of Public Health, 
2017a; Skrivarhaug et al., 2014).
As in many other European countries, dietary risk factors are respon-
sible for a substantial share of deaths (15%, compared to 18% in the EU 
on average) (Fig. 1.2). Low intake of vegetables, fruit, fish and wholegrain 
foods and high intake of saturated fat, sugar and salt are risk factors for 
developing many chronic conditions, including type 2 diabetes, CVDs and 
different types of cancer.
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TABLE 1.3 Mortality and health indicators, 1995–2017, selected years
1995 2000 2005 2010 2015 2017* EU28
Life expectancy at birth, total 77.9 78.8 80.3 81.2 82.4 82.7 80.9
Life expectancy at birth, male 74.8 76.0 77.8 79.0 80.5 81.0 78.3
Life expectancy at birth, female 80.9 81.5 82.7 83.3 84.2 84.3 83.5
Mortality, SDR per 100 000
 All causes 1 303 1 198 1 058 992 907 899 1 002
 Circulatory diseases 580 500 374 313 265 247 358
 Malignant neoplasms 295 287 278 270 246 243 259
 Communicable diseases 13 15 20 22 22 19 16
 External causes 60 59 57 56 52 55 46
Infant mortality rate (per 
1 000 live births) 4.0 3.8 3.1 2.8 2.3 2.3 3.6
Maternal mortality rate per 100 000 
live births (modelled estimate) - 6 5 4 3 2 6
Note: EU data for 2017 or latest available; *Latest mortality by cause data for Norway and EU is for 2016.
Source: European Commission (2019); World Bank (2019) for maternal mortality






Communicable, maternal, neonatal and nutritional diseases 4.8 4.8
Noncommunicable diseases 85.7 85.7
 Cardiovascular diseases 13.4 4.5
 Neoplasms 17.1 2.4
 Mental disorders 8.2 15.1
 Substance use disorders 2.7 2.2
 Diabetes and kidney diseases 4.2 5.5
 Chronic respiratory diseases 5.2 4.7
 Musculoskeletal disorders 11.8 21.2
 Neurological disorders 9.4 9.9
 Digestive diseases 2.8 2.3
 Cirrhosis and other chronic liver diseases 0.7 0.2
Other noncommunicable diseases 4.7 6.8
Injuries 9.5 9.5
 Self-harm 1.8 0.1
Source: Institute for Health Metrics and Evaluation (2019)
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Lack of physical activity is an important risk factor for both type 2 
diabetes and other chronic diseases. According to OECD data, Norway is 
among the countries with the largest share of the adult population partici-
pating in moderate weekly physical activity. The proportion of 15-year-olds 
participating in moderate to vigorous daily physical activity in Norway is 
similar to the OECD average. The obesity rate in the population has increased 
from about 5% in 1996 to 12% in 2015 (OECD, 2018a). Still, the prevalence 
of overweight and obesity in Norway remains slightly lower than in the EU 
on average (Table 1.5).
The percentage of daily smokers in Norway has decreased considerably 
from over 40% in the 1970s to 12% in 2016, which is lower than the EU 
average (Skretting, Vedøy & Lund, 2017). An additional 9% of the population 
smoke occasionally. In addition to smoking, about 16% use snus (tobacco 
snuff ) on a regular or occasional basis. The number of people engaging 
in harmful alcohol consumption is high, with 42% of survey respondents 
admitting to binge drinking at least once a month – more than double the 
EU average (Table 1.5). An estimated 10–20% of the population experience 
health problems caused by harmful consumption of alcohol and/or other 
substances in their lifetime (Amundsen, 2017). Nevertheless, the total alcohol 
consumption per adult in Norway is among the lowest in Europe.















Note: The overall number of deaths related to these risk factors (13 500) is lower than the 
sum of each one taken individually (14 200), because the same death can be attributed 
to more than one risk factor. Dietary risks include 14 components such as low fruit and 
vegetable consumption, and high sugar-sweetened beverages and salt consumption.
Sources: Institute for Health Metrics and Evaluation (2019), Global 
Health Data Exchange (estimates refer to 2017), in OECD/European 
Observatory on Health Systems and Policies (2019)
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TABLE 1.5 Morbidity and factors affecting health status (percentage respond-
ents), 2014





Chronic depression 6.9 7.1
BMI
Overweight and obesity 47.8 50.2
Obesity 12.6 15.4
Smoking Daily smokers 12.5 18.4
Alcohol Binge drinking at least once a month 41.7 14.4
Nutrition
Consumption of fruit and vegetables at least once a day 69.1 65.7
Consumption of fruit and vegetables at least five portions a day 6.5 14.3
Physical  
activity
Walking for transport 66.0 78.4
Cycling for transport 26.6 19.7
Aerobic sport 70.0 44.4
Notes: Self-reported data.
Source: European Commission (2019)
In 2007 Norway developed the national strategy to reduce social ine-
qualities in health. The strategy targeted social determinants of health, such 
as income structure, employment opportunities and affordable child-care, 
and was directed at the entire social gradient rather than just towards the 
socially disadvantaged (Norwegian Ministry of Health and Care Services, 
2007).
There are also major geographical differences in life expectancy and 
health outcomes between Norwegian municipalities and counties, with some 
of the largest differences (up to nine years) observed among the districts 
within Oslo (Norwegian Institute of Public Health, 2018). These differences 
in life expectancy can be linked to socioeconomic differences (income and 
educational levels) and they appear to persist in spite of the overall rise in 
life expectancy in Norway.
Differences in life expectancy at age 30 by education level are smaller 
than in many high-income countries and have been stable between 2007 and 
2017, and amounted to about 4 years. However, in neighbouring Sweden, 
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which has very similar life expectancy, the educational gap over the same 
period is smaller – about 3.5 years. In 2017 men aged 30 with the highest 
level of education can expect to live 4.7 years longer than men with the 
lowest level of education; the difference for women was 3.2 years (European 
Commission, 2019). Smoking prevalence is believed to be the major reason 
behind differences in life expectancy across education levels, since people 
with higher education were the first to quit smoking (Vedøy, 2018). As the 
share of daily smokers has been declining across all levels of education, it is 
expected that the gap in life expectancy will eventually decrease. However, 
the considerable lag between smoking and development of smoking-related 
diseases may contribute to the persistence of this gap for decades.
Lower educational attainment is also associated with higher infant 
mortality, lower birth weight and a higher risk of premature birth. Children 
and adolescents from lower socioeconomic backgrounds also report poorer 
health, both somatic and mental (Dahl, Bergsli & van der Wel, 2014).
Although communicable diseases are not a major cause of concern in 
Norway, the Norwegian Institute of Public Health has warned about increases 
in some infectious diseases, including sexually transmitted infections and 
those due to international travel and imported food, as well as of growth in 
anti-microbial resistance.
Dental health of young Norwegians has improved significantly over the 
past 25 years. In 2017, 81% of 5-year-olds had no decayed, missing or filled 
teeth (DMFT), while the corresponding figures for 12 and 18-year-olds 
were 60% and 26.6%. There are significant differences in the proportions of 
children with no DMFT between the counties: for 5-year-olds it is lowest 
in Oslo (73%) and highest in Aust-Agder (85%), whereas for 18-year-olds 




  Norway has a universal, nationalized health care system. The system 
is semi-decentralized: the central government is responsible for spe-
cialist care, which is delivered through four regional health authorities 
(RHAs), which own 20 hospital trusts; municipalities are responsible 
for primary care and, increasingly, for other types of care.
  The Ministry of Health and Care Services is responsible for the 
regulation and supervision of the system and ensures that health and 
social services are provided in accordance with national legislation 
and regulations. The Ministry controls the activities of its subordinate 
agencies through direct steering (in the case of national agencies), 
ownership arrangements, such as budgets and letters of instructions 
(RHAs), and legislation and financial instruments (counties and 
municipalities). The 2012 Coordination Reform established manda-
tory network governance structures encompassing hospitals and the 
municipalities to improve coordination of specialist and primary care.
  Intersectoral cooperation has been high on the agenda for more 
than a decade as a means of addressing social inequalities in health 
and to ensure a more patient-centred health service. Furthermore, 
impact on health must be considered when developing policies and 
implementing action plans in all sectors. Counties are responsible for 
intersectoral planning, and many have developed health promotion 
plans to support their municipalities in improving public health.
14 Health Systems in Transition
  Public monitoring of health system performance has become more 
readily available over the past three decades. It is used to systemati-
cally measure performance at the national as well as the international 
level and it has a clear influence on the national health policy goals.
  Empowering patients and carers continues to be a policy priority 
through comprehensive patients’ rights legislation and regulation of 
issues such as patient choice and complaint procedures. Most recently, 
children’s right to be heard as a patient, the right to confidentiality 
and shared decision-making have been strengthened.
2.1 Historical background
The present structure of the Norwegian health system was established largely 
in the second half of the twentieth century, seeing emergence of the key actors: 
MOHCS, the National Insurance Scheme (NIS), the Directorate of Health 
and the Board of Health Supervision. The health sector saw rapid expansion 
between 1950 and 1970, followed by large investments alongside the country’s 
economic growth after the discovery of petroleum resources in the North Sea 
in the 1970s. Around that time, the role of hospitals increased, with grow-
ing provision of specialist services. Between 1969 and 2002 counties were 
responsible for planning, building and managing hospitals, and from 2002 this 
responsibility was transferred to the five (at the time) RHAs. Municipalities 
became responsible for primary care in 1982, and their role gradually expanded 
to include environmental health services and providing services for older people 
and people with disabilities. In 2001 the regular GP scheme was introduced. 
By the late 2000s reform efforts were focused on coordination between the 
municipalities and the RHA, and increased attention was given to the aspects 
of quality of care and patient safety (Ringard et al, 2013).
2.2 Organization
The organizational structure of the Norwegian health care system is built 
on the principle of equal access to services for all inhabitants, regardless of 
their social or economic status and geographical location. This overarching 
goal has been a long-standing feature of the Norwegian welfare system and 
15Norway
is embedded in national health care legislation and strategic documents 
(Norwegian Ministry of Health and Care Services, 2019).
At the national level, the parliament serves as the political decision-
making body. The Office of the Auditor General is an independent agency 
that acts as the supreme audit institution and the supervisory body of the 
parliament. Its main tasks are to monitor public assets and ensure that 
these are used and administered according to sound financial principles and 
according to the decisions and intentions of the parliament. Fig. 2.1 presents 
an overview of the health system.
FIG. 2.1 Overview of the health system
Parliament Subordinate agencies
• Directorate of Health 
 (incl. Helfo* and POBO**)
• Directorate of eHealth (NDE)
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• Norwegian Food Safety 
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• Radiation Protection Agency
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 Services
• System of Patient Injury 
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 Investigation Board
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• The Wine Monopoly
• The Health Net trust
• Regional Health Authorities 
 (RHAs)
Government
Ministry of Labour and Social Affairs

















Health care providers 
Regulatory relationshipHierarchical relationship
Ministry of Health and Care Services
Municipalities
Notes : * Helfo = Health Economics Administration; ** POBO = Health and Social Services Ombudsmen.
Source : Authors
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Health care is organized at three main levels: national, Regional Health 
Authorities (RHAs), and municipalities. The system is regulated through 
a large number of Acts and secondary legislation, broadly reflecting the 
decentralized nature of the health care system (see also Table 2.1 and 
Section 2.3).
At the national level, the government decides on general national prior-
ities and proposes legislation and the national budget, which is subsequently 
discussed by the parliament. The parliament adopts the annual national 
budget, proposed by the Ministry of Finance. The Standing Committee on 
Health and Care Services within the parliament is responsible for matters 
relating to health care and social care services, public health, drug and alcohol 
policy, and pharmaceuticals.
The Ministry of Health and Care Services (MOHCS) determines 
the national health policy, prepares and oversees legislation and implements 
national health policy with the help of the Directorate of Health and other 
subordinate institutions (see Table 2.1). The Board of Health Supervision 
(Board of Health hereafter) is responsible for the supervision of health and 
social services at national and local levels; it receives instructions from the 
MOHCS and is assisted in its supervisory role by County Medical Officers 
(fylkeslegen) stationed in the counties. The MOHCS also has administrative 
responsibility for a number of other subordinate agencies (see Fig. 2.1 and 
Table 2.1). The MOHCS is the owner of the RHAs, which in turn own 
the hospital trusts; the MOHCS has direct responsibility for the provision 
of specialist care. It is also responsible for overseeing the provision of all 
other types of care and their coordination. Further, the MOHCS owns the 
Norwegian Health Net trust which is responsible for provision of secure 
electronic exchange of patient information via a health communication 
network between all relevant parties within the health and social services 
sectors (see Section 4.1). The Directorate of e-Health within the ministry 
has the overall responsibility for digitalization of the health care sector. The 
MOHCS is also the owner of the Wine Monopoly, which is the only com-
pany in Norway allowed to sell alcoholic beverages with alcohol content of 
more than 4.75%.
The RHAs are owned by the MOHCS and are responsible for the 
provision of specialized care, including both somatic and mental health 
care, special care for persons with drug and alcohol addictions, as well 
as other specialized medical services, such as laboratory, radiology and 
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TABLE 2.1 Agencies subordinate to the Ministry of Health and Care Services
NAME OF AGENCY KEY RESPONSIBILITIES
Directorate 
of Health
 • Implements national health policy through integrated and targeted activities across services, 
sectors and administrative levels, including preparing ordinances, national guidelines and 
campaigns.
 • Advises central authorities, municipalities, RHAs and the voluntary sector.
 • Grants authorizations and licences for all categories of health personnel (since 2016 the 
Norwegian Regulatory Authority for Health personnel (SAK) has been integrated into the 
Directorate).
 • The Health Economics Administration (Helfo) (subordinate agency) is responsible for 
administering the health part of the National Health Insurance (NIS) scheme and direct 
payments to various health service providers, individual reimbursement for certain medicines, 
dental services and health services abroad. Helfo is also in charge of the regular GP scheme 
(fastlege) and issuing the European Health Insurance Card (EHIC).
 • The Health and Social Services Ombudsmen (POBO) (affiliated agency) are located in all 
counties to assist patients and clients who do not get the help or treatment they need. POBO 
is legally and administratively connected to the Directorate of Health but acts independently.
Directorate 
of e-Health
 • Since its establishment in 2016 it implements the national policy on e-Health, establishes 
the requisite standards, and administers the use of e-Health methodology nationwide.
Board of Health 
Supervision
 • Provides general supervision of health and social services at national and local levels (through 
Offices of the County Governors).
 • Monitors the population’s health and social services needs.
Norwegian 
Institute of Public 
Health (NIPH)
 • Provides monitoring, expertise and research in the areas of epidemiology, infectious disease 
control, environment (e.g. air quality) and health services. The Norwegian Knowledge Centre 
for Health Services has been part of the NIPH since 2016.
The Complaint 
Body for Health 
Services
 • This body, established in 2016, acts as secretariat for the NPE (see next item), as well as 
for other complaints related to health services.
 • Provides an independent assessment of complaints for health care users whose claim has 






 • Handles compensation claims for health care users who have sustained an injury while 
receiving health care services.
 • Collects and collates data on such injuries to support quality improvement and injury 
prevention.






 • Since its establishment in 2019 it investigates adverse events and other cases of serious 




 • In charge of granting marketing authorizations, classification, vigilance, pricing, reimbursement 
and providing information on medicines to prescribers and the public.
 • Since 2018 it has also been the competent body for medical devices, having taken over this 
role from the Directorate of Health.
Norwegian Food 
Safety Authority
 • Monitors food safety as well as plant, fish and animal health; advises government ministries 




 • Evaluates the social and ethical consequences of modern biotechnology and supports usage 





 • Monitors the use of radioactive substances and fissile material.
 • Coordinates contingency plans against nuclear accidents and radioactive fallout.
 • Monitors natural and artificial radiation in the environment and workplace.
 • Assists all ministries on matters related to radiation protection and nuclear safety.
Source: Authors
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ambulatory services. The RHAs also participate in research and medical 
education. There are four RHAs in Norway: Northern Norway (Helse 
Nord), Central Norway (Helse Midt Norge), Western Norway (Helse 
Vest) and South-Eastern Norway (Helse Sør-Øst). The latter is the largest 
RHA and covers approximately 56% of the population and consumes 
54% of the total RHAs budget (Statistics Norway, 2019). The RHAs are 
owners of the health trusts (see Section 4.1); there are currently 28 health 
trusts, of which 20 are hospital trusts. In addition, the RHAs have joint 
ownership of the following health trusts: Procurement Services Health 
Trust, National Air Ambulance Services Health Trust, Patient Travel 
Health Trust, EmergencyNet Health Trust, and the National IT Health 
Trust, as well as an Agency for Hospital Construction. The RHAs are 
also responsible for the ‘New Methods’ system for introducing health 
technologies (see Box 2.1 and Section 2.4). The RHAs and the health 
trusts are independent legal entities with governing bodies at regional 
and local levels.
In the counties, the county municipality (fylkeskommune) with an elected 
county council (fylkesting) is responsible mainly for secondary education, 
public transport, regional road planning, culture, etc. The county governor 
(fylkesmannen) is an authority acting on behalf of the Norwegian government 
and is responsible for monitoring the decisions, objectives and guidelines 
set out by the parliament and government and their implementation by 
the municipalities. They also serve as an administrative appeal body for the 
municipal decisions, including those concerning health services. In the area 
of health care, the responsibilities of counties have increasingly included 
coordination of care and provision of public health services (see Sections 
5.2 and 5.1). In addition, counties are also responsible for safeguarding 
patients’ access to health and care services through the Ombudsman service 
(POBO). The counties’ role in the provision of curative health care services 
is limited to dental care.
Municipalities are responsible for the provision and financing of 
primary care, including rehabilitation, physiotherapy and nursing, and 
after-hours emergency services (see Chapter 5). They are also responsible 
for a wide range of public health and preventive measures, as well as the 
provision of local emergency care beds for patients with a need for pre- 
or post-hospital services. Some responsibilities over these services have 
been retained at the central level, mainly to maintain equal access. For 
19Norway
example, all decisions regarding GP funding continue to be determined 
by the central government (see Section 3.7.2). The government in power 
since 2017 has a stated objective for the municipalities to deliver a larger 
proportion of health care services, with the goal of bringing care closer 
to the patient, and to strengthen public health efforts and preventive 
services (Political platform for the Norwegian Government, formed by 
the Conservative Party, the Progress Party and the Liberal Party (The 
Jeløya-platform), 2018).
Health care providers are associated in three organizations: Spekter, 
Virke and the Norwegian Association of Local and Regional Authorities. 
Within health care, Spekter represents both public and private hospitals. 
Together with the trade unions, it plays an important role in the national 
salary negotiations for employees (see Section 3.7.2). Spekter also participates 
in the development of the legal framework regulating general employment 
conditions. Virke (Enterprise Federation of Norway) represents not-for-
profit organizations within health care, as well as pharmacies and several of 
the private rehabilitation centres. The Norwegian Association of Local and 
Regional Authorities is the only employers’ association for the municipali-
ties and counties. Its main tasks are to advocate the interests of its members 
to the central government (including collective bargaining), parliament, 
labour and other organizations; to advise and inform its members about 
all matters and developments of importance to local government; and to 
facilitate the exchange of experience between its members. Since 2006 all 
municipalities and counties, as well as approximately 500 public enterprises, 
have been members.
The private health care sector is relatively small but well regulated. At 
the level of primary care the majority of GPs are self-employed, even though 
they are fully embedded in the public system through contracts with the 
municipalities (see Section 5.3). Private for-profit providers play a smaller 
role in the provision of specialist care, accounting for about 10% of the total 
operating cost for somatic services and 13% of mental health care, plus nearly 
37% for substance abuse services and about 11% of nursing beds (Statistics 
Norway, 2019a). Not-for-profit provision also includes private for-profit 
hospitals and hospitals set up as foundations that are financed from and 
seen as an integral part of public health services, e.g. the Diaconal hospital 
foundation in Oslo, which is owned by the Norwegian Church. Private for-
profit hospitals receive most of their funding from the state (on average 76% 
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of their total budgets), whereas this share is 96% for private not-for-profit 
hospitals (Statistics Norway, 2019a).
Among other state actors, the Ministry of Labour is involved in the 
health care system, mainly through the Labour and Welfare Administration 
(NAV), which administers different benefit schemes within the National 
Insurance Scheme (NIS), such as sick leave and disability benefits. It is also 
responsible for implementation of the Working Environment Act (2008), 
which ensures safe working conditions and equal treatment among workers, 
and creates a health-promoting environment at workplaces. A number of 
other ministries are also involved in issues of relevance to the health care 
system. For example, the Ministry of Education is involved through plan-
ning of the health workforce and provision of health education (see Section 
2.5); the Ministry of Finance is involved through taxation and budgeting. 
The overall responsibility for the information and communication technol-
ogy (ICT) strategy for the public sector lies with the Ministry of Local 
Government and Modernization.
2.3 Decentralization and centralization
Scandinavian health care systems are often characterized as being run 
according to a decentralized national health service (NHS) model; fund-
ing is predominantly raised by taxation and the main actors are public 
(Magnussen, Vrangbaek & Saltman, 2009). In Norway municipal gov-
ernments play an important role in the allocation of resources and the 
provision of primary and ambulatory care. While in the second part of 
the twentieth century much power was devolved from the central to the 
municipal level, both decentralization and centralization tendencies could 
be observed in the 2000s (Magnussen & Martinussen, 2013; Ringard et 
al., 2013).
In recent years increasing responsibility for health care and social care has 
been shifted from the state and counties to the municipalities (see Section 
6.1). At the same time the 2012 coordination reform established mandatory 
network governance structures encompassing hospitals and the municipal-
ities, in order to better coordinate specialist and primary care (Torjesen & 
Vabo, 2014). Centralization tendencies are also visible in the areas of quality 
monitoring and setting performance standards.
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2.4 Planning
The MOHCS has the main responsibility for health policy and for some 
aspects of social security policy. It fulfils this responsibility by means of 
legislation, annual budgetary allocations to the RHAs, a yearly letter of 
instruction to the RHAs, and through various governmental institutions. 
Whenever relevant, EU regulations are taken into account. Efforts to develop 
a systematic approach to setting policy priorities in health care have been 
longstanding and can be linked to the fundamental goals of ensuring equal 
access to health care services to the entire population, irrespective of their 
socioeconomic and other characteristics (Box 2.1). The Public Health Act 
(2011) requires local authorities to have an overview of health conditions 
and influencing factors. The NIPH has developed ‘public health profiles’ 
in order to help them identify and monitor areas for improvement in each 
region/municipality (see Section 7.1).
The National Health Plans are the key strategic planning tools in the 
health care sector. Their planning horizon is normally four years, which is 
longer than the planning horizon of the annual health care budget. The 
latest plan was published in 2016 (see Section 7.1). They are developed 
by the MOHCS and present the current status of the health care system, 
including the key challenges, and suggest policy goals and measures aimed 
at meeting them (Ringard et al., 2013). As broad policy statements, these 
Plans are not formally evaluated.
The MOHCS is responsible for the planning of human resources for 
health (see Section 4.2). In addition, hospital trusts and municipalities have a 
responsibility to plan, recruit and retain human resources. The MOHCS pro-
vides input regarding personnel and skill needs to the Ministry of Education, 
which is responsible for determining the educational capacity for different 
health personnel groups.
The overall responsibility for the planning of infrastructure and capital 
investment in public health care providers lies with the RHAs for specialist 
care and with the municipalities for primary care. Both the RHAs and the 
municipalities have a wide authority to plan their own infrastructure. RHAs 
have to consult the MOHCS for major investments in infrastructure (e.g. the 
building of new hospitals) (see Section 4.1). In 2015 the RHAs established 
the Agency for Hospital Construction (Sykehusbygg HF) providing expertise 
for planning of hospital infrastructure to all hospital trusts.
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BOX 2.1 Evaluating priority setting and planning
Five government commissions have evaluated the principles for priority setting 
in the health care sector over the last 30 years, most recently in 2018 with the 
first evaluation report targeting prioritization principles for municipal health and 
care services and publicly funded dental health services (Norwegian Ministry of 
Health and Care Services, 2018). The report concluded that the existing principles 
for priority setting in specialist care (presented below) were suited for municipal 
services, but should incorporate assessment of individual patients’ physical, 
psychological and social functioning.
The following three principles are set as the foundation of priority-setting in 
the health and care sector (Norwegian Ministry of Health and Care Services, 
2016b):
1. The health-benefit criterion: the priority of an intervention increases with 
the expected health benefit (and other relevant welfare benefits) from the 
intervention. The expected benefit of an intervention is assessed through 
knowledge-based practice that indicates that the medical intervention 
will extend the patient’s life and/or enhance the patient’s quality of life 
by increasing the likelihood of: survival or reduced loss of function; 
improvement of physical or mental function; reduction of pain, physical 
or mental distress.
2. The resource criterion: the fewer resources an intervention requires, the 
greater the priority of this intervention.
3. The severity criterion: the priority of an intervention increases in keeping 
with the severity of the condition. The severity of the condition is to be 
assessed on the basis of: risk of death or loss of function; the degree of 
loss of physical and/or mental function; pain, physical or mental distress.
Between 2002 and 2017 the National Council for Priority Setting in Health Care 
advised the government on public health issues and on issues of relevance to 
the health system as a whole. The objective of the Council was to contribute to 
a more comprehensive approach to priority setting in health and care services. 
The Council contributed to a shared understanding of the current situation and 
problems among key actors within the health and care services. The Council 
recommended establishing a National System for the Managed Introduction of 
New Health Technologies (‘New Methods’) within the Specialist Health Service 
in Norway (see Section 2.7.3). The ‘New Methods’ system was established in 
2013 with a public mandate to recommend and decide on the introduction of new 
health technologies in Norway.
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STATED OBJECTIVES OF THE HEALTH SYSTEM
The objectives of the Norwegian health care system are embedded in the 
national legislation and in various strategy documents. Health care coverage 
is universal, and health care services are expected to be of high quality and 
the same for all. The goal of ensuring “equal access to health care of good 
quality” is explicitly stated in the 1999 Patients’ Rights Act. Access to ser-
vice should be according to health needs, with equal access for equal needs, 
regardless of gender, social and economic background, and geographical 
location. The principle of equality of access is supplemented by three other 
principles, giving priority to: (1) those in greater health need (i.e. according 
to the severity of medical condition); (2) interventions that are likely to lead 
to health improvement; and (3) interventions where the ratio between the 
expected benefit and cost is reasonable (i.e. the intervention is considered 
to be cost-effective) (Bringedal, 2005; Patients’ Rights Act 1999; Ringard 
et al., 2013).
The key policy documents for the period 2013–2018 are the National 
Health Plan for the period 2011–2015 and the current National Health and 
Hospital Plan for the period 2016–2019. The key goals of the National Health 
Plan 2011–2015 were to increase QALYs and reduce social inequalities in 
health. The National Health and Hospital Plan 2016–2019 has seven main 
goals, including strengthening mental health care, improving the skill-mix 
of health professionals and coordination of services (see Table 6.1).
2.5 Intersectorality
Historically, there have been no direct mechanisms to ensure that health is 
taken into account by ministries other than the MOHCS. This changed with 
the introduction of the Public Health Act in 2011, in which the ‘Health in 
All Policies’ approach featured prominently. In line with this approach, impact 
on health must now be considered when developing policies and imple-
menting action plans in all sectors, and counties have a special responsibility 
for intersectoral planning. Even though the counties are not mandated to 
develop health promotion plans, many counties have done so and the role 
of supporting the municipalities in their planning process is regarded as an 
important priority for the counties (Fosse & Helgesen, 2017). The role of 
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the counties is also to act as public health coordinators and advocates for 
the municipalities (see Section 6.1.5).
Over the years national strategies and national action plans encom-
passing more than one policy area have become increasingly important. 
These are developed through cooperation and coordination between the 
ministries, with each involved ministry subsequently given the respon-
sibility for implementing and monitoring a specific part of the plan. A 
recent example of this is the National Action Plan on Better Nutrition 
2017–2021, which is the result of cooperation among seven ministries 
(Norwegian Ministries, 2017).
The mandate of the Norwegian Directorate for Civil Protection is 
to maintain a complete overview of various risks and vulnerabilities to 
the country’s population in general and report to the Ministry of Justice 
and Public Security. This includes local, regional and national prepared-
ness and emergency planning, fire safety, electrical safety, handling and 
transport of hazardous substances, as well as product and consumer safety. 
Generic guidelines for emergency preparedness for all sectors, as well 
as sector-specific risk assessment, including on access to pharmaceuti-
cals in Norway, have been published (Norwegian Directorate for Civil 
Protection (DSB), 2018). Other ministries that play a role in population 
health are: the Ministry of Agriculture and Food (through policies and 
measures related to food and water safety); the Ministry of Climate 
and Environment; and the Ministry of Transport and Communication, 
which has overall responsibility for transport policies, which also includes 
road safety.
2.6 Health information systems
Norwegian health registries contain various types of health data for various 
purposes. The increasing amount of data availability has led to a reform of 
the legal framework and organization of health registries. The 2014 Act on 
the Personal Health Data Registries distinguishes between consent-based 
registries, mandatory registries where patients can opt out, and statutory 
registries which do not require consent. The purpose of these registries is to 
provide current, reliable and secure information about the population’s health 
and the quality of health care. Information from these registers is analysed 
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TABLE 2.2 Overview of the statutory and mandatory health registries, December 2019
HEALTH REGISTRY YEAR ESTABLISHED
BODIES RESPONSIBLE FOR 
COLLECTION AND ANALYSIS TYPES OF DATA
Statutory (containing identifiable data)
Cause of Death Registry 1925/1951 NIPH (collection);Statistics Norway (analysis) All deaths as reported in death certificates










Vaccinations in the childhood 
immunization programme
Registry of the Armed 
Forces Medical Services 2005
Ministry of Defence 
(collection); Armed Forces 
Medical Services (analysis)
Health information on personnel 
serving in the armed forces
Cardiovascular 
Disease Registry 2010 NIPH
Inpatient and outpatient visits for 
patients with cardiovascular diseases
Cancer Registry 1952
South-Eastern RHA 
(collection); Cancer Registry 
of Norway (analysis)
Information on all patients 
with cancer diagnoses
Patient Registry (NPR) 1997/2007 Directorate of Health Information on all inpatient and outpatient care, and substance abuse treatment
Municipal Patient and 
User Registry (KPR) 2017 Directorate of Health
Information on patient contacts 
with primary care and costs
System for adverse event 
reporting for pharmacology Norwegian Medicines Agency Awaiting enactment (2019)
Mandatory registries (containing anonymized data)
Surveillance System 




University Hospital North 
Norway (analysis)
Data about antibiotic resistance 
of microbe isolates
Surveillance System for 
Infections in Hospitals (NOIS) 2005 NIPH




Data on prescribed drug use 
in humans and animals
Information System 
for the Nursing and 
Care Sector (IPLOS)
2006
Directorate of Health 
(collection); Statistics 
Norway (analysis)
Patient information (about received care) 
from local nursing and care services
e-Prescription 2008
Directorate of Health 
(collection); Ergo 
Group (analysis)
Electronic prescriptions from 
doctors to pharmacies
Registry of Pregnancy 
Termination 1979/2007 NIPH All hospital-induced abortions
Genetic screening 
of newborns 2012 Oslo University Hospital
All samples collected for newborn 
screening are stored
Surveillance System for 
Virus Resistance (RAVN) 2014 NIPH
Monitoring viral resistance for influenza, 
HIV, CMV, HSV and Hepatitis B
Sources: Norwegian Institute of Public Health website (www.fhi.no) and the websites of individual registries.
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and published as part of public statistics. Table 2.2 provides an overview 
of the registries and bodies responsible for data collection and analysis. 
In general, data in these registers are considered to be of high quality 
(Norwegian Institute of Public Health, 2016; Office of the Auditor General 
of Norway, 2018). In 2019 there were ten statutory registries and eight 
mandatory registries with anonymized patient data.
In addition to the above-mentioned health registries, there are 54 
national medical quality registries. The Centre for Clinical Documentation 
and Evaluation in Tromsø has been a national support centre for the medical 
quality registries since 2009. These registries can be initiated by individuals, 
hospitals or educational institutions, and contain comprehensive informa-
tion for assessing the effects of different treatments and for benchmarking 
efficiency at the level of hospital wards. They may also be used for quality 
assurance, research and service improvement. With support from the RHAs, 
a medical quality registry may be turned into a national quality registry. The 
RHAs are responsible for funding and managing national quality registries, 
and the four RHAs have the final say on which registries may be imple-
mented at the national level.
In 2014 the infrastructure project “Health registries for research” 
(2014–2019) was implemented to support health care research. The project 
is funded by the Research Council of Norway and includes the establish-
ment of a research documentation service that provides methodology and 
metadata from the health registries, as well as a statistical support service. 
The project enhances data security by facilitating the use of secure servers 
for storage and analysis of research data (HRR metadatabase for Nasjonale 
Helseregistre, 2019). In 2017 the Directorate for e-Health established the 
National Health Data Programme, which aims to improve availability of 
health data for quality improvement, health monitoring, management and 
research. Users include government agencies, researchers, and health care 
professionals, as well as residents. The Health Registries for Research project 
and the National Health Data Programme may be seen as national initiatives 
aimed at facilitating the use of existing data for health care improvement, 
monitoring, management and research purposes.
An audit of the existing health and quality registries, undertaken by 
the Office of the Auditor General in 2017, revealed severe shortcomings in 
how some of the quality registries are managed, including incompleteness 
of data, and lacking and/or unpublished information. Of the 54 national 
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medical quality registries, fewer than a third had country-wide coverage. 
Fifteen years after the initial mapping of medical quality registries there are 
still medical areas that are not covered, such as epilepsy, mental health and 
substance abuse (Office of the Auditor General of Norway, 2018; Saunes 
& Danielsen, 2005). The recommendations from the audit called for the 
establishment of performance management and monitoring mechanisms 
and for strengthening of the registers’ frameworks to promote their effective 
functioning. In addition, the RHAs need to ensure cross-regional cooperation 
in the area of medical quality registries.
Another challenge is posed by the lack of linkages between Statistics 
Norway and the health registries for purposes such as quality improvement, 
management or planning. According to the legislation in place (Statistics Act, 
1989), it is only possible to link data for research purposes. So, for example, 
information about social inequalities can be linked with health data from the 
registries for research purposes but not for planning purposes. However, the 
Statistics Act has been under public consultation in 2019 and its amended 
version may address data linkage problems.
MONITORING HEALTH SYSTEM PERFORMANCE
Statistics Norway has been monitoring the provision of hospital care and 
health status in the population since 1856 with indicators including number 
of patients treated, length of stay, bed occupancy rate and cause of death 
(Bore, 2007). A century later, the Cancer Registry of Norway was the first of 
the disease-based registries to monitor health outcomes and quality of care 
in detail for cancer patients. Public reporting on hospital resources started 
in 1989 and became systematic a decade later, while reporting on patient 
experiences and mortality after hospitalization started in 1997 (Guldvog & 
Kopjar, 1999). A new database with comparative data on health and social 
care services at the municipality level (KOSTRA) was established in 2018. 
Municipalities, health trusts and state agencies all provide data to Statistics 
Norway.
The Directorate of Health (see Table 2.1) is responsible for the devel-
opment, maintenance and dissemination of the results from the National 
Quality Indicator System (NQIS), which was introduced in 2014. The 
system serves several purposes: to support health care users and their next 
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of kin in making informed choices about health care providers; to inform 
the public about the quality of health care services; and to generate data 
to support management and quality improvement in health care. The 
Directorate of Health also publishes annual SAMDATA reports – a col-
lection of comparative statistics and performance indicators for hospital 
trusts containing information on specialist care, including mental health 
care (since 2017 also at municipality level). The MOHCS can also instruct 
the RHAs to provide indicators in order to monitor new policy initiatives. 
All indicators are published as part of the NQIS. In addition, the NIPH 
governs ten statutory central health registries (see Table 2.2) and collects 
quality indicators for the Directorate of Health. It also produces annual 
national overviews of population health and county- as well as municipal-
level health profiles.
The Research Council of Norway (under the Ministry of Education) 
administers research-based evaluations of political initiatives and reforms. 
The evaluations are not mandatory but are designed to create a knowledge 
base derived from the experience gained from politically initiated reforms and 
schemes. Ongoing evaluations include the free choice of provider treatment 
reform (2017–2020) and cancer patient pathways (2017–2020).
2.7 Regulation
2.7.1 Regulation and governance of third-party payers
The key third-party payer in the Norwegian health care system is the National 
Insurance Scheme (NIS). The NIS is financed by contributions from employ-
ees, self-employed persons and other members, employers’ contributions and 
contributions from the state. As a general rule, all residents of Norway are 
members of the NIS. NIS covers a wide range of social benefits and pensions, 
as well as health services (see Section 3.2). Since 2009 the health care part 
of the NIS budget has been under the responsibility of the MOHCS. The 
NIS is regulated by the National Insurance Act (1997), and reimbursements 
for health services are managed by the Helfo in the Directorate of Health 
(see Table 2.1).
Other third-party payers are the providers of voluntary health insurance 
(VHI). The activity of private for-profit VHI providers is regulated in the 
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general insurance legislation, with the current law dating from 2005. For 
more information on VHI, see Section 3.5.
2.7.2 Regulation and governance of provision
REGULATION
The Board of Health together with the County Governors are supervision 
authorities. They conduct surveillance, which provides a general picture 
of the quality of services, as well as system audits, and also react on infor-
mation on possible deficiencies in services. The Board of Health can give 
warnings or withdrawal of authorization (if relevant) against health care 
personnel. All statutory services are subject to supervision (municipalities, 
private providers, publicly owned hospitals or health care personnel with 
private practice). In 2017 the parliament adopted a Supervision of Health 
Services Act, thus collecting all regulations on health supervision (at all 
levels, including municipal care) into one legislative act. The Act has partly 
been enacted as of July 2019.
The municipalities have a great deal of freedom in organising health 
services without a direct command and control line from the central author-
ities (Norwegian Ministry of Health and Care Services, 2015b). However, 
this freedom has been challenged by an increasing amount of regulations 
on how these services should be delivered (see Section 6.1). The main task 
of the central government is to ensure the high quality of services across 
the municipalities through funding arrangements and legislation, such as 
through the Municipal Health and Care Act (2011). Each municipality must 
ensure that services are provided in a coordinated manner and that health 
care personnel have the necessary competences.
Hospitals and specialist care, organized at the level of the RHAs, are reg-
ulated mainly by the Specialist Care Act (1999) and the Health Authorities 
and Health Trusts Act (2001). The MOHCS annually provides instructions 
to the four RHAs, containing RHA-specific tasks and requirements. For 
example, the 2018 annual letter of instruction to the South-Eastern RHA 
contains information on the total budget placed at its disposal and some 
notes on specific uses of this allocation, including comments on the areas of 
services the MOHCS would like the RHA to focus more on in the coming 
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year (e.g. waiting times, mental health, substance abuse and quality and 
patient safety).
Certain areas of care that span across organizational levels are regulated 
by separate legislation, for example, the Mental Care Act (1999) and the 
Public Health Act (2011). Other key pieces of legislation are the Patients’ 
Rights Act (1999) and the National Insurance Act (1997). The latter reg-
ulates financing and entitlement to certain non-medical benefits, such as 
rehabilitation, and benefits received in case of sickness, maternity, disability 
or occupational injury.
RHAs, hospitals, municipal providers and private practitioners are 
themselves responsible for ensuring the quality of their services. There is no 
requirement for provider accreditation or reaccreditation, although some 
hospitals or hospital departments are accredited (see below).
The Specialist Care Act (1999) states that every hospital must have a 
quality assurance commission as part of its mandated system of internal 
control. The Municipal Health and Care Act (2011) includes a similar 
requirement for primary health care providers. Systematic quality assurance 
is a legal requirement for all institutions providing health and care services 
in Norway (Norwegian Ministry of Health and Care Services, 2016a) and 
supervision of providers is increasingly targeted at establishing whether 
systems of internal control have been implemented and are functional. The 
Board of Health is responsible for the Reporting System for Serious Adverse 
Events, which previously applied only to the specialized health services, but 
since the enactment of the Supervision of Health Services Act in 2019 it 
also applies to municipal health care services, as well as to dental care and 
all privately provided health care services.
From 2012 to mid-2019 the Directorate of Health operated the National 
Reporting and Learning System (NRLS), which collected reports from hos-
pitals and other providers of specialized care (private and public) on serious 
medical events (e.g. unexpected deaths), as well as events that could have 
resulted in patient harm (i.e. near misses) caused by the delivery of health 
care or where injury was inflicted on one patient by another. The NRLS was 
discontinued in May 2019 (see Section 7.6). Since then, the Norwegian 
Health Care Investigation Board has been established to investigate adverse 
events (see Table 2.1).
The Municipal Health and Care Act (2011) gave the Directorate of 
Health sole responsibility to develop, disseminate and maintain national 
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clinical guidelines. These guidelines provide normative guidance but are 
not legally binding. There are currently 400 guidelines for GPs, local health 
centres, nursing homes, hospitals, etc. (for very specific interventions). These 
are distributed to health care personnel in print and are also available online 
via the Electronic Health Library. The RHAs, municipalities and managers 
of health care institutions are responsible for facilitating the implementation 
of national guidelines.
QUALITY
In 2017 the Regulation on internal control in health services was replaced 
with the Regulation on leadership and quality improvement in the health 
services and obligated the Directorate of Health to “work systematically with 
quality-improvement and patient- and clients safety in all services”, and to 
ensure documentation of planning, implementation, evaluation and corrective 
measures taken to improve quality and patient safety. These changes are also 
reflected in the new Action Plan for Patient Safety and Quality Improvement 
2019–2023 (Norwegian Directorate of Health, 2019a).
2.7.3 Regulation of services and goods
BASIC BENEFIT PACKAGE
The scope of the statutory coverage is determined by parliament as part of the 
public budget approval process (see Section 3.3). Municipal authorities are 
responsible for providing health care and social care services at the municipal 
level. They assess needs and determine access to services. All residents are 
entitled to essential medical and care services. This entitlement is included 
in the legislation of the Patients’ Rights Act of 1999, the Municipal Health 
and Care Act of 2011, and the Specialist Care Act of 1999, as well as the 
National Insurance Act of 1997. There is no positive list of services covered 
by the statutory system; access is based on need, according to the principles of 
prioritizing (see Box 2.1). Decisions on public coverage of specialist services 
are informed by health technology assessment (see below).
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TABLE 2.3 Overview of the regulation of providers
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A system for health technology assessment (HTA) was originally established 
in 1998 and NIPH hass been responsible for it since 2016. Initially, the goal of 
HTA was to assess the clinical effectiveness of new medical technologies for 
clinicians. With rising health expenditure, the importance of cost–effectiveness 
analysis increased and the user base of HTAs has expanded from clinicians to 
managers. Evidence-based policy-making has also been embraced at national 
level and in 2013 the National System for the Managed Introduction of New 
Health Technologies, the so-called ‘New Methods’ system*, was established 
within the specialist health service. It is based on a broad cooperation between 
multiple agencies: the four RHAs, the Procurement Services for the RHAs, 
the Directorate of Health, NIPH, NoMA and the Norwegian Radiation 
and Nuclear Safety Authority. A broader stakeholder group was established 
to support further development of the system. The secretariat was initially 
based at the Directorate of Health to coordinate the cooperation internally 
and externally, to build a website with information on all commissions and 
deliveries from the system, to monitor the introduction of new technologies 
and to promote the development and consolidation of the system. In 2018 the 
ownership of the system was transferred from the MOHCS to the RHAs.
The ‘New Methods’ system has two levels: a national level where decisions 
are made jointly by the RHAs based on single or full HTAs prepared by the 
NoMA and the NIPH, and a local (i.e. hospital) level, where decisions are 
made based on rapid/mini HTAs performed in a single hospital. The level of 
assessment depends on the type of technology and its intended authorized 
area of use. For example, certain technologies, such as medicines, are always 
assessed at the national level. Single HTAs focus on one health technology 
whereas full HTAs may be used to compare various technologies that have 
been used in clinical practice for some time. The aim of rapid/mini HTA 
reports is to ensure that patients have fast access to new and effective hos-
pital treatments and that treatments that are ineffective or dangerous can be 
quickly discontinued. Since late 2015, in order to optimize the introduction 
of new technologies, single HTAs have been conducted for all new drugs 
and indications and HTA reports are thus available soon after a marketing 
authorization has been granted.
* Information on the ‘New methods’ is based on https://nyemetoder.no/english.
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Proposals for assessments can be submitted by specialist health care pro-
viders, patients and patient organizations, industry, authorities and the general 
public. In addition, horizon scanning reports can identify new technologies 
for assessment. Submitted national-level HTA proposals are discussed and 
prioritised by a Commissioning Forum (Bestillerforum) consisting of the four 
medical directors (one from each RHA) and two delegates from the Directorate 
of Health, based on submitted proposals and horizon scanning reports. Further, 
each hospital has procedures for selecting technologies for rapid/mini HTAs; 
the HTA results are public and the RHAs jointly decide which technologies to 
introduce. After a single HTA has been completed, the Procurement Services 
health trust (Sykehusinnkjøp HF) conducts negotiations. Subsequently, a 
Decision Forum comprised of the four CEOs (one from each RHA) makes 
decisions in consensus whether to introduce the technology or not. If the 
technology is of relevance for the national clinical guidelines developed by the 
Directorate of Health, the guidelines will have to be updated.
From the system’s introduction in 2014 to May 2019, 166 decisions on 
pharmaceutical and 30 decisions on other medical technologies have been 
made (Fig. 2.2). Even though there is no formal cost/effectiveness threshold, 
there is a de facto upper limit* of cost/quality assessment that is used.









































Note: *From January until May 2019.
Source: Personal communication with the secretariat for the National System 
for the Managed Introduction of New Health Technologies
* A review of decisions estimated a limit of NKr6–700 000 NKr (€60–70 000) per year of good 
health (Meld. St. 34 (2015–2016) (https://tidsskriftet.no/2017/10/aktuelt-i-foreningen/onsker-
apenhet-om-helsekostnader). An overview of all methods and status for decision is available at 
https://nyemetoder.no/metoder. 
35Norway
2.7.4 Regulation and governance of pharmaceuticals
REGULATION OF PHARMACEUTICALS
The MOHCS is responsible for the management and supervision of the 
production, import and distribution of medicines, with a particular emphasis 
on legislative and financial measures, including the reimbursement scheme 
for patients with medical expenses above a certain limit (see Section 3.4).
NoMA is in charge of marketing authorization, classification, pharma-
covigilance, pricing, reimbursement and providing information on medicines 
to prescribers and the public (see Section 5.6). Since Norway is a member of 
the EEA, the regulation of pharmaceuticals is harmonized with the relevant 
EU regulations.
Pharmaceutical companies must apply for a marketing authorization 
in order to sell their products on the Norwegian market, and the system is 
aligned with the European Medicines Agency’s process. There are four pro-
cedures that may be used when applying for a marketing authorization: the 
national procedure; mutual recognition procedure; decentralized procedure; 
or centralized procedure. Within the national procedure, the application is 
filed with the NoMA and must contain information on the quality, safety 
and (medical) efficacy of the product. A marketing authorization will not 
be issued if the potential risks associated with using a product outweigh 
its potential benefits. Since 2012 the total time schedule for the national 
procedure has been harmonized with the decentralized procedure and is 
set at 210 calendar days (excluding ‘clock stops’). Authorization is valid for 
five years.
After market access has been granted within the national procedure, 
the applicant may apply, through the mutual recognition procedure, for the 
national authorization to be recognized in other EEA member states. The 
applicant may choose to seek authorization separately from all member 
states (decentralized procedure) or apply directly to the European Medicines 
Agency (centralized procedure).
The NoMA is responsible for the monitoring of adverse reactions of 
all medicinal products used in Norway. It also contributes to the European 
Medicines Agency’s Pharmacovigilance Risk Assessment Committee 
(PRAC). A pharmaceutical company that markets medicines in Norway (i.e. 
the marketing authorization holder, MAH) has the primary responsibility 
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over the efficacy and safety of their medicinal products, and must ensure that 
it has an appropriate system of pharmacovigilance and risk management in 
place for those products. In order to fulfil these requirements, the MAH 
must ensure that all information relevant to assessing the potential risks and 
benefits of their products is periodically reported to the authorities through 
periodic safety update reports (PSURs) and continuously through expedited 
reporting of individual case safety reports (ICSRs). According to the 1992 
Medicinal Products Act, physicians and dentists must also report adverse 
drug reactions to the NoMA. In 2017 the NoMa established a new national 
pharmacovigilance database, VigiNor. This database is compatible with the 
EudraVigilance system of the European Medicines Agency.
Norway is a signatory of the 1994 Agreement on Trade-Related Aspects 
of Intellectual Property Rights (TRIPS), which regulates pharmaceuti-
cal patent protection between signatory countries. Patent protection is 
normally granted for 20 years in Norway, which is the same as in the 
EU. Patents can cover: the active substance; how the active substance is 
produced; medical preparation (when the active substance is not new but 
the application is); and new medical uses (i.e. new indications) for existing 
drugs and formulations (e.g. tablets). A generic product cannot be put on 
the market if the patent has not expired (even if the market authorization 
period has expired).
The advertising of pharmaceuticals is regulated by the Medicinal 
Products Act (1992) and is monitored by the NoMA. Direct advertising 
to patients, including advertising on the Internet, is only allowed for over-
the-counter (OTC) pharmaceuticals. Promotion of OTC drugs within 
and outside pharmacies is restricted and staff handling these medicines are 
prohibited from marketing the products and giving any recommendations 
(except for generic substitutes). Advertising to health care professionals is 
allowed, but cannot be combined with handing out objects, gifts, services, 
awards or other items of economic value. Any supply of free medicine samples 
to doctors is strictly regulated.
REGULATION OF PHARMACIES AND WHOLESALERS
The activities of pharmacies are regulated by the Pharmacy Act and related 
regulations. The Act liberalized the pharmaceutical market in 2001 by 
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removing some of the limitations on the ownership of pharmacies, but the 
requirement that pharmacies must be run by a pharmacist was retained. 
Manufacturers of medicinal products and persons with the right to prescribe 
medicinal products cannot be granted a pharmacy licence. In addition, 
the limitations on establishing new pharmacies were removed. Since then 
pharmaceutical wholesalers have taken over the majority of private phar-
macies – 84% in 2017 (Norwegian Pharmacy Association, 2018). Pharmacy 
chains are allowed.
Each pharmacy must have two separate licences: one licence to own 
the pharmacy (the proprietor’s licence) and the other to run the pharmacy 
(the operating licence). Only pharmacies or medicinal outlets (controlled by 
pharmacies) may carry out the retail sale of pharmaceutical products requir-
ing prescription. The first online pharmacies selling prescription drugs were 
established in 2016, after a change in regulation, and the NoMA publishes 
a list of approved online pharmacies on its website. Online pharmacies must 
offer all medicines approved in Norway, with the exemption of pharmaceu-
tical products with specific requirements for storage and delivery (such as 
temperature). Online pharmacies must meet the same safety regulations as 
traditional pharmacies, and must be registered with the NoMA.
Generic substitution has been allowed in Norway since 2001. Pharmacies 
are not allowed to substitute therapeutically (i.e. to dispense a medicine 
with equal therapeutic benefits, but with a different active ingredient) nor 
to substitute biological medicinal products with biosimilar products. The 
NoMA evaluates new medicines on the Norwegian market in terms of 
their interchangeability and publishes a ‘substitution list’, which is updated 
monthly. In recent years there has been an increase in the use of biosimilar 
medicinal products in Norway. For example, biosimilars such as Epoetin 
and Anti-Tumour Necrosis Factor (Anti-TNF) had more than 80% of the 
market share (in terms of volume) in 2015 (OECD, 2017).
The EU Falsified Pharmaceuticals Directive 2011 / 62 / EU was adopted 
into Norwegian legislation and became effective in October 2015. While 
importing pharmaceutical products from the European Union or the EEA 
for private use was previously permitted, all personal imports of prescription 
pharmaceuticals are now prohibited, except for special cases where an import 
permit has been granted (e.g. for people who come to Norway for a temporary 
stay). The purpose of the strict regulation is to prevent incorrect use and to 
protect consumers from illegal products. Private import of OTC products 
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authorized in Norway is still permitted, subject to certain rules (for example, 
the imported quantity must not exceed three months’ personal use). Private 
import of homoeopathic medicines from the EU is permitted. Counterfeit 
pharmaceuticals rarely appear on the Norwegian market (Weltzien, Kjendlie 
& Gaarder-Olsen, 2017).
PRICING OF PRESCRIPTION PHARMACEUTICALS
Manufacturers’ prices are not regulated and wholesalers are free to negotiate 
mark-ups with the manufacturers. The NoMA is responsible for setting 
maximum pharmacy purchase prices. Suppliers of prescription medicines 
must apply for a maximum retail price, whether or not they are seeking 
reimbursement for the product. Medicines can only be sold at or below the 
maximum retail price level. An international price referencing system has 
been used since July 2002 to set maximum prices for both new and existing 
medicines. Prices are based on the average of the three lowest pharmacy 
purchase prices in Austria, Belgium, Denmark, Finland, Germany, Ireland, 
the Netherlands, Sweden and the UK. If a medicine is marketed in fewer 
than three of the reference countries, the mean price is taken of the countries 
where a market price exists.
Pharmacy mark-ups for prescription products (both reimbursed and 
non-reimbursed) are fixed at 2.0% for all medicines. There is also a flat rate 
add-on of NKr29 (€3) per pack, plus value added tax (VAT) of 25%. An 
additional add-on of 0.5% is applied to products which require refrigeration.
Generic prices cannot exceed the maximum market price of the original 
branded product. In 2005 a stepped price model was implemented in order 
to reduce public expenditure on generic drugs covered by Helfo. Under this 
scheme, a maximum reimbursement price is set for both branded and generic 
pharmaceuticals included in the scheme. The maximum reimbursement price 
level is automatically reduced (in steps) following patent expiry. The size of 
these reductions depends on annual sales prior to the establishment of generic 
competition and time since competition was established. There is no regula-
tion of pharmacy mark-ups within this step-wise price system. Pharmacies 
therefore have a financial incentive to carry out generic substitution and to 
dispense the cheaper product. Since 1995 prices of over-the-counter (OTC) 
medicines have not been regulated.
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PUBLIC REIMBURSEMENT OF PHARMACEUTICALS
Reimbursement decisions for medicines used outside hospitals are made by 
the NoMA. When applying for reimbursement, pharmaceutical companies 
need to follow the guidelines for the submission of documentation for single 
technology assessment of pharmaceuticals. Cost–effectiveness analysis is well 
established in Norway and the use of quality-adjusted life years (QALYs) 
as a parameter has been increasing. No maximum payment threshold per 
QALY has been defined. For products associated with a substantial cost to 
the public budget, decisions on reimbursement are taken by the MOHCS. 
Helfo decides on reimbursement for individual patients for pharmaceuti-
cals without general reimbursement or indications not covered by general 
reimbursement (Schedule 3 in Table 2.4).
There are three reimbursement categories for pharmaceuticals (see Table 
2.4). Schedule 2 (the so-called “blue list”) is de facto a “positive list” which 
lists medicines that may be publicly reimbursed for specified diagnoses (see 
also Section 3.3.1).
TABLE 2.4 Reimbursement categories for pharmaceuticals
CATEGORY REIMBURSEMENT RATE (%) DESCRIPTION
Schedule 2 61
For medicines on the reimbursement list, which are 
reimbursed in case of specified diagnoses in the list 
and only for long-term (>3 months) treatment.
Schedule 3 61
For medicines other than those under Schedules 2 and 4. In this case, 
reimbursement can be granted upon submission of an individual 
application and only for long-term (>3 months) treatment.
Schedule 4 100 For medicines used to treat serious contagious diseases such as tuberculosis, meningococcal disease or chlamydia.
Source: PHIS (2018)
In 2006 the H-prescription scheme was established for medicinal 
products that can be administered by the patients themselves (medicines 
prescribed in the hospital but for outpatient use), but where the expenses 
are covered by the RHAs. The scheme builds on a solution involving direct 
payment between a pharmacy and a health trust (hospital). The patient 
receives the H-prescription and can pick up the medicinal product from 
the pharmacy of his/her choice. From 2014 cancer medicines have been 
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included in the H-prescription scheme. Effective from 2018, medicines for 
treatment of HIV and Hepatitis B and C have also been transferred from 
the blue list to the H-prescription scheme. In 2019 a number of orphan 
drugs were included.
2.7.5 Regulation of medical devices and aids
Between 2003 and 2016 the Health Agency Procurement Service 
(Helseforetakenes Innkjøpsservice, HINAS) established by the RHAs coordi-
nated procurement of medical equipment among public hospital trusts. In 
2016 HINAS became part of the Agency for Hospital Procurement Services, 
which took over this coordinating function. The rationale behind having a 
single agency in charge of all procurement agreements was that, through 
concentrated purchasing power, it would be able to achieve savings through 
better contractual terms. The common procurement policy is not applied 
to all purchases, but only to those that are large enough, in both monetary 
value and volume, to represent a possible gain if conducted on a national 
scale. The common procurement policy has since expanded beyond Norway, 
as part of cooperation with other Nordic countries.
The introduction of new medical technologies, including medical devices 
and aids, is evidence-based. This is ensured by the ‘New Methods’ system (see 
Section 2.7.3). Since 2018 the manufacturing and distribution of medical 
devices and aids has been supervised by NoMA (previously, the Directorate 
of Health had legislative responsibility in this area).
2.8 Person-centred care
There are a number of patient organizations, ranging in size and set-up. Some 
are mostly related to particular diseases or disease groups while others have 
a broader scope, for example, the Norwegian Patient Association, founded 
in 1983. Patient organizations are often closely linked to user committees, 
which are a legal entity of all RHAs and local trusts. According to Statistics 
Norway, almost one in ten adults were members of an organization for 




The availability of patient information in Norway is good and substantial 
improvements have been made in this area in recent years. HelseNorge 
(www.helsenorge.no), launched in 2011, is the main entry portal provid-
ing patient information, whether it is general advice or individual patient 
information (Table 2.5). In addition, one of the health trusts in the Western 
RHA has launched a website* with information about patient pathways for 
young people, focusing on issues such as eating disorders, anxiety problems, 
traumatic experiences, autism, etc. There is also free public access to guide-
lines, systematic reviews, and a wide range of scientific journals, as well as 
other full-text resources, through the Norwegian Electronic Health Library 
(www.helsebiblioteket.no). The library also provides health care professionals 
and students free access to bibliographic databases with over 3000 full text 
journals.
The HelseNorge portal contains information on statutory benefits and 
serves as a guide to health care services. Information is currently available 
in Norwegian and selected information is also available in English. Age-
specific information is available for children and young adults. The portal 
provides users with access to several self-service options, for example, they 
can access information on their user fees, electronic prescriptions and vac-
cinations, out-of-hours services and hospitals, including information to 
assist patients with their choice of hospitals. Over 200 quality indicators 
to support patients in choosing hospitals are available, covering areas such 
as cancer treatment, childbirth and psychiatric care. This information can 
also be obtained via a dedicated telephone helpline (800HELSE). Patients 
can also access their Summary Care Record (Kjernejournal) which con-
tains selected key information about their health that can be accessed by 
all health care providers (this is in addition to the medical records kept by 
GPs). It contains information from the national registries, information on 
serious medical conditions or allergies registered by the physician, and any 
information entered by the patients themselves and the patients’ physicians 
in consultation with the patients.
According to the Patients’ Rights Act (1999), patients are entitled to 
access their medical records and, upon request, they are also entitled to a 
* https://helse-fonna.no/barn-og-unges-helseteneste.
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free copy of these records plus a brief explanation of the medical terms used. 
This may be ordered through the HelseNorge portal. The portal has been 
increasingly used by patients to view their logged hospital appointments 
and obtain information about their personal point of contact at the hospital. 
The portal also contains information on prevention, health, wellness, illness, 
treatment and patients’ rights, with the aims of helping people take better care 
of their own health and encouraging more active involvement in the health 
system. According to a survey conducted in 2018, 76% of the respondents 
were aware of this portal (Norwegian Directorate of eHealth, 2019).
TABLE 2.5 Patient information
TYPE OF INFORMATION IS IT EASILY AVAILABLE? (Y/N) COMMENTS
Information about statutory benefits Y HelseNorge
Information on hospital 
clinical outcomes Y HelseNorge
Information on hospital 
waiting times Y HelseNorge
Comparative information about the 
quality of other providers (e.g. GPs) Y/N Information only on hospitals
Patient access to own 
medical record Y
Summary Care Record (Kjernejournal) 
available for all (HelseNorge); patient 
journal (under implementation by 
HelseNorge); information on own 
user-fees, electronic prescriptions 
and vaccinations (HelseNorge)
Interactive web or 24/7 
telephone information Y
Dedicated telephone lines providing out-
of-hours medical advice; mental health 
helplines, including helplines for children 
and youths living in families with mental 
health problems or with substance abuse.
In addition, there is a public portal 
with chat-line for young people 
(www.ung.no) providing information 
about prevention, lifestyle, etc.*
Information on patient satisfaction 
collected (systematically 
or occasionally)
Y Annual survey by the NIPH
Information on medical errors Y Annual report to the parliament (with indicators) by the Directorate of Health




Statutory coverage in Norway is obligatory and opting out is not permitted. 
There is no choice of the statutory benefits package. Patients can choose 
their provider (GP, specialist and hospital for elective care) and participate 
in treatment decisions (see Table 2.6).
TABLE 2.6 Patient choice
TYPE OF CHOICE IS IT AVAILABLE? (Y/N) COMMENTS
Choices around coverage
Choice of being covered or not N
Choice of public or 
private coverage N
Choice of purchasing 
organization N
Choice of care provider
Choice of primary 
care practitioner Y
Higher fees apply when patients choose to see a 
GP other than the one they are registered with
Direct access to specialists N
Choice of hospital Y
Country-wide choice and includes private 
hospitals that entered into agreements with 
the RHAs (choice applies to somatic and 
psychiatric services, and treatment for alcohol 
and substance abuse); level of hospital treatment 
(secondary or tertiary) cannot be chosen
Choice to have 
treatment abroad Y
Choice of treatment in any EU/




Right to informed consent Y
Right to request a 
second opinion Y
Right to information about 
alternative treatment options Y
Source: Authors
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CHOICE OF PROVIDER
Patients are in general free to choose their GP. All citizens who are reg-
istered in the National Population Register are entitled to a regular GP. 
Switching a regular GP is possible up to twice a year, provided that the new 
GP has space on his or her list. Patients may choose to stay on a waiting 
list if no space is available. Although registration with a GP is voluntary, 
it covers virtually the entire population and it is strongly encouraged – 
patients who do not have a regular GP will be responsible for finding a 
GP who can give them an appointment and will also have to pay a higher 
fee for the service.
In order to access specialist care (i.e. privately practising specialists 
or hospitals), patients need a referral from their GP or from another spe-
cialist. According to the Patients’ Rights Act (1999), patients have the 
right to choose any hospital. Patients cannot choose the level of hospital 
treatment (secondary or tertiary). In November 2015 amendments to the 
Patients’ Rights Act came into force, changing access to elective specialist 
care. According to these changes, all patients in need of specialist care, 
regardless of the degree of need, have the right to receive such care. Access 
to treatment is determined according to two criteria: (1) clinical effectiveness 
of treatment; and (2) cost-effectiveness of treatment. The severity of the 
condition is only used to determine the maximum waiting time. The new 
legislation also required a revision of 33 discipline-specific clinical priority 
guidelines, which set condition-specific thresholds for obtaining access to 
specialist care.
USER INVOLVEMENT IN TREATMENT DECISIONS
According to the Patients’ Rights Act (1999), patients are entitled to 
participate in the decisions around their health care. This includes the 
right to participate in choosing between available and medically sound 
methods of examination and treatment. The form of participation needs 
to be adapted to the individual patient’s ability to give and receive infor-
mation. If a patient is not competent to give consent, their next of kin is 
entitled to participate in decisions, together with the patient. Patients are 
entitled to information that is necessary to obtain an insight into their 
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condition and treatment options, and have to be informed of possible 
risks and side-effects.
In 2014 important amendments to the Public Administration Act and 
the Electronic Public Administration Regulations were made in order to 
implement ICT solutions. The requirement to obtain consent from recipients 
before corresponding online with individuals, enterprises and others was 
abolished. For individuals, the requirement for consent was replaced by an 
option to opt out from receiving correspondence from public administration 
digitally.
In addition to receiving information, there is an increased focus on shared 
decision-making. It was included as a specific measure in the annual letter 
of instruction from the government to the RHAs in 2015/16. In 2017/18 
the government requested that access to high quality decision-making aids 
(such as leaflets) should be made available on the HelseNorge portal (Kasper 
et al., 2017).
2.8.3 Patients’ rights
The key legal act governing patients’ rights in Norway is the Patients’ Rights 
Act (1999). The Act has been amended several times, further strengthening 
patients’ rights (Winblad & Ringard, 2009). Patients’ rights guaranteed in 
the Act can be divided into three main groups: rights to become a patient, 
rights as a patient, and procedural rights such as the right to have decisions 
reviewed and reversed (Table 2.7).
In June 2017 the parliament sanctioned amendments to the Patients’ 
Rights Act, the Health Personnel Act and the Personal Health Data Filing 
System Act in order to strengthen the rights of children and adolescents as 
patients. Important changes concern the right to be heard as a patient, as 
well as the right to confidentiality and shared decision-making. Children 
from 7 years of age are entitled to have a say in consenting to treatment and 
to receive information about planned treatment; children and adolescents 
from 12 years of age have increasing influence on decisions regarding their 
treatment (Saunes & Lindahl, 2017).
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TABLE 2.7 Patients’ rights
Y/N COMMENTS
Protection of patients’ rights
Does a formal definition of patients’ 
rights exist at national level? Y Patients’ Rights Act 1999
Are patients’ rights included in specific 
legislation or in more than one law? Y
Patients’ Rights Act 1999
Health Personnel Act 2011
Does the legislation conform with WHO’s 
patients’ rights framework? Y
Patient complaints avenues
Are hospitals required to have a designated 
desk responsible for collecting and 
resolving patient complaints?
N
Is a health-specific Ombudsman responsible 
for investigating and resolving patient 
complaints about health services?
Y Each county has a patients ombudsman
Other complaint avenues? Y Norwegian Board of Health Supervision
Liability/compensation
Is liability insurance required for physicians 
and/or other medical professionals? N/Y
Only mandatory for physicians/medical 
professionals with no public funding
Can legal redress be sought through the 
courts in the case of medical error? Y Yes, but rarely used
Is there a basis for no-fault compensation? Y
In exceptional cases; through 
the Norwegian System of 
Patient Injury Compensation
If a tort system exists, can patients obtain damage 
awards for economic and non-economic losses? Y
Can class action suits be taken against health care 
providers, pharmaceutical companies, etc.? Y
Source: Authors
COMPLAINT PROCEDURES (MEDIATION, CLAIMS)
Patients’ rights in Norway are well-defined legal rights and can be actionable 
against specific parties. There are several mechanisms in place for patient 
complaints.
According to the Patients’ Rights Act, every county must have a Health 
and Social Services Ombudsman (POBO), whose purpose is to safeguard 
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patients’ rights, interests and legal rights in relation to primary and specialist 
health care, and to improve the quality of the health service. The ombudsman 
can provide information, advice and guidance to anyone who requests it on 
matters within their remit of work. The ombudsman determines whether 
the request provides adequate grounds for investigation. If the ombudsman 
decides not to handle the case, the person who made the request must be 
notified and be given a brief explanation for this decision.
Patients can make a complaint if they think that they have not received 
health services to which they are entitled, or if they disagree with the assess-
ment of their treatment needs. Complaints should be addressed to the person 
or body who took the disputed decision. If the complaint is not upheld, it will 
be referred to the county office of the Board of Health. Decisions made at 
county level can be appealed to the central office of the Board at the national 
level. The Board has the power to issue warnings to health personnel and to 
revoke licences/authorizations. The assessment by the county office does not 
give any automatic right to compensation or to a new course of treatment. 
The vast majority of complaints are brought to the county office of the Board 
of Health, and only a few cases are brought to the courts (Norwegian Board 
of Health Supervision, 2017).
The Norwegian Complaint Body for the Health Services was established 
in 2016. It is an independent agency and secretariat for the Norwegian 
System for Patient Injury Compensation (NPE) as well as other complaints 
within the health services. It ensures an independent assessment when 
patients disagree with the decisions of complaint bodies.
COMPENSATION
The Patient Injury Act (2001) was expanded in 2009 to handle compensa-
tion claims free of charge for patients who have sustained an injury while 
accessing statutory health services. Since then it has also encompassed harm 
caused by private for-profit providers (e.g. dental care services for adults). In 
order to be eligible for compensation, four conditions must be fulfilled: the 
injury must have been caused by the treatment and, specifically, by failings 
in the treatment provided; it must have caused financial loss; and it must 
have occurred no more than three years before the claim is made. The NPE 
plays an active part in the handling of such cases and in establishing possible 
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grounds for liability (they do not apportion blame but find out whether or 
not the patient is entitled to compensation). Decisions made by the NPE are 
binding for the hospital authorities and municipalities, but can be appealed 
by a complainant to the Norwegian Complaint Body for the Health Services 
or before the civil courts.
The compensation process, including the assessed compensations (by the 
NPE, the Board or court), is financed by contributions from both hospital 
owners and municipal authorities.
2.8.4 Patients and cross-border health care
Cross-border health care has not been an important issue on the policy 
agenda in Norway (Ringard et al., 2013). The number of hospital contacts 
made by foreigners is reported on an annual basis by the Norwegian Patient 
Register and it is very small compared to the total number of patients treated 
within the system (NOMESKO, 2017). Foreign patients seeking medical 
care in Norway must cover all treatment costs, except citizens from Nordic 
countries and European Health Insurance Card holders.
Since March 2015 Norwegian patients referred for specialist treatment can 
choose to receive it in any EU/EEA country. Treatment expenses are covered 
up to the cost of the equivalent treatment in Norway, while any additional 
treatment and travel expenses are usually not covered. The Helfo decides on 
the reimbursement on a case-by-case basis. Only treatments equivalent to 
those that the patients are entitled to at home may be covered. Patients who 
have had their waiting-time guarantee breached have the right to receive 
assistance in selecting a foreign provider and to extended cost coverage.
Norwegian citizens who are in another EU/EEA country when the need 
for health care arises must obtain a referral from a health care professional 
who is authorised to make referrals in the country of treatment. In the case 
of emergency care, no referral is required.
Members of the NIS are entitled to travel to a country outside the EU/
EEA to give birth, but only the costs of the actual childbirth will be covered. 
Neither mother nor child will be entitled to coverage of further expenses 
outside the EU/EEA.
Members of the NIS with the right to extended subsidization (i.e. 
students and persons stationed abroad by their Norwegian employer) are 
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eligible for reimbursement of a percentage of the expenses during their stay 
abroad. Only health care services covered by the NIS are subsidized. As a 
consequence, no subsidization is granted for vaccination, ordinary dentistry 
for children, home help service, nursing home residence, rehabilitation 
services, health checks and other services under the Norwegian Health 
and Care Services Act, Dental Health Services Act and Specialist Health 
Services Act.
In 2017 reimbursement for health services in another EEA country 
totalled NKr63 million (€6 million). The main types of care that were 
reimbursed were physiotherapy and dental care and most treatments took 
place in Spain (Norwegian Ministry of Finance, 2018). There are no official 
figures on the number of Norwegians travelling abroad to receive treatment 




  Health care expenditure accounted for 10.4% of Norway’s GDP 
in 2017, ranking fifth in the WHO European Region in terms of 
the share of GDP spent on health. With Norway’s per capita GDP 
being one of the highest in the world, the country’s per capita health 
expenditure is also much higher than in most countries.
  Public sources account for over 85% of current health expenditure, 
which is the highest share in Europe, and comprise financing from 
central and local governments and the National Insurance Scheme.
  Private health financing comes from households’ out-of-pocket 
payments, of which most is spent on pharmaceuticals, dental care 
and long-term care. The number of Norwegians holding private 
health insurance policies has increased over the past decade, but 
the role of such insurance in health financing remains negligible.
  Hospital care, as well as outpatient psychiatry and outpatient treat-
ment of drug and alcohol abuse, is financed through block grants 
and DRG-based case payments from the central government to 
the Regional Health Authorities. Other types of specialist care are 
mainly financed through global budgets, with elements of case pay-
ments. Quality-based funding is being piloted at the national level.
  Primary care is financed from municipal taxes, block grants from 
the central government and earmarked grants for specific purposes; 
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other major sources of financing of primary care are the National 
Insurance Scheme and user fees. The financing structure is aimed 
at both containing costs and giving providers sufficient flexibility 
to ensure the best mix of services for patients.
3.1 Health expenditure
In 2017 Norway was ranked fifth in the WHO European Region in 
terms of the share of GDP spent on health (Fig. 3.1). The share of GDP 
spent on health increased over the years, from 8.3% in 2005 to 10.4% 
in 2017 (Table 3.1). However, part of this increase may be explained 
by a decrease in GDP due to a reduction in oil prices affecting the 
budget from 2013, while health spending continued to grow. In purchas-
ing power parity (PPP) per capita terms health spending increased by 
60% between 2005 and 2017, albeit at slower pace from 2013 onwards. 
Compared to Sweden, Germany and France, Norway spends on average 
a smaller share of its GDP on health (Fig. 3.2). Given Norway’s high 
GDP, total per capita spending on health in Norway continues to be 
amongst the highest in the WHO European Region – ranking second 
after Switzerland (Fig. 3.3).
In 2017 Norway had the highest share of public spending on health 
in the WHO European Region, with compulsory financing arrangements 
accounting for over 85% of the current health expenditure (Fig. 3.4). This 
share has increased slightly over the years (it was 82% in 2000). The share of 
total general government expenditure spent on health has also been increasing 
and was 17.9% in 2017, which was the fifth highest in the WHO European 
Region (Fig. 3.5).
The share of private spending in current health spending has decreased 
since 2000 in line with growth in public spending, but remained at around 
15% in more recent years (Table 3.1). Private spending almost entirely 
consists of out-of-pocket (OOP) payments, which reduced from 17.9% to 
14.2% of current expenditure on health between 2000 and 2017. Private 
health insurance plays a negligible role, accounting for less than 1% of current 
health expenditure (Tynkkynen et al., 2018).
Table 3.2 presents national data on health expenditure according to 
function and financing scheme. Norway has traditionally spent more on 
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long-term care as a share of current spending on health compared to other 
European countries. In 2017 this share reached 28.2%, with Sweden and the 
Netherlands (26%) and Denmark (25%) following closely behind (OECD, 
2018a). All these countries tend to have well-established formal arrangements 
in place for their older and disabled populations (see Section 5.8). The share 
of inpatient care also amounted to over 28% of current spending on health 
(2017) and is almost entirely financed from public sources. Budget propos-
als for 2019 foresee a small (2%) increase in hospital financing and similar 
increases have been implemented in previous years. This is linked to the 
expected increase in demand due to population ageing, as well as to shifting 
the costs of pharmaceuticals to hospitals (H-prescription; see Section 2.7.4) 
and investments in infrastructure (Ministry of Finance, 2018).
Private expenditure plays a larger role in financing outpatient care as 
nearly 30% of expenditure on outpatient care is paid by patients out of their 
pocket. However, the share of private financing is the highest for pharmaceu-
ticals and medical goods, where it amounts to almost half of current spending.
TABLE 3.1 Trends in health expenditure in Norway, 2000–2017 (selected years)
2000 2005 2010 2015 2016 2017
Current Health Expenditure 
(CHE) per capita in PPP  2 856  3 995  5 190  6 144  6 143  6 518 
Current Health Expenditure 
(CHE) as % of GDP 7.7 8.3 8.9 10.1 10.5 10.4
Public expenditure on 
health as % of CHE 81.7 83.1 84.7 85.5 85.4 85.5
Private expenditure on 
health as % of CHE 18.3 16.9 15.3 14.5 14.6 14.5
General government expenditure 
on health as % of general 
government expenditure
15.0 16.5 16.8 17.7 17.7 17.9
Public expenditure on 
health as % of GDP 6.3 6.9 7.5 8.6 9 8.9
Out-of-pocket payments  
as % of CHE 17.9 16.7 15.0 14.1 14.3 14.2
Out-of-pocket payments as % of 
private expenditure on health 97.9 98.6 98.5 97.6 97.6 97.6
Private insurance as % of private 
expenditure on health 2.1 1.4 1.5 2.4 2.4 2.4
Source: WHO (2019)
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FIG. 3.1 Current health expenditure as a share (%) of GDP in the WHO European 
Region, 2017
% of GDP
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TABLE 3.2 Expenditure on health in Norway according to function and type of 



























































































Public expenditure (including NIS) 28.3 15.3 25.9 5.6 2.5 0.7 7.2 85.5
Private expenditure 0.3 5.9 2.3 5.2 0.4 - 0.4 14.5
Private out-of-pocket 0.3 5.9 2.3 5.2 - - 0.5 14.2
Private insurance - - - - 0.4 - - 0.4
All financing schemes 28.6 21.2 28.2 10.8 2.9 0.7 7.6 100.0
Notes: a Excluding administrative cost at the municipal level. Public dental care is included 
in preventive care and private dental care is included in outpatient care. National health 
accounts data do not distinguish NIS as a separate financing scheme.
Source: OECD (2019)
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FIG. 3.3 Current health expenditure in US$PPP per capita in the WHO European 
Region, 2017
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FIG. 3.4 Public sector health expenditure as a share (%) of current health expendi-
ture in the WHO European Region, 2017
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Source: WHO (2019)
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FIG. 3.5 General government health expenditure as a share (%) of general govern-
ment expenditure in the WHO European Region, 2017
% of current health expenditure
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3.2 Sources of revenue and financial flows
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General taxation is the main source of revenue for the Norwegian health 
care system, but some public funds also come from the National Insurance 
Scheme (NIS) managed by Helfo (see Section 2.7.1). Furthermore, OOP 
payments play a substantial role in financing some of the services (Table 3.2). 
The split between public and private sources of health revenues has been 
relatively stable since 2000. Public sources account for the vast majority of 
health expenditure, approximately 85%, and consist of transfers from the 
general government (national, county and municipal tax revenues) (74%) 
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and from the NIS (11%). National taxes are used to finance provision of 
secondary care and partly provision of primary care, while municipal taxes 
are the main source of funding for primary care. The national tax admin-
istration (Skatteetaten) ensures that taxes and other claims are correctly 
assessed, paid and redistributed. Revenues from the state are distributed 
among the RHAs, local authorities and Helfo (which is financed through 
the NIS; see Section 2.7). The NIS is financed from insurance contributions 
by its members (32%), payroll (40%) and national (28%) taxes. Patients pay 
out-of-pocket for most types of care (see Section 3.4). The financial flows 
are shown in Fig. 3.6.
3.3 Overview of the statutory financing 
system
The scope of the statutory coverage, as well as the criteria for co-payments 
and the safety net, are determined by the parliament as part of the public 
budget approval process. After deliberations between the ministries and 
the government have been concluded, the Ministry of Finance sets up 
a complete fiscal budget proposal, which includes the NIS. The budget 
receives the official approval of the King in Council, whereupon it is 
submitted to the parliament for the final approval. Changes to the budget 
proposal are in general minor, amounting to less than 1% of the budget 
annually.
3.3.1 Coverage
BREADTH: WHO IS COVERED?
All residents of Norway are entitled to essential medical and care services. 
This entitlement, as well as the scope of coverage, is included in legislation 
(the Municipal Health and Care Act of 2011, the Specialist Care Act of 1999 
and the National Insurance Act of 1997). As a general rule, all residents in 
Norway are members of the NIS.
Everybody, regardless of citizenship or residency status, has access to 
acute emergency care. All pregnant women and children have access to 
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primary health care (including vaccination) regardless of citizenship or res-
idency status. Residents from the EEA and EU have in principle the same 
entitlement to health services as Norwegians and are reimbursed according 
to EEA regulations and bilateral agreements. Foreigners from outside the 
EEA normally have to pay the full cost for services received (if there is no 
bilateral agreement) (see also Section 2.8.4). Undocumented migrants are 
expected to cover health care expenses, beyond their limited entitlement, 
out of pocket.
SCOPE: WHAT IS COVERED?
There is no positive list of services covered by the statutory system, but in 
practice public coverage includes:
  approved prescription drugs, i.e. drugs included on the ‘blue list’ 
approved by the NoMA (see Section 2.7.4);
  preventive services including check-ups, screening and the immu-
nization of infants and school children; preventive mental health 
services (mostly for children and adolescents); public health initia-
tives or campaigns to promote a healthy lifestyle and reduce social 
health disparities (depending on the municipality);
  primary care, including services provided by GPs, physiotherapists 
and chiropractors;
  most specialist ambulatory and hospital care; however, certain 
treatments, such as plastic surgery, must be considered medically 
essential for the patient to qualify for public coverage;
  emergency care, including emergency after-hours specialist care;
  nursing care;
  dental care for children and a few selected groups;
  medical eye care (glasses are usually excluded).
Non-medical eye care, most adult dental care and complementary medicine 
are not covered from public sources.
In addition, the NIS covers many risks related to the loss of income 
through income benefits. Persons insured under the NIS are entitled to 
retirement, survivor and disability pensions, basic benefits and attendance 
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benefit in case of disability, rehabilitation or occupational injury. There are also 
some benefits for single parents, cash benefits in case of sickness, maternity, 
adoption and unemployment, as well as funeral benefits.
DEPTH: HOW MUCH OF BENEFIT COST IS COVERED?
All inpatient care in public hospitals or private hospitals contracted by the 
RHAs is free of charge. Certain preventive services, such as child immuni-
zations, are also exempt from cost-sharing. Home-based services, including 
home nursing, are also mainly free of charge.
Cost-sharing is applied to most other services and outpatient phar-
maceuticals (see Table 3.3). However, due to cost-sharing limits, the extent 
of OOP spending is generally moderate, with the exception of dental care 
and institutional care (Box 3.1). For certain types of services, such as dental 
care, the extent of cost-sharing is substantial and is not covered or counted 
towards the cost-sharing ceiling. Institutional care for older or disabled 
people also requires a high degree of cost-sharing, with co-payment levels 
depending on income.
Cost-sharing limits are set by the parliament (for more information see 
Sections 2.7.3 and 3.4). There are exemptions from cost-sharing provisions 
for certain diseases and groups of people and other protection mechanisms, 
including tax deductions (see Section 3.4 for more information). For example, 
patients who incur health care costs due to long-term illness are entitled to 
deduct them from their pre-tax incomes.
BOX 3.1 Assessing coverage
Health coverage in Norway is fairly comprehensive and includes a broad range 
of services for residents. Cost-sharing requirements are moderate on the whole, 
and the share of OOP spending is among the lowest in the EU/EEA – at 15% in 
2017. Cost-sharing ceilings apply to most services and prescribed medications 
to limit OOP costs and other protection mechanisms are also in place. However, 
increasing costs of innovative medicines have been raising concerns about equal 
access to medicines in the context of debates on priority-setting. Dental care is 
another area where access may be obstructed by the limited public financing, 
which may lead to unmet need (see Section 7.2).
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3.3.2 Collection
GENERAL TAXATION
The Ministry of Finance is Norway’s highest taxation authority. Taxes are 
collected by central and local governments (see Fig. 3.6). The main sources 
of tax revenues are individual income tax and value added tax (VAT). The 
share of direct taxes is relatively high – about 70% of the total tax revenue.
Income from labour and pensions is taxed at progressive rates, with 
marginal tax rates reaching 47%. The remaining forms of income are usually 
taxed at a flat rate (e.g. capital income from individuals is taxed at a uniform 
rate of 25%). The tax system for individual taxpayers is on the whole pro-
gressive (i.e. the average tax rate increases in line with income) (Norwegian 
Ministry of Finance, 2017).
SOCIAL SECURITY CONTRIBUTIONS
All persons who are either residents, or are working as employees in Norway 
or on permanent or movable installations on the Norwegian Continental 
Shelf, must be insured in the NIS and pay social insurance contributions. The 
same applies to persons living in Svalbard (Spitsbergen), Jan Mayen and the 
Antarctic and Sub-Antarctic dependencies provided that they are employed 
by a Norwegian employer or insured under the National Insurance Act prior 
to their stay in these areas. Insurance is also compulsory for certain catego-
ries of Norwegian citizens working abroad. National insurance contribution 
rates are set by the parliament. They are payable by employees and levied on 
personal and pension incomes. In 2019 the contribution rates were: 8.2% for 
employees, 11.45% for self-employed and 5.1% for pensioners. Contributions 
payable by individuals are deducted from their pay or pension. NIS rates 
paid by employers vary regionally and range from 0.0% to 14.1% (2019). 
Social security contributions to the National Insurance Scheme (made by 
employers and employees, and self-employed, as well as by the state on behalf 
of the non-employed) accounted for 26% of total tax revenue of mainland 
Norway (Norwegian Ministry of Finance, 2018). No NIS contributions are 
levied on incomes below NKr54 650 (€5246) per year (2019)*.
* Conversion rate at 1NKr=€0.096, average for 2018 according to Norges Bank.
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According to the EEA agreement (1994), Norway follows EU regula-
tions with regard to social security. Employees, self-employed and freelancers 
are all members of the social security system. Those who do not fulfil these 
requirements can apply for voluntary membership in the NIS if their stay 
in Norway exceeds three months. From January 2016 collection of taxes 
(including the NIS contributions) has been the responsibility of the Tax 
Administration (Skatteetaten). Before that, it was split between the Tax 
Administration and the Norwegian Customs.
3.3.3 Pooling and allocation of funds
ALLOCATION FROM COLLECTION AGENCIES TO POOLING AGENCIES
The Ministry of Finance annually allocates resources for different func-
tions (e.g. social protection, education, health) following a parliamentary 
budget process. Each October the government presents its budget bill for 
the upcoming year to the parliament for approval. Revenues from taxes and 
NIS contribution revenues are not specifically earmarked for health care; 
however, the share of tax revenue allocated to health has been stable since 
2011. In 2017, 17.9% of the total general government expenditure was allo-
cated to health (Table 3.1). This allocation forms the budget of the Ministry 
of Health and Care Services. According to the law, all public services must 
be carried out within the approved annual budget.
BOX 3.2 Assessing progressivity and equity of health financing
The three main sources of revenue for the Norwegian health care system are 
the general tax system, NIS contributions and households’ OOP payments. The 
Norwegian tax system is largely progressive, with most of the tax revenue coming 
from direct taxes and with the average tax burden increasing with higher income. 
However, the NIS contributions are largely proportional, while the OOP payments 
are regressive. But given the dominance of public over private spending, health 
financing on the whole is largely progressive.
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ALLOCATING RESOURCES TO PURCHASERS
The Ministry of Health and Care Services distributes its budget among the 
municipalities and counties, the RHAs and the Helfo.
The state has a distribution formula called the General Purpose Grant 
Scheme, which determines the amounts that are distributed to the munici-
palities and counties. The Scheme takes account of both structural cost dif-
ferences (expenditure equalization) and differences in tax revenues (income 
equalization). Special grants are also available, such as rural grants, grants 
for small municipalities, urban grants, a VAT compensation fund, and dis-
cretionary grants which are granted in specific circumstances (UCLG & 
OECD, 2016).
Funds for public hospitals are allocated to the four RHAs, which are 
free to decide how the hospitals are paid (see Section 3.7.1). For somatic 
care, outpatient psychiatry and treatment of drug and alcohol abuse, funding 
comprises block grants and activity-based funding (in roughly equal shares) 
and, since 2014, quality-based financing (0.5%). The block grant for each 
RHA is based on the number and age of inhabitants in the region, several 
health indicators (such as mortality and the share of disabled people in the 
region), socioeconomic indicators (e.g. the share of inhabitants with only 
primary education) and the cost level. The activity-based funding is based on 
the Nordic diagnosis-related groups (DRG) system to classify patients and, 
since 2017, covers outpatient psychiatry and treatment of drug and alcohol 
abuse (Norwegian Directorate of Health, 2017b). Inpatient psychiatry and 
inpatient treatment of drug and alcohol abuse are mainly financed by block 
grants. Activity-based funding for somatic and mental health care is currently 
administered separately. In December 2019 a Royal Commission appointed 
by the government issued advice on changes to distribution of the block 
grant between the RHAs for specialist care to better fit the delivery model 
and regional costs.
The share of national insurance contributions allocated to Helfo is 
also decided through the annual budget process in the parliament, as part 
of discussions over the NIS expenses. The allocation is made on the basis 
of estimates rather than in the form of hard budgets and may be adjusted 
at the end of the year depending on the actual amount spent (Norwegian 
Directorate of Health, 2017b).
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3.3.4 Purchasing and purchaser–provider relations
Integrated purchaser–provider relations had been the dominant feature 
of the Norwegian health care system. However, in the last two decades 
attempts have been made to introduce a more clear-cut purchaser–provider 
split. Purchaser–provider separation was first introduced for nursing and 
care services in the early 1990s, using models initially tried out in Sweden 
(Martinussen & Magnussen, 2009). More recently, contracts between munic-
ipalities and private providers are considered an important tool for guar-
anteeing good quality of services and also for securing good cooperation 
BOX 3.3 Assessing allocative efficiency
According to a recent analysis, regional effects account for about half of the 
variation in health care utilization (with patient characteristics accounting for the 
other half) (Godøy & Huitfeldt, 2018), and thus there may be room for improvement 
in the use of resources.
On the whole, allocation of resources reflects current health needs (block 
grants and activity-based funding), demographic forecasts and priorities. For 
example, in the 2016 letter of instruction to the RHAs, the government has given 
priority to mental health and substance abuse treatment, meaning that growth 
in expenditure for these services should be larger than for somatic health care. 
Efforts are also made to improve coordination between the various types of care 
and they are reflected in the payment methods and funding decisions.
In terms of dividing resources among various types of care, Norway allocates 
similar shares of the budget to inpatient and long-term care (LTC) – just under 
30% of current spending on each. The share allocated to LTC is higher than in any 
other OECD country and the share allocated to hospitals has increased slightly 
over the past years – both in anticipation of increasing population ageing. Higher 
spending on hospital care is also related to the shift in financing of outpatient 
medicines prescribed at hospitals (H-prescription), meant to increase shared 
financial responsibility and coordination between inpatient and outpatient care. 
The obligation for municipalities to provide emergency care beds since late 2015 
serves the same goals.
The National System for the Managed Introduction of New Health Technologies 
(‘New methods’) has been implemented in the specialist service since 2013, with 
one of the aims being improved allocation of resources (see also Sections 2.7.3 
and 7.6.1).
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with other parts of the health system. Municipalities also have contractual 
relationships with GPs, as part of the regular GP scheme (see Section 5.3).
Within specialist care, the health trust model is at least in theory based 
on a purchaser–provider division, with RHAs acting as purchasers and health 
trusts acting as providers (Magnussen & Martinussen, 2013). However, the 
RHAs own health trusts and are therefore responsible for the public pro-
vider function. The regions can purchase health services from a variety of 
providers, including private ones. Even though a purchaser–provider split 
is possible, an integrated organization of health care has traditionally been 
favoured – due to dispersion of the population and concerns about costs and 
lack of expertise in commissioning (OECD, 2014).
3.4 Out-of-pocket payments
3.4.1 Cost sharing (user charges)
Cost-sharing has been a long-standing feature of the Norwegian health 
care system and has been in place since the early 1980s. The main aim has 
been to reduce the growth in public spending and to free up resources for 
high-priority areas. Another aim has been to curb the demand from people 
with minor health issues.
Most publicly funded health services, including primary care, require 
cost-sharing (Table 3.3). The exemptions are for inpatient care and long-term 
home-based nursing care, where no cost-sharing is required (see Section 
3.3). Cost-sharing usually takes the form of co-payments and their level 
is set nationally. Exceptions are applied for certain diseases and groups of 
people and Helfo provides subsidies for prioritized patients (see Table 3.3). 
General dental care for adults is one area where the share of out-of-pocket 
payments is very high (approximately 70% of total spending on dental care) 
(Statistics Norway, 2016). Most adult patients bear the full cost of dental 
care. In 2016, 12.1% of the adult population received reimbursements for 
dental treatment/care. Between 2014 and 2016 this proportion increased, 
but the average amount of reimbursement decreased (Ekornrud, Skjøstad 
& Texmon, 2017). However, children under 18 years old are entitled to free 
publicly provided dental care. Long-term care in institutional dwellings is 
another type of care that is subject to high co-payments.
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TABLE 3.3 User charges for health services in Norway, 2019









GP visit Co-payment of NKr155 (€15) per visit
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For drugs on the ‘blue 
list’*: 39% of the price 
up to NKr520 (€50) 
for three months’ 
supply; full fee for 
all other drugs
Dental care
Full user fee for adults;
Co-payment for 
children under 18 
for complex care
Free for children under 18 
for standard dental care;
reduced rates for young 
adults (19–22 years old); 
exemptions for older 
people in LTC and nursing 
institutions, disabled 








Children under 16, and 










based care Full user fee
Ceiling for people on 
minimum income
Nursing home Co-payment level related to income
Patients are entitled to 
keep 25% of minimum 
income (i.e. NKr25 000 
or €2400) and 15% 
of income above the 
minimum income
Note:* Blue list (or Schedule 2) – see Table 2.4 for details. 
1 Fifteen diseases are listed, among them cancer in the mouth, lip palate, periodontitis and bite anomalies.
Source: Based on Helsenorge.no
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Two annual cost-sharing ceilings are set by the parliament each year. 
Ceiling 1, amounting to NKr2369 (€227) in 2019, applies to treatment 
by physicians and psychologists, medicines on the ‘blue list’, diagnostic 
tests and transportation expenses related to examination and treatment. 
Once the ceiling is reached, an exemption card for health care services is 
issued, which entitles the holder to free treatment and benefits for the 
remainder of the calendar year. Ceiling 2, amounting to NKr2085 (€200) 
in 2019, applies to physiotherapy, several forms of dental treatment subject 
to reimbursement, accommodation at rehabilitation centres and treatment 
abroad. Ceiling 1 and ceiling 2 are not related to individual income – 
everybody pays the same amount before an exemption card is granted. 
Municipal services, such as home care (except for nursing home care) for 
the elderly and disabled, and institutional nursing care for the elderly, are 
among the services that are not included in the ceiling for cost-sharing. 
These services are usually subject to considerable OOP expenses. Residents 
in nursing homes typically pay between 75% and 85% of their income to 
the municipalities.
Taxpayers who incur extra expenses due to long-term illness, which 
amount to at least NKr9180 per year (€881), were until 2013 entitled to 
deduct the amount of these expenses from their before-tax income (there is 
no maximum limit for the deduction). Due to concerns about its redistrib-
utive effects and high administrative costs, the tax deduction scheme was 
meant to be discontinued from the 2015 tax year. However, the scheme is 
still in place in 2019.
3.4.2 Direct payments
Full fees have to be paid for health care services provided by non-contracted 
private providers and for goods and services excluded from the statutory 
coverage. No information on the extent of these payments is available.
3.4.3 Informal payments
There is no evidence of the existence of informal payments in the health 
sector in Norway.
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3.5 Voluntary health insurance
As all residents of Norway are covered by the public system, VHI plays only 
a minor role. The most common VHI schemes provide supplementary cover, 
offering shorter waiting times for publicly covered non-emergency services 
and ambulatory care in semi-private or private facilities. Jumping waiting lists 
seems to be the major reason for purchasing VHI policies in Norway and in 
2016 about 10% (500 000) of Norwegians had such policies. This represents 
a substantial growth in the VHI market in terms of the number of customers 
compared to around 30 000 people in the early 2000s and 225 000 people in 
2012 (Finans Norge, 2017; Johnsen, 2006b). Nevertheless, VHI accounted 
for less than 1% of the total spending on health in 2017 (Table 3.1).
Companies are the main buyers of VHI. Almost 90% of VHI enrollees 
receive coverage through their employer. As a result, group contracts clearly 
dominate – they are ten times more common than individual contracts 
(around 45 000 individual VHI contracts were purchased in 2016 compared 
to 459 000 group contracts) (Finans Norge, 2017). The following popula-
tion groups seem to be more likely to purchase VHI coverage: those with 
higher incomes; blue-collar workers compared to white-collar workers (as 
they are more likely to work for smaller employers or be self-employed); 
the less-well educated (more likely to be a blue-collar worker) (Sagan & 
Thomson, 2016). All sellers of VHI in Norway are profit-making private 
enterprises, with the four largest companies holding 70% of the total VHI 
market in 2016.
3.6 Other financing
There are no other major sources of financing beyond those discussed above.
3.7 Payment mechanisms
3.7.1 Paying for health services
Table 3.4 presents the payment methods for publicly financed health care 
services.
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TABLE 3.4 Provider payment mechanisms
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Notes: OP – outpatient; IP – inpatient; Cap – capitation; FFS – fee for service; 
CP-DRG – case payment (based on DGRs); BG-DRG – block grants (based on DRGs); BG – block grants; 
P4Q – payments for quality; RP – reimbursement price; C&YP – children and young people.
Source: Authors
PUBLIC HEALTH
The majority of public health services are provided at the municipal level 
(see Section 5.1). Public health services for pre-school and school children 
are provided in special settings (municipal health centres, health centres in 
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schools), mainly by specially trained salaried nurses. In addition, contracted 
GPs are obliged to provide up to 7.5 hours a week of municipal health 
services (see “Primary care” below for more information on how GPs are 
remunerated).
PRIMARY CARE
Primary care services (including primary emergency care) provided by gen-
eral practices are financed from three sources: the municipalities (capita-
tion, approximately NKr450 (€43) per patient); out-of-pocket payments 
(co-payments); and the Helfo (fee-for-service, FFS). Capitation payments 
amount to about 30% of GPs’ incomes, while the other two sources pro-
vide the remaining 70%. GPs may also be salaried and employed by the 
municipality, in which case the municipality receives a subsidy (FFS) from 
the Helfo.
Dental care for children and young adults is financed from block grants 
from the counties. Adult dental care is mainly financed from OOP payments 
and, for certain conditions, FFS from the Helfo are also available.
Other primary care services, for example services provided by con-
tracted primary care psychologists and physiotherapists, are funded by the 
Helfo (FFS) and patient co-payments. These health professionals are usually 
self-employed practitioners contracted by municipalities, and receive FFS 
directly from the Helfo. Privately practising midwives contracted by the 
municipalities also receive FFS directly from the Helfo. Midwives working 
in municipal health centres are salaried employees.
NURSING AND LONG-TERM CARE
Nursing homes and LTC providers are funded from local and national taxes 
and user charges. User charges for institutional care amount to approx-
imately 80% of the residents’ income, accounting for about 15% of the 
total expenses on such care. After user charges and state transfers, the 
municipalities have full responsibility over the funding of nursing and 
long-term care.
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SPECIALIST HEALTH CARE
Somatic care
Hospital financing evolved from per diem reimbursement (1970–1980), 
through block grant financing (1980–1997), to a mixed financing system 
consisting of block grants and case-based payment (since 1997), comple-
mented by quality-based financing (piloted since 2014 and accounting 
for about 0.5% of the block grant budget; Olsen & Brandborg, 2016). All 
financing for public and private hospitals comes from the RHAs (some 
of it is transfers by the Helfo on behalf of the NIS) and from OOP pay-
ments for outpatient care. Block grants are allocated from the national 
level to the RHAs based on a number of social, health and demographic 
indicators (see Section 3.3). Case-based payment is based on DRGs and 
the reimbursement rate amounts to approximately 50% of the national 
average cost. It covers somatic care for both inpatients and outpatients, 
and outpatient psychiatry and outpatient treatment of drug and alcohol 
abuse. A small share of funding (about 0.5%) is quality-based funding. 
The RHAs are entitled to allocate funding according to their own prior-
ities – this is mainly done by shifting money within the grant funding. 
Case-based payment based on DRGs is usually passed on unmodified 
down to the hospital level.
Quality-based financing of specialist care was introduced in 2014. It is 
based on a set of 33 indicators of clinical outcomes, processes and patient 
satisfaction. Patients’ experiences with specialist care have been measured 
for over 15 years (see Box 5.6). A national quality indicator system has been 
piloted since 2014 and consists of over 150 indicators, mainly focusing on 
specialist care. An early evaluation of the system in 2015 was inconclusive, 
failing to demonstrate any negative or positive effects on the quality of care 
(Sirona Health Solution, 2015). Quality-based financing was made perma-
nent as of 2016.
Mental health care
Specialized mental health services, including treatment of alcohol and drug 
addiction, are financed by block transfers from the state to the RHAs and by 
earmarked funding. Case-based funding was introduced for some outpatient 
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mental health care services from 2017. According to the white paper on 
the local government reform (Norwegian Ministry of Local Government 
and Modernisation, 2017), the municipalities are expected to increase their 
responsibility over and funding for, among others, mental health services. 
However, so far this has only occurred through pilots.
Other specialized care
Privately practising specialists under contract with the RHAs are funded 
from three different sources: operating grants from the RHAs; FFS from 
the Helfo; and co-payments from patients. Services provided by laboratory 
and radiology units owned by the health trusts are financed on a FFS basis 
(paid by the Helfo to the RHAs) for outpatients and case-based payment 
(DRGs) for inpatients. Private laboratories are subject to a different set of 
tariffs and are paid for directly by the Helfo, according to their agreements 
with the RHAs.
PHARMACEUTICAL CARE
The government sets maximum prices for prescription drugs by setting the 
pharmacy purchase price, the maximum pharmacy mark-up and the VAT. 
Outpatient prescription drugs included in the ‘blue list’ are financed in part 
from patient co-payments and in part by the Helfo. Prescription drugs not 
included in this list and non-prescription drugs are paid for in full by the 
patients. Pharmaceuticals in hospitals, H-prescriptions (see Section 2.7.4) 
and nursing homes are free of charge to the patients and are paid for by, 
respectively, the RHAs and the municipalities.
3.7.2 Paying health workers
Tripartite national collective agreements between the confederations of 
employees’ trade unions, employers’ associations and the state play an impor-
tant role in determining sector/industry-specific pay and working conditions. 
More than half of Norway’s employees are members of trade unions, over 
1.8 million in 2018 according to Statistics Norway (Statistics Norway, 2019a). 
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The majority of unions are grouped in four confederations: LO, UNIO, 
YS and Akademikerne. Associations for health care workers can be found 
within all four confederations. The main associations are the Nurses Union 
(c. 115 600 members), the Norwegian Union of Municipal and General 
Employees (c. 366 000 members), the Norwegian Medical Association 
(c. 35 200 members), the Dental Association (c. 6600 members) and the 
Psychological Association (c. 9500 members). All these organizations func-
tion both as trade unions and as professional associations. As trade unions, 
they aim to safeguard the financial, political and professional interests of 
their members. As professional associations, they are involved in matters 
concerning a wide range of professional issues, such as national health policy, 
education and ethics.
Norwegian health care personnel are mainly salaried employees. However, 
there are important exceptions, such as GPs who are typically contracted (see 
Section 3.7.1). Salaries of health professionals employed in public facilities are 
usually set through negotiations between the state, the municipalities (rep-
resented by the Norwegian Association of Local and Regional Authorities 
(KS)), health enterprises (represented by an organization called Spekter; see 
Section 2.2) and their counterpart member organizations for employees, such 
as the Medical Association of Norway, the Nurses Association of Norway 
and the Dentist Association.
The capitation rate for GPs is negotiated centrally between the 
Norwegian Medical Association and the KS and is the same throughout 
the country. GP unions and the state negotiate the FFS rates and the level of 
patient co-payments. FFS and co-payments to privately practising special-
ists contracted by the RHAs are also negotiated centrally and are uniform 
throughout the country.
In 2017 physicians employed by the RHAs earned NKr85 000 (€8160) 
per month on average (including compensation for working overtime and 
non-regular hours, etc.). The average for nurses was NKr43 400 (€4166) per 
month. In comparison, the average monthly salary in 2017 for all employees 
in Norway was NKr44 310 (€4254) (Statistics Norway, 2019a).
4
Physical and human 
resources
Chapter summary
  Responsibility for the planning of infrastructure in public facilities 
lies with their respective owners: municipalities (for primary care 
and other care provided at the municipal level), RHAs (for hospitals) 
and the MOHCS for large capital investment projects.
  Currently four RHAs oversee twenty hospital trusts, which account 
for 96% of all hospital beds. The number of acute hospital beds in 
Norway has fallen in line with other European countries. The dis-
tribution of hospitals in Norway reflects geographical differences 
in population density.
  Norway has a comprehensive eHealth policy, and IT infrastructure 
is well-developed. The Norwegian Directorate for eHealth is respon-
sible for governance of the eHealth system, while the Norwegian 
Health Network, covering the vast majority of providers, has recently 
taken over implementation of major eHealth developments.
  The numbers of doctors and nurses in Norway are among the 
highest in Europe, and so is the ratio of nurses to doctors, but the 
distribution of health personnel, particularly doctors, is uneven 
across municipalities. Shortages of nurses have been forecast and in 
response the government has developed a plan to increase recruit-
ment and to improve the competencies and professional develop-
ment of the health workforce in the municipalities.
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4.1 Physical resources
4.1.1 Infrastructure, capital stock and investments
INFRASTRUCTURE
In 2017 there were 3.2 acute hospital beds per 1000 inhabitants in Norway, 
more than other Scandinavian countries but much less than in Germany, for 
example (Fig. 4.1). In total, there were around 17 000 beds in the hospital 
sector in 2018 (Table 4.1). The number of hospital beds has been declining 
over the years and reflects the government’s efforts to improve resource 
allocation by shifting inpatients into outpatient settings in the community 
and into day surgery.
The geographic distribution of hospital beds is uneven (see Box 4.1).
TABLE 4.1 Total number of hospital beds, 2005–2018 (selected years)
HOSPITAL BEDS 2005 2010 2015 2018*
Beds in acute and general hospitals 16 693 14 516 13 621 13 141
Beds in psychiatric hospitals 5370 4658 3971 3700
Note: *The way private hospital beds with public contracts are counted has changed after 2015.
Source: Statistics Norway (2019a)



































































In 2019 the four RHAs oversaw a total of 20 hospital trusts. The number 
of hospital trusts reflects population size, with the greatest number of trusts 
located in the South-Eastern RHA (see Table 4.2). The size of hospital 
trusts varies, from about 160 beds in the smallest (Sunnaas) trust to more 
than 1600 beds in the largest (Oslo University Hospital) trust (both in the 
South-Eastern RHA). Four trusts have more than 1000 beds, eight have 
between 500 and 1000 beds, and eight have fewer than 500 beds. The hospital 
trusts, in turn, comprise smaller hospitals and other institutional entities 
at different locations. A single trust can cover vast geographical areas. For 
example, in the county of Nordland, the distance between hospitals within 
a trust can exceed 500 kilometres.
Each region has one regional hospital, which is a university hospital 
offering the largest range of services in the region. The regional hospital may 
have interregional responsibilities in some areas, i.e. provide certain services 
to patients from all regions, or head networks within specialties at regional 
and/or national level. A new national hospital plan, released in November 
2019, organizes hospitals into a three-tier network (see Section 5.4.2).
In 2017 beds in publicly financed providers accounted for 96% of the 
total number of hospital beds (Statistics Norway, 2019a).
TABLE 4.2 Hospital trusts and beds by RHA, 2017
RHA SOUTH-EASTERN WEST CENTRAL NORTH TOTAL









Number of hospital trusts 9 4 3 4 20
Source: Statistics Norway (2018)
The age and condition of hospitals vary across the country (RIF, 2015). 
According to the survey conducted by the Auditor General in 2011 (latest 
information available) (Auditor General, 2011), the average age of hospital 
buildings was approximately 45 years in that year but there were large var-
iations in the condition of the facilities, with half of them being in good or 
acceptable condition, 40% in unsatisfactory condition in need of corrective 
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measures and 10% in poor condition and in need of major technical upgrad-
ing. In general, the condition of hospital facilities was poorer in the Northern 
and Western RHAs.
REGULATION OF CAPITAL INVESTMENT
Overall responsibility for the planning of infrastructure and capital invest-
ments in public facilities lies with their respective owners. The municipal-
ities decide on investments in primary care and other care provided at the 
municipal level, with investment decisions in each municipality taken by 
the local municipal council (see Sections 5.1–3 and 5.6–11). Decisions on 
investments in hospitals are taken by the RHAs, which represent directors 
of the local hospital trusts. Investment proposals are made by the boards of 
local hospital trusts, which later also approve the investment decisions of 
the RHAs. The exception is the South-Eastern region, where the RHA is 
responsible for all larger investments. While the RHAs have a wide authority 
to plan and manage their hospital infrastructure, the MOHCS is responsible 
for monitoring investments in specialist care. In addition, the MOHCS has 
the authority to approve larger capital investment projects for which 30% or 
more of funding comes from the RHAs.
In 2015 the RHAs established the Agency for Hospital Construction 
(Sykehusbygg HF). The Agency is funded by the RHAs with additional 
funding allocated by the government (Norwegian Ministry of Finance, 2017). 
It provides expertise on hospital planning and construction to all hospital 
trusts and can assist them in the acquisition and sale of real estate.
BOX 4.1 Assessing the geographic distribution of health resources
The distribution of hospitals in Norway reflects geographical differences in 
population density and thus the South-Eastern Region has the largest hospital 
network (highly specialized hospitals serving the whole country are also in this 
region) and the largest distances are between hospitals in the Northern region. 
Given the long travel distances in the more sparsely populated areas, the aver-
age length of hospital stay (ALOS) tends to be longer for patients living in these 
areas and the average number of hospital beds per 1000 inhabitants also tends 
to be somewhat higher than in more densely populated areas. This may lead to 
inequalities in access to care (see Section 7.2).
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INVESTMENT FUNDING
Hospital trusts finance capital investments and annual depreciation costs 
from their general incomes, i.e. from allocations from the RHAs. In case 
of large capital investments, they may apply (via their RHA and with the 
support of the Agency for Hospital Construction) for a special investment 
loan from MOHCS for 70% of the funding. If hospital trusts enter into 
contracts with private service providers, the contracts must take into account 
the capital investment needs of these providers.
The RHAs may finance investments in the health trusts by borrowing 
(debt financing). RHAs are not allowed to borrow money in the private 
market, but can borrow from the Norwegian Central Bank. Private financ-
ing occurs occasionally in the form of donations, e.g. equipment donations.
Investment decisions at the municipal level are taken by the municipal-
ities according to local needs and means. There are also earmarked central 
grants for certain investment, e.g. for providing local emergency care beds 
to support early hospital discharge (see Box 5.3).
4.1.2 Medical equipment
Medical equipment is financed in the same way as capital investments (see 
Section 4.1.1). The availability of medical equipment varies and its utiliza-
tion rates are mixed compared to other countries in the EU (see Table 4.3).
Almost all imaging diagnostic equipment is in specialist care. There are 
documented differences both between and within regions in accessibility of 
medical equipment such as positron emission tomography (PET) or com-
puted tomography (PET-CT) scanners, as well as palliative radiotherapy 
(PRT) (Asli et al., 2018; Office of the Auditor General of Norway, 2017).
TABLE 4.3 MRI and CT exams per 1000 population, yearly average 2012–2015
ITEM NORWAY EU AVERAGE
MRI exams 120 64
CT exams 74 143
Sources: Auditor General (Report 1 2017) and Eurostat/OECD Health Data (HAG 2017)
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4.1.3 Information technology and eHealth
IT USE IN THE HEALTH SYSTEM
The Norwegian Health Network (NHN) was established in 2004. The NHN is 
responsible for provision of efficient and secure electronic exchange of patient 
information via a health communication network between all relevant parties 
within the health and social services sectors, including across the regions and 
different administrative levels. Since 2016 the NHN has been responsible for 
delivering ICT-services to the central health administration and its subordinate 
agencies. Currently, all public hospitals and pharmacies and 365 municipalities, 
together covering over 90% of the population, are covered by this network 
(www.nhn.no). From January 2020 their responsibility will be extended to 
include Summary Care Records (see below), as well as e-prescriptions.
The Norwegian Directorate of eHealth was established in 2016 with 
the mandate to implement the national policy on eHealth, establish the 
requisite standards, and administer the use of eHealth methodology nation-
wide (see also Section 2.2). It has been responsible for the development of 
the above-mentioned Summary Care Records and e-prescriptions, which 
will be transferred to the NHN from 2020. While the NHN takes on more 
responsibility for implementation, it is envisaged that the Directorate of 
eHealth will strengthen its governance role.
The National ICT Health Trust, established in 2014 by the RHAs, 
currently implements a system of electronic medical records, known as 
Summary Care Records. By December 2018 the system was accessible to 
all citizens; however, only 35% had accessed their record and 6% entered or 
corrected their information (Norwegian Directorate of eHealth, 2019). At 
the same time it was used by 71% of GP practices and 86% of pre-hospital 
emergency medical services (see Section 5.5).
Almost all (98%) GP practices have computers. According to the 
Directorate of eHealth’s monitor (Norwegian Directorate of eHealth, 2019), 
in early 2019 more than 400 municipalities (out of a total of 429) had an 
electronic system for exchanging patient information with hospital trusts, 
as well as a system for exchanging patient information among GP practices. 
Most GP practices (93%) use computers and decision-support systems during 
consultations. The use of electronic exchange of patient data is also high. The 
use of e-referrals to specialist and hospital care has increased dramatically 
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since 2013. In 2017, 96% of the municipalities sent electronic referrals to 
hospitals. In 2017 nearly all patient information sent from hospitals to 
municipalities was sent electronically.
E-prescriptions were implemented nationally for GPs in 2011, and for 
hospitals in 2016. By the end of 2018 more than 92% of all human prescrip-
tions were e-prescriptions and about 12% of these prescriptions were issued 
by hospitals (Norwegian Directorate of eHealth, 2019). With e-prescriptions, 
patients can collect their prescription medicines from any pharmacy in 
Norway and may also authorize others to collect their medicines for them. 
In addition, since 2013 a service within helsenorge.no has given patients 
access to information about their active prescriptions and medicines collected 
during the past month, as well as about all prescriptions in the previous three 
years. The next step is a roll-out of e-prescriptions for unit dose dispensing.*
Telemedicine is routinely used to improve access to care and to provide 
continuous education to health personnel in remote areas. In recent years 
the use of telemedicine has been piloted for monitoring people with chronic 
diseases and a national scale up of the pilots has been recommended.
According to Statistics Norway, use of the internet as a source for health-
related information increased from 39% in 2009 to 65% of the population in 
2018 (Statistics Norway, 2019a). The Directorate of Health promotes the use 
of mobile applications for those who seek a healthier lifestyle and to improve 
their mental wellbeing. Via the website “Bare du”, people can download rele-
vant applications, e.g. to help them quit smoking and reduce alcohol intake.
4.2 Human resources
4.2.1 Planning and registration of human resources
The Norwegian Authority for Health Personnel, which is part of the 
Directorate of Health, is responsible for the licensing and authorization of 
health care personnel in Norway. Currently, 29 categories of health person-
nel are licensed. The Directorate of Health and Statistics Norway share the 
responsibility for monitoring and evaluating health workforce trends.
* The unit dose dispensing system of medications is a pharmacy-coordinated method of 
dispensing and controlling medications.
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Since the mid-1990s Statistics Norway has been modelling long-term 
supply and demand trends in health personnel. Its model (HELSEMOD) 
contains predictions for more than 20 different categories of health person-
nel groups (Statistics Norway, 2019b) and has informed human resources 
policies in the health sector.
The Directorate of Health issues certificates of specialization to medical 
doctors, in accordance with specific and transparent requirements. Except 
for GPs, there is no system for re-evaluation or re-authorization for medical 
doctors.
4.2.2 Trends in the health workforce
The number of physicians per 1000 inhabitants has been increasing over the 
last few decades. At 4.8 per 1000 in 2018, the ratio in Norway was higher 
than in all the comparator countries featured in Fig. 4.2.
In 2016, 17 606 physicians worked in Norway. Out of these, 4606 (26%) 
worked in the municipalities (as GPs or other), 12 000 (68%) worked as 
specialists in hospitals and 1000 (6%) worked as specialists outside hospitals. 
The proportion of physicians working for the municipalities increased by 
13% between 2013 and 2016 (Norwegian Directorate of Health, 2016). Yet 
the distribution is uneven and some municipalities experience shortage of 
GPs (see Box 4.2).
BOX 4.2 Evaluating the geographic distribution of GPs
There are regional variations in access to GPs, with patients living in rural and 
smaller municipalities having poorer access. In nine municipalities, six of them in 
Northern Norway, there were no GPs at the end of 2018 (Norwegian Directorate of 
Health, 2018c). In three counties, Finnmark, Nordland and Møre & Romsdal, vacant 
GP positions have left 2–4% of their populations without a GP, and the vacancies 
have been not filled for a long time (Norwegian Directorate of Health, 2017c).
A Commonwealth Fund population survey of persons aged 65+, conducted 
in 2017 in Australia, Canada, France, Germany, the Netherlands, New Zealand, 
Norway, Sweden, Switzerland, the UK and the USA found that the proportion of 
respondents reporting that they waited two or more days to access a GP was larger 
in Norway than in other countries (53% vs 38% on average) (Skudal et al., 2016).
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The ratio of nurses to inhabitants has also increased over recent years and 
at 17.8 nurses per 1000 inhabitants remains among the highest in the EU/
EEA (Fig. 4.3). However, despite these high numbers, nurse shortages are 
predicted in the years to come (see Section 7.2). Given these forecasts, since 
2015 municipalities have had the opportunity to apply for state subsidies 
to employ more nurses and municipal health care workers. These subsidies 
are available until 2020.




















































































































Note: Professionally active nurses for France
Source: OECD (2019)
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The number of dentists in Norway has been stable over the past decade, 
and remains fairly high – at 0.9 per 1000 inhabitants in 2018. Although 
Statistics Norway projected a shortage of dentists by 2020, these projections 
have been met with scepticism from universities offering education in den-
tistry and there are currently no plans to increase the educational capacity at 
these universities. The number of pharmacists in Norway increased substan-
tially between 2009 and 2018 to 0.8 per 1000 inhabitants, which is similar 
to the OECD average (OECD, 2019).
4.2.3 Professional mobility of health workers
Norway employs a large number of health workers trained abroad – a 
total of 18% of its health workforce in 2015. Out of 37 700 foreign work-
ers within the health care sector there were about 11 000 nurses (29%), 
10 300 health care workers (27%) and 5200 doctors (14%) (Statistics 
Norway, 2019a).
The share of foreign-trained physicians was slightly above 40% of the 
total in 2018 and the respective figure for nurses was 9% (OECD, 2019). 
Among OECD countries, only Israel, New Zealand and Ireland have a 
higher share of foreign-trained doctors. Nearly half of foreign-trained 
doctors were Norwegian-born, but completed their medical studies abroad 
(Norwegian Medical Association, 2016). A majority of the foreign-trained 
nurses were trained in the other Nordic countries or in other EU/EEA 
countries.
Health personnel trained abroad whose native language is not Norwegian 
must pass a language proficiency test and prove that they have knowledge 
of Norwegian health and care services, health, social security and social 
rights, Norwegian culture, and key national issues. In addition, they must 
pass courses in the safe handling of medicines and a medical proficiency test, 
which is adapted to different professions.
4.2.4 Training of health personnel
An authorization from the Directorate of Health is required for all categories 
of regulated health professions in order to practise in Norway.
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PHYSICIANS
Medical study programmes are offered at four public universities in Norway 
(Oslo, Bergen, Trondheim and Tromsø), with a total educational capacity 
of 600 students in 2016. The curricula of the medical faculties have so far 
not been subject to detailed regulation and may differ, especially as regards 
teaching methods and the organization of the study programmes. Between 
2005 and 2015 the government signalled several new requirements regarding 
medical competencies for basic medical education. The suggestions covered 
a wide variety of areas from patient safety, innovation, teamwork, patient 
pathways, patient involvement and public health to disease prevention, and 
the universities have responded by implementing changes in the medical 
curricula (Frich, 2016).
Basic medical education lasts six years, after which all medical school 
graduates may obtain an authorization to practise. Since 2013 medical 
students applied for available residency positions and hospitals selected 
the candidates they wanted to employ. A new system of competency 
training was introduced in 2017. The previous system with internships 
has been replaced by a system of specialization called ‘LIS’ (Leger i spe-
sialisering – Physicians in specialization). LIS1 (Part 1) consists of one 
year of hospital training and six months of training in primary care (in 
the municipalities). LIS2 (Part 2) introduces shared competency platforms 
for groups of specialties (such as internal medicine and surgery) (36 
months), while LIS3 (Part 3) covers training unique to each specialty (24 
months). LIS2 only applies to 17 specialties, which means that medical 
students pursuing these specialties must complete all three parts of the 
training. Students enrolled in the remaining 25 specialties must complete 
only part 1 and 3 of the training. The LIS education programme takes 
6.5 years in total. The new competency training system is coordinated 
nationally, with a regional coordinating centre in each RHA. All GPs 
working in primary care are required to become specialists in general 
medicine by 2022.
A degree in dentistry (Masters in Dentistry) is awarded after five years 
of study. The first two years of this programme are integrated with the med-
ical study programme. Dental specialization programmes are offered by the 
University of Oslo and last three or five years (longer for oral surgery and 
oral medicine).
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Studies in pharmacology are divided into a three-year Bachelor’s and 
a two-year Master’s degree. The Master’s programme usually includes six 
months’ practical training in a hospital or community pharmacy.
NURSES
There are two types of nursing practitioner in Norway: registered nurses 
(RNs) and licensed practical nurses (LPNs). The latter are not included in 
the figures shown in Fig. 4.3.
There are 10 educational institutions in Norway offering basic RN 
education at more than 35 locations, mainly in universities. An increasing 
number of colleges offer decentralized (e.g. web-based training or train-
ing in local educational institutions) or part-time study programmes. The 
minimum requirement for entering the RN programme is a general study 
competence, which usually means that the applicant has completed three 
years of upper secondary education. The basic RN degree takes three years 
or 180 ECTS points and nurses who have completed it are awarded a 
Bachelor’s degree and are authorized to practise. Half of the study time is 
devoted to clinical training, organized by the RHAs and the municipali-
ties. After completing the Bachelor’s degree, RNs can subsequently pursue 
a Master’s degree or enter a specialization programme in nursing (60–90 
ECTS points), for example in intensive care or operating theatre nursing. 
Specialization programmes are not part of the Bologna system; however, 
these programmes are now being included in Master’s degree programmes 
at university colleges (Råholm et al., 2013). Nurses undergoing full-time 
specialist education are usually paid an allowance by their employer for the 
duration of their studies and, in exchange, commit to work for the same 
employer for a certain number of years after finishing the specialization. 
Master’s degree curricula can differ as there is no single national standard in 
this area. However, streamlining the Master’s degree is part of the planned 
educational reforms for the welfare sector.
LPNs are classified as health care workers and obtain a certificate upon 
completion of vocational training in upper secondary school. This system was 
introduced in 2008, replacing the former auxiliary nurse and care worker edu-
cation. In order to receive a certificate and to be able to apply for a licence to 
practise, the nurse must complete two years of secondary vocational education 
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and two years of training. LPNs may undertake further specialization, e.g. 
in mental health nursing or music-based therapy, and might qualify for an 
intake to nursing schools to become RNs.
Given the predicted shortages of nurses (see Section 6.1), in 2016 the 
government set out an action plan, the Competence Lift 2020 (Kompetanseløft 
2020), to increase recruitment and improve the competencies and profes-
sional development of the health workforce in the municipalities (Norwegian 
Directorate of Health, 2017c).
OTHER HEALTH CARE PROFESSIONALS
Besides physicians, dentists, psychologists and nurses, several other profes-
sional work titles within the health sector are protected by law. These include 
midwife, medical secretary (providing administrative support), ambulance 
worker and physiotherapist. All these professions need an issued authori-
zation in order to practise.
4.2.5 Physicians’ and nurses’ career paths
Physicians and nurses can pursue a clinical career (with or without managerial 
responsibility), an academic career or a combination of both (in which case 
they usually base their research on clinical practice). Most physicians and a 
large number of nurses choose to continue their studies in order to qualify 
as specialists after receiving their authorization to practise. For nurses, an 
academic career is more difficult to combine with clinical practice.
Graduate medical education requires a minimum of four to five years 
of residency (see Section 4.2.4). Upon completing the residency training, 
residents are usually employed as specialists at the hospital where they com-
pleted their residency training.
4.2.6 Other health workers’ career paths
Strengthening education in general management has been a national policy 
priority since the 1990s. An analysis of managers in the municipal care 
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sector, based on data from the Norwegian Association of Local and Regional 
Authorities (KS), reveals a shift in management from 2007 to 2015, with 
an increase of managers for home services and a decrease in managers for 
institution-based services. The majority, nearly 70% of all managers, have 
a background in nursing. Since 2015 the Norwegian Business School has 
been contracted by the Directorate of Health and KS to offer management 





  The overall responsibility for public health rests with the Ministry 
of Health and Care Services, while the municipalities are respon-
sible for implementing cross-sectoral public health interventions 
locally. Various governmental and non-governmental actors are 
involved in public health activities. The Public Health Act (2012) 
improved horizontal and vertical coordination of public health 
work. In 2015 the government presented a white paper with a 
comprehensive overview of public health initiatives, including 
incorporation of mental health as an integral part of public 
health.
  Primary care is provided at the municipal level, mostly by self-
employed physicians and as part of municipal services (in nursing 
homes and as part of home-based services). GPs act as gatekeep-
ers, referring patients to more complex care. Inpatient specialized 
care is mainly provided by hospital trusts owned by the RHAs. 
Hospitals also provide outpatient specialist care in their outpatient 
departments. As in many other countries, there has been a marked 
shift from inpatient hospital care into outpatient and day surgery 
and care settings, as well as an expansion of home care. Delivery 
of primary care through multidisciplinary teams is currently being 
tested alongside new primary care financing models. Policy efforts 
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have also aimed at improving coordination between municipal and 
specialist care.
  Emergency care services are largely the responsibility of munici-
palities at the primary care level, and are provided by GPs or local 
emergency centres, which are a first point of contact in case of 
medical emergency. Referral from a physician or the ambulance 
service is needed to attend hospital A&E departments.
  Access to pharmaceuticals, including innovative therapies, is 
generally good in Norway. Generic substitution, introduced in 
2001, has led to substantial reductions in the cost of pharmaceu-
ticals financed through the NIS. The share of generics in 2018 
accounted for 52% of total sales volume – more than double what 
it was in 2001.
  More than a quarter of spending on health in Norway is devoted 
to long-term care. It is provided in three types of setting: patients’ 
homes, nursing homes or sheltered homes run by the municipali-
ties. With the exception of home care, long-term care in municipal 
settings requires substantial co-payments by users.
  Specialized mental health services are the responsibility of the 
RHAs and are provided in highly specialized mental health hos-
pitals/departments, community mental health centres and in out-
patient settings. Mental health centres play an increasing role in 
the decentralization of mental health services, as they provide acute 
mental health treatment and rehabilitation, and offer supervision 
and support for other providers in primary care.
5.1 Public health
The overall responsibility for public health rests with the Ministry of Health 
and Care Services, while the municipalities are responsible for implementing 
cross-sectoral public health interventions locally and ensure that they are 
knowledge-based, systematic and long-term orientated. Various governmental 
and non-governmental actors are involved in public health activities. The 
Directorate of Health, the NIPH and the Board of Health (see Section 2.1) 
all play important roles in supporting the implementation and monitoring 
of public health policies at the national level.
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The Public Health Act introduced on 1 January 2012 aimed to improve 
coordination of public health work horizontally, across various sectors 
and actors, and vertically, between authorities at the local, regional and 
national levels. The Public Health Act is based on five guiding principles for 
public health work: equity, health in all policies, sustainable development, 
precaution and participation, which were further elaborated in the White 
Paper “Public Health Report: Good health – a common responsibility” 
(Norwegian Ministry of Health and Care Services, 2013). The strategic 
goals included in the White Paper are to increase life expectancy, ensure 
more years of good health and well-being for the entire population, reduce 
social inequalities in health, and create a society that promotes good 
health throughout the entire population. These goals were also embraced 
by the next government in their White Paper entitled “Public Health 
Report – Accomplishments and possibilities” (Norwegian Ministry of 
Health and Care Services, 2015c). This updated public health strategy 
emphasizes promotion of mental health measures, especially targeted at 
young people, reducing work absenteeism, promoting healthy lifestyles, 
active ageing, and empowering children and young people, as well as 
improving cross-sectoral cooperation in public health. These goals are 
detailed and operationalized in a number of strategies and national action 
plans, including:
  #Youth Health – the Norwegian government’s strategy for youth 
health 2016–2021, which is the first national youth health strategy 
in Norway and emphasizes the impact social media has on body 
image;
  the National Action Plan for a Healthier Diet (2017–2021);
  the National Action Plan for Diabetes (2017–2021);
  the National Brain Health Strategy (2018–2024);
  Dementia Plan (2020);
  “A tobacco-free future” – the National Strategy for Tobacco Control 
(2013–2016);
  Action Plan for Prevention of Suicide and Self-harm (2014–2017);
  More Years – More Opportunities (2016), which is a national 
strategy to make society more age-friendly, and to better harness 
the resources offered by older people in terms of participation and 
contribution to society.
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Public health is an integrated part of the Strategy for Good Mental Health 
(2017–2022) and the Action Plan for Mental Health in Children and 
Adolescents (2019–2024). In addition, the Action Plan for Prevention of 
Suicide and Self-Harm (2014–2017) is envisaged to be followed by a new 
action plan for prevention of suicide in the general population as well as in 
the health services in 2020.
An assessment of the effectiveness of public health interventions is 
provided in Box 5.1.
While counties play an important coordinating role (see Section 2.3), 
public health activities are mainly carried out at the municipal level. Counties 
are expected to have an overview of the health status in their territory, 
including risk factors as well as factors that influence health positively. 
Municipalities are expected to monitor the health status of their population 
and factors that may influence this; such information provides the basis 
for planning their local public health strategies. Municipal public health 
activities include promotion of the population’s health and well-being; 
prevention of mental and somatic illnesses, disorders and injuries; and 
ensuring good social and environmental conditions. The actual provision 
of services is carried out by GPs, the Municipal Medical Officers (one in 
each municipality), at municipal health care centres/clinics, in school health 
services and nursing homes, etc. The municipalities are also responsible for 
facilitating cooperation with the voluntary sector (Public Health Care Act 
2012 4).
IMMUNIZATIONS AND OTHER PREVENTIVE SERVICES
Municipalities are responsible for delivering vaccines included in the 
Norwegian Childhood Immunization Programme. The Programme began 
in 1952 and currently offers free childhood vaccinations against 13 dif-
ferent diseases: measles, mumps and rubella (MMR), diphtheria, tetanus, 
whooping cough, Haemophilus influenzae type B (Hib), pneumococcal 
disease, poliomyelitis, rotavirus, Hepatitis B, and human papilloma virus 
(HPV). Some children are also offered vaccination against tuberculosis. 
Children usually receive their first vaccinations at 3 months and follow the 
programme until they are 15 or 16 years old. Booster doses of vaccines are 
administered once school age is reached. Vaccination is not compulsory, 
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but coverage is well above 90% for most of the vaccines included in the 
programme (Norwegian Institute of Public Health, 2017b). The rubella 
vaccine for adults is offered free of charge to women of childbearing age 
who do not have immunity against rubella. Influenza and pneumococcal 
vaccines are recommended to risk groups, including pregnant women and 
people over 65 years old. Vaccines are mainly provided by GPs and are 
subject to co-payment.
Municipalities are also responsible for providing family planning and 
antenatal services. The services are provided either by a midwife at the local 
Maternity and Child Health Care Centre (helsestasjon) or by the regular 
GP. This normally includes eight antenatal appointments, including one 
ultrasound screening during pregnancy. The consultations are free of charge, 
and working women who are pregnant have the right to paid time off work 
for attending antenatal appointments.
Since 1996 Healthy Life Centres (HLC) have been established in 
the municipalities offering interdisciplinary primary care services such as 
exercise groups and counselling for people who need support in changing 
their health behaviour or coping with health problems and chronic disease. 
While there is no statutory obligation for a municipality to establish HLCs, 
the Directorate of Health recommends that all municipalities create one 
in order to manage the preventive health services they provide (Saunes, 
2016a). In 2018, 64% of the municipalities had an HLC (Statistics Norway, 
2019a).
SCREENING PROGRAMMES
Norway has three national cancer screening programmes. Two of them, for 
breast cancer for women aged 50–59 and for cervical cancer for women aged 
25–69, have been in place since 1995, while the third one, for colorectal 
cancer, is currently being piloted for men and women aged 50–74. From the 
autumn of 2019 men and women turning 55 years of age will be invited to 
participate in the screening programme and national coverage is expected 
to be reached in 2024. The screening programmes are all administered by 
the Cancer Registry of Norway.
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SURVEILLANCE OF COMMUNICABLE DISEASES
The NIPH runs the Norwegian Surveillance System for Communicable 
Diseases (Meldingssystem for smittsomme sykdommer, MSIS) and contributes 
to international surveillance in collaboration with the European Centre 
for Disease Prevention and Control and the World Health Organization. 
The MSIS distinguishes between three groups of diseases. Reports on 
group A diseases (e.g. cholera, hepatitis) from medical microbiological 
laboratories and doctors are sent to the NIPH immediately after detection 
with full patient identity. Copies of the notifications are also sent to the 
Municipality Medical Officer in the patient’s municipality of residence. 
For group B diseases (gonorrhea, HIV and syphilis), reports are also sent 
immediately to the NIPH by doctors and medical microbiological labo-
ratories, but the patient’s identity is not disclosed. Copies of the notifi-
cations are also sent to the Municipality Medical Officer in the patient’s 
municipality of residence. For group C diseases (genital chlamydia and 
clostridium difficile), reports also do not disclose the patient’s identity but 
they are not sent immediately. Early warning notification (i.e. immediate 
notification outside the regular written notification system) is required 
in isolated cases of selected group A diseases, such as rabies and rubella. 
The warning must be delivered to the local Municipality Medical Officer, 
who will then immediately notify the NIPH and the County Physician. 
This applies both within and outside the hospital setting. If there is a 
suspicion or confirmation of an infectious disease that can be transmitted 
in food or water, the Municipality Medical Officer must also notify the 
local Food Safety Agency.
OCCUPATIONAL HEALTH SERVICES
According to the Working Environment Act 2005, which regulates occupa-
tional health, employers are responsible for ensuring that health and safety 
standards are met in workplaces and must have written objectives for health, 
environment and safety activities. Implementation of this Act is monitored by 
the Norwegian Labour Inspection Authority under the Ministry of Labour 
and Social Affairs. The Labour Authority has seven regional offices and 16 
local offices around the country. The latter guide and supervise individual 
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employers in local communities and oversee that they comply with the legal 
requirements (Norwegian Labour Inspection Authority, 2018).
Norway has the highest rate of work absences of full-time employees 
among OECD countries (see Section 1.4). A series of inclusive workplace 
agreements between employers, employees and the NAV have been in 
place since the early 2000s in order to reduce work absenteeism due to 
sickness; to increase the employment rate among employees with func-
tional impairment; and to increase the actual retirement age. The current 
agreement covers the period from 1 January 2019 to 31 December 2022. 
Employees of companies that have signed the agreement have the right to 
take sick leave without a physician’s certificate for up to eight calendar days 
per single absence, up to a total of 24 days per calendar year. Occupational 
health services provided by the workplace to help bring employees on 
prolonged sick leave back to work and get them off disability benefits 
may be refunded at a special rate under the NIS. The employment rate 
among employees with a functional impairment was 44% in 2018 compared 
to 70.4% for the population between 15 and 66 years of age (Statistics 
Norway, 2019a). A report documenting goal attainment for the inclusive 
workplace agreement from 2012 to 2018 documented rather stable levels 
of sickness absenteeism and employment rate of people with functional 
impairment, while there has been an increase in the actual retirement age 
(Telle et al., 2018).
BOX 5.1 Assessing the effectiveness of public health interventions
For more than 50 years Norway has implemented targeted anti-tobacco interven-
tions. They include high taxes on tobacco, warnings on all tobacco packaging and 
restriction on smoking in public, with smoking restricted in public areas since 1988 
and prohibited in all indoor public areas since 2004. These interventions have led 
to decreasing rates of tobacco smoking (see Section 1.4). About 25% of former 
smokers have substituted cigarettes with a moist powder tobacco (snus), which 
is becoming increasingly popular also amongst non-smokers. The most recent 
regulations on tobacco products, which came into effect on 1 July 2017, require 
standardized packaging of cigarettes, roll-your-own tobacco, and snus. They also 
extended the existing smoking restrictions to the use of e-cigarettes. New legis-
lation on electronic cigarettes, herbal products for smoking and novel tobacco 
and nicotine products, largely based on the EU Tobacco Products Directive 
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2014/40/EU, is expected to enter into force in 2020. The government launched 
a new national tobacco control strategy in 2019, where the focus continues on 
making tobacco products less attractive to young people, increasing smoking 
cessation among heavy smokers and reducing the tobacco industry’s influence 
and marketing possibilities.
In the area of nutrition, a collaboration between MOHCS and the private sector 
was established in 2014, and resulted in a memorandum of understanding on 
healthy diets (2016–2021), which involved about 100 enterprises in addition to the 
MOHCS. Norway’s major food providers are involved as participants, whereas 
non-profit organizations take part as observers. The aim of this collaboration is to 
reduce the intake of salt, sugar and saturated fat, and increase the consumption 
of fruit, vegetables, wholegrain foods and fish. Evidence on the effectiveness of 
this initiative is not yet available.
In 2015 the government launched the National Strategy against Antibiotic 
Resistance for 2015–2020. The goal was to reduce the use of antibiotics in humans 
by 30% by 2020. In the period 2012–2015 the use of antibiotics in inpatient care 
decreased by 13% (Norwegian Ministries, 2015). There has also been a sub-
stantial decline in the use of second line antibiotics within primary care. In the 
period 2012–2018 the prescription of antibiotics decreased by 27% (Norwegian 
Directorate of Health, 2018e). Use of antibiotics in animals in Norway is among 
the lowest in Europe and is partly explained by the use of vaccines in aquacul-
ture – since 1987 antibiotic use in aquaculture, measured as total weight, has 
decreased by 99%.
Participation rates in screening for breast cancer reveal variation. According to 
a study in 2016 on average 84% of invited women aged 50–69 attended screening 
at least once in their life. Participation rate among immigrant women was 67% 
(Bhargava et al., 2018). The five-year survival rate for breast cancer in Norway is 
amongst the highest in the world (OECD, 2017), reflecting both earlier diagnosis 
in some cases and effective treatment once diagnosed.
Immunization rates in children have been increasing and the vast majority of 
children and young people are vaccinated against the diseases recommended in 
the Norwegian Childhood Immunization Programme. The current coverage rate of 
immunizations for diphtheria, tetanus, pertussis (DTP) and measles is 96%, which 
is higher than the WHO recommended rate of 95% (Norwegian Institute of Public 
Health, 2017b). The vaccination rate for influenza is 14% in the total population 
and 56% in older patients with a chronic disease. The total vaccination rate for 
influenza for people aged 65+ is 38% in Norway, compared to 43% in the EU (OECD 
Health Statistics, 2018). Measures are being implemented to increase vaccination 
rates for influenza, such as reducing the vaccine price for the target population 
and easier access, e.g. by organizing so-called vaccination days.
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5.2 Patient pathways
The patient’s first contact with the health care system is usually through 
the regular GP or the on-call physician at one of the emergency centres 
that are located in all municipalities (see Section 5.3). Physicians in the 
municipalities have a gatekeeping role to specialist care. However, in case 
of medical emergencies, patients may attend the emergency department at 
the nearest hospital. For elective specialist care, the GP can either make an 
appropriate appointment on behalf of the patient or provide a referral so 
that the patient can arrange the appointment. A typical patient pathway is 
described in Box 5.2. A number of clinical pathways exist within specialized 
care for certain conditions (see examples in Box 5.3).
BOX 5.2 Example of a patient pathway
A 75-year-old woman with a slight limp and pain in the hip would typically take 
the following steps:
• She visits her regular GP, who examines her, makes a tentative diagnosis 
of arthritis and refers her for a radiology examination. Co-payments are 
due for most outpatient consultations.
• After receiving the radiology examination results, the GP refers her to 
an orthopaedic department, usually at a public hospital in the region, 
for examination and, subsequently, an operation or conservative treat-
ment. The patient may choose the hospital where the procedure will be 
performed (see Section 2.5.2). Information on hospital waiting times and 
volumes are available online and patients may also seek advice from the 
national helpline. Waiting time for orthopaedic evaluation varies from 2 
to 20 weeks. The GP prescribes any necessary medication before, but 
not during, hospitalization.
• For conservative treatment, she will be referred to a physiotherapist, 
receive adequate pain management and be scheduled for a follow-up 
appointment for re-evaluation of the condition.
• For an operation, the patient has to wait up to seven months for elective 
surgery. She has free access to any public hospital in Norway, and her 
GP might advise her to seek treatment in a hospital with a shorter waiting 
list. Change of hospital after the initial evaluation may, however, result in 
prolonged waiting time, as some hospitals request in-house orthopaedic 
98 Health Systems in Transition
evaluation. If she cannot get treatment within the individual waiting time 
set by the first hospital, Helfo will contact the patient to offer assistance 
with finding timely care at another hospital. A private hospital may also 
be chosen if it is pre-approved by the Directorate of Health.
• Following surgery and rehabilitation at the hospital the patient is released 
home, where she might need home care (home nursing and/or home 
assistance). If this is prescribed by the hospital or her GP, it will be pro-
vided by the municipality free of charge.
• The GP is responsible for any further follow-up, such as providing a 
referral to a physiotherapist (a small co-payment would then have to be 
paid for physiotherapy).
• A follow-up hospital visit is likely to take place in order to check the 
result of the treatment.
• The Helfo covers part of the costs incurred at the GPs and for surgery, 
part of the travel costs, part of the cost of specialist examinations, all 
inpatient and rehabilitation costs at the hospital and part of the cost of 
physiotherapy (see Section 3.4 – cost sharing).
BOX 5.3 Integration of care
The Practice Consultant Scheme (Praksiskonsulent, PKO) has been in place since 
1995 to help plan patient pathways and improve cooperation between primary 
care and specialized services. Within this scheme, GPs work part time (10–20%) in 
hospitals. However, the scheme faces challenges, given the limited time GPs can 
spend in hospitals due to increasing care responsibilities within municipalities. In 
some areas, especially for geriatric care and cancer treatment, specialist multi-
disciplinary mobile teams have been established by the hospitals. They provide 
guidance and care to patients at home or in other settings within the community.
Standardized patient pathways are implemented in municipalities and hospitals 
in Norway to ensure good coordination of evidence-based care. The RHAs distin-
guish between three categories of patient pathways comprising hospital-based 
services, municipal health care services, and specialized health care services 
provided outside hospitals: (1) internal hospital pathways where patients stay and 
receive treatment and follow-up within the same hospital; (2) pathways involving 
several hospitals within the same hospital trust; (3) pathways involving different 
trusts in the RHAs. Separate pathways exist for adults with psychiatric and/or sub-
stance abuse problems, requiring somatic care. In 2018 pathways were developed 
for children and youngsters with mental health and substance abuse problems.
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INTEGRATION BETWEEN MUNICIPAL AND SPECIALIST CARE
The care coordination reform of 2012 put more emphasis on municipalities’ 
responsibility for 24-hour care and care after hospital discharge, including 
obligating the municipalities to establish individual treatment plans for 
patients with chronic diseases. These plans are created in cooperation with 
other service providers to ensure comprehensive care for the individual. 
Initially, municipalities became responsible for co-financing of somatic 
non-surgical specialist health care services provided in hospitals and for 
National, standardized cancer patient pathways, known as Cancer Patient 
Pathways Programmes (CPP-P), have existed since 2015. The goals of CPP-Ps 
are to prevent unnecessary waiting time for examination and treatment, and to 
improve cooperation with GPs to ensure adequate information and involvement of 
patients in relation to their cancer diagnosis and treatment. Indicators showing the 
proportion of patients receiving care within the specified timeframe are published 
for 26 CPP-Ps. Surveys among the general population, cancer patients and GPs 
following the introduction of CPP-Ps have shown small but positive changes in 
the evaluation of cancer care (Iversen, Bjertnæs &Holmboe, 2015). According to 
the MOHCS, by 2017, 78% of the patients diagnosed with cancer were enrolled in 
CPP-Ps, and 70% of all cases followed the recommended pathway (Norwegian 
Ministry of Health and Care Services, 2017a). A recent study of waiting times 
shows a significant decrease in waiting times between 2007 and 2016, although 
little impact from the CPP-P introduced in 2015 (Nilssen et al., 2019). Authors find 
the reduction in median waiting time for radiotherapy among colorectal, lung 
and prostate cancer patients was reduced by two to seven weeks. For surgery, 
median waiting time remained about 21 days for colorectal and breast cancers, 
and decreased by 7 days for lung and by 36 days for prostate cancers. The 
regional differences were also significantly reduced, and the reductions occurred 
gradually over a decade.
Studies of development and implementation of other clinical pathways, which 
include follow-up in primary care, reveal that serious shortcomings in collabo-
ration between hospitals and the municipalities remain, especially for patients 
with multimorbidities (Grimsmo et al., 2018). This has led some municipalities to 
develop generic care pathways, which appear to be a more sustainable model 
of care for patients with multiple chronic conditions. In 2017 the Directorate of 
Health published national guidelines to support municipalities in developing 
comprehensive patient pathways for patients with multi-morbidities with a high 
level of care needs (see Section 6.1 – primary care reform).
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patients ready for discharge. However, this scheme was abandoned in 2014 
after a change of government (Saunes & Ringard, 2014). Since late 2015 
municipalities have been responsible for providing emergency care beds 
on a 24/7 basis for patients in need of pre- or post-hospital services. From 
2016 length of stay there has been limited to 72 hours for a single episode 
of care to ensure that municipal emergency beds are not used for patients 
with long-term care needs (Saunes, 2016b).
In addition, in response to patient surveys that showed that hospital 
discharge was the least satisfying aspect of a hospital stay, Norway began 
reorganizing the discharge process, including starting the discharge planning 
process at admission, communicating important information to municipal-
ities during the admission, facilitating a discharge discussion with patients 
and families, and creating a discharge checklist. Hospitals are now required 
to contact municipalities within 24 hours of an admission if they believe 
the patient will require follow-up from health or social care services once 
discharged (OECD, 2018a).
As part of the coordination reform, hospitals and municipalities must 
establish formal contracts on the provision of care for patients with complex 
needs to improve integration of care. However, these contracts do not seem 
to reduce tensions between hospitals and municipalities over organizing 
and financing of care and regular day-to-day dialogue continues to be of 
importance (Gautun, Martens & Veenstra, 2016). When serious conflicts 
arise between hospitals, trusts and municipalities, the National Committee 
for Dispute Resolution established by the Directorate of Health is in place 
to help resolve them by providing legal assessment and guidance to the 
parties involved. Between 2013 and 2019 the Committee settled or advised 
in 18 cases.
5.3 Primary care
Municipalities are responsible for providing primary care, including reha-
bilitation, physiotherapy and nursing, and after-hours emergency services, 
as well as non-hospital emergency care beds for patients needing pre- or 
post-hospital services. They are also responsible for a wide range of public 
health and preventive measures (see Section 5.1). Municipalities are free to 
decide how to organize the provision of care, including deciding on whether 
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to hire GPs as public employees or signing contracts with private physicians 
(see also Section 6.1).
Most GPs are self-employed and work under contract with munic-
ipalities. A typical practice usually consists of two to six physicians and 
auxiliary personnel. From 2017 new GPs have been required to either have 
a specialization in general medicine, or be enrolled in the specialization 
programme. Most GPs (97% in 2016) participate in the regular GP scheme 
(Statistics Norway, 2019a), which obligates them to give priority to patients 
on their lists (see Section 2.5.2). Virtually the entire population (>99%) are 
registered with their regular GP, while only about 20 000 people (0.4% of 
the population) do not see their regular GP. The average number of patients 
on a GP’s list was 1157 at the national level in 2017, but with large geo-
graphical variation. For example, in Finnmark (the northernmost county) 
the average was 800 patients, while in Oslo it was 1400 patients. The upper 
limit for patients on a GP list is 2500, while lists with a lower number than 
500 require special contracts with the municipalities (Norwegian Directorate 
of Health, 2017c).
GPs have a key role in the health system as gatekeepers for patients 
with regard to accessing specialist care (see Section 5.2) and care for 
patients with chronic diseases. Their responsibilities include: making pri-
mary diagnoses; treating simple everyday health problems; issuing sickness 
certificates; prescribing drugs; and referring patients to specialist care 
when necessary. Only physicians or ambulance services can refer patients 
to an emergency hospital consultation or to a hospital (for admission). 
GPs are also obliged, through their contracts with municipalities, to serve 
as on-call physicians in the local emergency centres (see Section 5.5). 
Moreover, they play an important role in health promotion and public 
health (see Section 5.1).
In 2015 a comprehensive overview of primary health care was pre-
sented in a White Paper (Norwegian Ministry of Health and Care 
Services, 2015b). The White Paper proposed reorganizing primary care 
by instituting interdisciplinary primary care teams as the basic unit of 
care provision. Two types of interdisciplinary teams were distinguished: 
(1) teams providing general primary health care to the local popula-
tions; and (2) Complex Chronic Care Teams looking after patients 
with complex care needs. The teams were piloted between 2018 and 
2019 and consist of GPs, nurses and medical secretaries, led by a GP 
102 Health Systems in Transition
(see Section 6.1). This is a narrower service than envisaged originally 
in the 2015 White Paper, as it does not include other health or social 
care personnel. A separate action plan on recruitment, competencies 
and professional development in primary health care has since been 
developed (also described in Section 6.1), and a system for educating 
managers at the municipal level to support the reforms has been estab-
lished (see Section 4.2).
BOX 5.4 Assessing the strength of primary care
Primary health care has long been, and continues to be, high on the policy 
agenda, with the coordination reform of 2012 setting a strategic vision for the 
health care system as a whole (OECD, 2014). In terms of access, 33% of patients 
see their GP on the same day (40% of patients within the next four days, and 
waiting times for non-emergency care appearing to be rather stable), and with 
more than 50% reporting a rather easy access to out-of-hours care (Skudal et 
al., 2016) Nevertheless, there may be some gaps in access due to lack of GPs 
in some areas (see Box 4.2), as well as the existence of user fees (see Section 
3.4). A comparative study of primary care published in 2015 ranked the overall 
level of comprehensiveness of primary care in Norway as high, the level of 
accessibility and continuity as medium, and the level of coordination as low 
compared to other countries in Europe (Kringos, 2015). The overall strength 
of primary care, which also takes into account structural and organizational 
factors, was assessed as medium in the same study. The ongoing primary care 
reform (see Section 6.1) is aimed, among others, at improving the accessibil-
ity of primary care. The responsibilities of the municipalities will be extended 
to include more preventive health services, and primary health professionals 
other than medical doctors will be given the right to oversee follow-up care 
for chronic patients.
To date, quality of municipal health services has not been measured regularly. 
But the creation of a new national registry, the Municipal Patient and User Registry 
(kommunalt pasient- og brukerregister, KPR) in 2017 is expected to improve the 
evaluation as well as planning and management of these services. KPR uses 
information from pre-existing registries and contains information such as medical 
diagnoses and health care provided by the municipalities. From 2019, after merging 
with the Norwegian Information System for the Nursing and Care Sector (IPLOS), 
KPR will also include information about social care services. Given that a registry 
covering specialist health care already exists (the Norwegian Patient Registry), 




5.4.1 Specialized ambulatory care
Specialized outpatient care is usually provided in hospital outpatient depart-
ments called polyclinics. There are outpatient departments for somatic care, 
mental health care, and alcohol and substance abuse treatment. These depart-
ments also provide laboratory and radiology services.
Outpatient specialist care is also provided by self-employed privately 
practising specialists (e.g. obstetricians, specialists in internal medicine, etc.), 
mostly working in their own practices under a contractual agreement with the 
RHAs (Gurmu, 2017). They account for about 25% of all specialist outpatient 
consultations, both somatic and mental health care. For somatic care, nearly 70% 
of services provided by self-employed specialists are provided by ophthalmol-
ogists, ENT specialists and dermatologists. For mental health care, one third 
of the specialists are psychiatrists and two thirds are psychologists (Norwegian 
Directorate of Health, 2019b). There is also substantial regional variation in 
the use of privately practising specialists. People in the South-Eastern RHA 
are the most frequent users, whereas people in the Northern RHA are the least 
frequent users of somatic services and people in the Central Norway RHA 
are the least frequent users of privately practising specialists in mental health.
In the rural and more remote parts of the country, care is provided within 
community hospitals (traditionally named sykestue). They provide care that 
cannot be received at the patient’s home but does not require a hospital 
admission, as well as post-hospital care, and decide whether hospitalization 
to an acute hospital is necessary. These institutions are often co-located with 
other municipal health services. Their organizational set-up varies greatly; 
for example, they may be set up as a local department of the nearest hospital 
with a limited range of inpatient care, or care may be provided by contracted 
self-employed specialists who only provide outpatient care and work in 
cooperation with primary care services.
5.4.2 Day care
An explicit policy goal to replace relatively expensive inpatient care with less 
costly outpatient and day surgery and care and bring care closer to patients’ 
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homes has been present in Norway since the 1980s. A range of treatments 
are now provided as day care, including somatic care (e.g. surgery), psychiatric 
care (e.g. treatment of eating disorders) and treatment of drug and alcohol 
addiction. This shift towards day care is reflected in the decline of average 
length of hospital stays, and the decline in the number of acute hospital 
beds (see Section 4.1.2).
A recent example of the substitution policy can be found in the area 
of dialysis treatment. In some municipalities dialysis is now provided on 
an outpatient basis (e.g. in nursing homes), although this is done in close 
cooperation with the local hospital. In 2018, 22% of Norwegian patients 
with chronic renal failure received dialysis at home (Norwegian Directorate 
of Health, 2018a).
5.4.3 Inpatient care
Inpatient specialized care is mainly provided by hospital trusts owned by the 
RHAs. It is also provided by seven privately owned for-profit and not-for-
profit hospitals under contracts with the RHAs. Patients must get a referral 
to access inpatient care but they are free to choose among public and private 
hospitals that are approved by the Directorate of Health (see Sections 2.5.2 
and 3.7.1). In 2015 freedom of choice of hospital was extended to any hospital 
in the EU/EEC, although transportation costs are not covered.
The new Health and Hospital Plan for 2016–2019 emphasizes decen-
tralization of hospital care with the exception of acute care services, where 
centralization is set to increase. According to this Plan, which at the time 
of writing in December 2019 has not yet been fully implemented, all 
hospitals are envisaged to be organized in networks, with regional hospi-
tals, larger acute care hospitals (providing specialized emergency care for 
60 000–80 000 or more inhabitants) and acute care hospitals with elective 
surgery and some acute care functions (specified and planned according 
to local needs). Within this network there are about 50 highly specialized 
competence centres providing services on a national scale. They are mostly 
located within the university hospitals, and mainly conduct activities related 
to professional development, competence evaluation and counselling, but 
sometimes also manage the process of patient treatment in the area of 
their competence.
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Specialist care is concentrated in urban areas, and people living in 
rural areas have to travel longer distances to access specialist services. The 
relatively low number of acute hospital beds per 100 000 inhabitants, com-
bined with high occupancy rates and relative long waiting times, indicates 
potential problems with accessibility of elective hospital care in Norway 
(see Box 5.5).
5.5 Urgent and emergency care
PRE-HOSPITAL EMERGENCY CARE
Provision of pre-hospital emergency medical services in Norway is shared 
between municipalities and hospital trusts. At the primary care level 
emergency primary care services in most municipalities are provided by 
BOX 5.5 Assessing the appropriateness of care
Appropriateness of health services provision features on the policy agenda in 
Norway, with the key concerns being overuse of diagnostics and inappropriate-
ness of treatment. For example, Norway is reported to use CT scans twice as 
often as Sweden (although comparable data are not readily available). There is 
also regional variation in the use of diagnostic CT scans for cancer (Office of the 
Auditor General of Norway, 2017). A national health atlas (https://helseatlas.no/
en) documents variation in the use of a range of health services. For example, 
there are large differences in the use of outpatient services and hospital admis-
sion rates for children, which do not appear to be explained by geographical 
differences in overall morbidity.
Both the number of hospital beds and the average length of stay have been 
declining over the past few decades and are lower than the respective EU aver-
ages (see Section 4.1.2). Long waiting lists have been a focus of policy debates 
and, although the average waiting times have decreased slightly over the past 
few years, those for specific elective surgeries, such as cataract surgery and hip 
replacement, remain much higher than in Denmark, the Netherlands, Italy and 
Sweden (see Section 7.3). These long waiting times may be related to capacity 
problems as well as to free hospital choice – patients may wish to wait longer 
for an elective surgery at a large hospital rather than have it done earlier at a 
smaller hospital.
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BOX 5.6 Patient evaluations of the care they receive
Since 2003/4 the NIPH has run a national programme for the measurement of 
patient experiences (patient-reported experience measures, PREMs) in sec-
ondary health care. It has conducted over 30 national surveys to date, including 
surveys of patients with cancer, mental health conditions, diabetes and substance 
dependence. Although the main focus of the programme is secondary health care, 
several surveys are devoted to municipal health and care services, including an 
ongoing national evaluation of patient experiences with their GPs.
Patient experiences with hospital care have improved over time. In 2016 patients 
gave the highest scores to their experiences with physicians and nurses, and these 
scores varied the least among the hospitals. The lowest scores were given to 
patient discharge. However, over time several aspects of hospital discharge, such 
as information on prescription drugs and written information on discharge from 
hospitals, have improved (Skudal et al., 2016). The greatest variation in scores 
was reported with regards to how patients evaluated the standard of hospitals 
(e.g. cleanliness).
Municipalities have a system for measuring patient experiences with munici-
pality services, including health care services, provided by KS (bedrekommune.
no). These surveys are voluntary for municipalities and are not published, but 
their results may be used for internal quality improvement. See Section 7.6 for a 
more detailed assessment of quality of care.
Patient-reported outcome measures (PROMs) have not been measured widely 
at the national level, but the national quality registries have started to prior-
itize this. NIPH has given the registries free access to the EQ-5D instrument 
measuring health-related quality of life developed by EuroQol (euroqol.org) to 
use it for quality improvement and research. NIPH cooperates with the Centre 
for Clinical Documentation and Evaluation on including PROMs and PREMs in 
the registries (see Section 7.1). An e-PROMs solution was first presented in 
2016 for use in the national quality registries and it is hoped to increase the 
use of PROMs.
Norway participates in international initiatives, including the OECD’s PaRIS 
Survey of Patients with Chronic Conditions, and the Commonwealth Fund interna-
tional health policy surveys, which include the perspectives of the general public, 
selected population groups and GPs on health care services and the health system. 
Norwegian respondents generally report poorer experiences with their regular 
GP than respondents from other countries in areas such as communication, user 
participation and consultation time.
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regular GPs (within office hours) and by on-call GPs (outside office hours) 
supported by telephone services. Since 2015 GPs providing emergency 
primary care services must have a specialization in general practice or 
fulfil other qualifications (see Section 4.2), or have access to an on-call 
specialist.
On-call services in smaller municipalities are often organized in an 
emergency ward at one of the community hospitals and cover the com-
bined area of all the participating municipalities. In very sparsely populated 
areas, pre-hospital emergency services may be provided within municipal 
home nursing facilities or (e.g. in Northern Norway) with the support 
of telemedicine. In the case of emergencies requiring the involvement of 
specialist health services, emergency centres collaborate with Emergency 
Medical Communication Centres (Akuttmedisinsk kommunikasjonssentral, 
AMKs; see below). In urban areas there are designated emergency care 
wards operating on a 24/7 basis by the municipalities and from January 
2016 all municipalities have to provide emergency care beds (also oper-
ating on a 24/7 basis) for patients who can be treated safely at the local 
level. These are usually staffed with full-time physicians and nurses who 
provide advice, assess the situation and direct the patient to other types of 
care when needed.
HOSPITAL EMERGENCY CARE
Accident and emergency departments (A&E) exist in all hospitals that 
provide emergency care. They are staffed by physicians, registered nurses 
and other health-care personnel. They usually have observational beds, 
where patients may be observed for several hours before being admitted 
to hospital or discharged, depending on their condition. A special fea-
ture of the Norwegian system is that patients are not allowed to seek 
treatment at an A&E department directly but have to be either referred 
by a physician or brought in by ambulance (see Section 5.3). The A&E 
departments communicate with ambulance services and other health 
resources involved in pre-hospital emergency care in order to provide 
advice and to ensure that necessary preparations are made to receive 
patients at the hospital.
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COMMUNICATION CENTRES SUPPORTING EMERGENCY CARE
There are two kinds of communication centres supporting the provision 
of emergency care services in Norway. At the level of primary emer-
gency care patients can call the six-digit number 116117 and the call will 
be directed to the nearest local on-call emergency ward. The centres are 
usually staffed with nurses. While larger centres operate on a 24 / 7 basis, 
smaller centres can only be accessed within set times (e.g. from 4pm until 
8am). The centres are connected to a digital radio system that is used to 
mobilize GPs or ambulances. The total number of such centres reduced 
from 146 in 2009 to 104 in 2016 (Norwegian Ministry of Health and 
Care Services, 2016b).
At the level of specialized care there are 16 Emergency Medical 
Communication Centres (AMKs), covering one or more hospital catch-
ment areas (Norwegian Ministry of Health and Care Services, 2016b). 
AMKs receive calls to the toll-free emergency number (113) and may pro-
vide advice on emergency medical procedures to callers and mobilize other 
resources (such as ambulances). These are staffed with nurses and ambulance 
coordinators.
AMBULANCE SERVICES
The ultimate responsibility for ambulance services rests with the RHAs. 
These services are provided by hospital trusts or by private sub-contractors. 
In order to reduce response times, ambulances may be located in decen-
tralized ambulance units in the hospitals or in the community. Highly spe-
cialized ambulances, including air ambulances, are staffed with physicians 
(e.g. anaesthesiologists) in addition to emergency medical technicians. Two 
companies provide air transport. Norsk Luftambulanse AS runs helicopters 
from twelve locations, while Babcock Scandinavian AirAmbulance operates 
nine ambulance airplanes from seven locations. Around 20 000 patients are 
transported each year.
Box 5.7 describes a typical patient pathway in an emergency care 
episode.
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Several trends have been observed in the area of emergency care in 
recent years. The focus has been on improving efficiency through greater 
centralization, for example through increased collaboration between the 
municipalities with the aim of reducing the number of emergency centres 
in favour of fewer but larger centres serving more than one municipality. 
However, the vast majority of emergency centres have only one physician on 
duty outside office hours, which, combined with longer travel distances to 
the nearest centre, results in poorer access to emergency care. The majority 
(73%) of cases seen at the emergency centres are characterized by a low level 
of emergency, while 2.5% are categorized as very high (Norwegian Ministry 
of Health and Care Services, 2015b).
BOX 5.7 Patient pathway in an emergency care episode
In Norway a person with acute appendicitis on a Sunday morning would take 
the following steps:
• The person (or someone else) calls the on-call GP service (ward or 
centre). The call will be answered by a nurse who decides, possibly after 
consulting a GP, that the patient needs to be further examined (note that 
the diagnosis is not yet made).
• The patient arrives at the emergency ward / centre. The GP on duty diag-
noses acute appendicitis and refers the patient to an A&E department.
• If needed, the patient is transported to the A&E department by 
an ambulance.
• At A&E a specialized nurse does the triage and estimates the urgency of 
the case. The patient will also be seen by a physician from the hospital 
department where he or she will be treated. The waiting time depends 
on the level of urgency.
• A surgeon performs surgery on the patient.
Another possibility is that the GP on duty travels to the patient’s home, makes 
a diagnosis and calls an ambulance, which will take the patient to the hospital.
The Manchester triage scale is a common tool for triage at emergency wards/
centres and A&E departments in Norway. The National competency centre for 
pre-hospital emergency care established the Norwegian Manchester Triage 
Group in 2010, and it is now represented at A&E departments and emergency 
wards/centres throughout the country.
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Other trends include growing specialization of ambulance staff as 
they provide increasingly complex treatment, placing greater demands on 
their medical skills as well as on communication and data transmission 
systems; better use of existing emergency care resources (for example, 
there has been a trend towards establishing observational beds within 
A&E departments); and improved communication between various public 
safety services.
5.6 Pharmaceutical care
THE PHARMACEUTICAL SECTOR IN NORWAY
Norway is a net importer of pharmaceuticals. In 2017 imports of medic-
inal products amounted to NKr19.7 billion (€2.11 billion) and exports 
to NKr7.8 billion (€0.8 billion) (LMI, 2019). All major pharmaceutical 
companies are represented in Norway, but only a few have established their 
own manufacturing units in the country. The five largest (in terms of market 
share) in 2018 were: Pfizer AS (6.2%), MSD (Norway) (6%), Novartis (5.9%), 
Gilead Sciences (4.7%) and Biogen Norway (3.6%). In the same year there 
were 11 domestic pharmaceutical manufacturers in Norway, the largest of 
them (in terms of revenues) being Pfizer AS, MSD (Norway) and Novartis 
Norge AS (LMI, 2019).
There are three wholesalers in the market, all three belonging to lead-
ing European pharmaceutical distribution companies: Alliance Healthcare 
AS (with a market share of 46%), Apokjeden AS (31%) and Norsk 
Medisinaldepot (23%). Each of the wholesalers is vertically integrated with 
their own pharmacy chain (LMI, 2019).
In general, only community and hospital pharmacies are allowed to 
dispense prescription medicines. Of the total number of 934 pharmacies in 
2018, 32 were public hospital pharmacies (Norwegian Pharmacy Association, 
2019). There are approximately 5670 inhabitants per pharmacy. In addition, 
prescription medicines are dispensed by small outlets belonging to the 
pharmacies (841 in 2018). Grocery stores, petrol stations, etc., are allowed 
to distribute a restricted list of OTC medicines (Norwegian Pharmacy 




After a decade with relatively stable consumption of pharmaceuticals, 
total consumption measured in the number of defined daily doses (DDD) 
increased by 2.2% between 2016 and 2017. In 2017 total pharmaceutical 
consumption amounted to 3020 million DDDs (Sakshaug et al., 2018). The 
per capita consumption of pharmaceuticals in Norway was €450 in 2018, 
which is higher than in Sweden (€409) but lower than in Denmark (€486) 
and Finland (€462). Prescription medicines account for the bulk of pharma-
ceutical consumption as measured in total sales (OTC medicines accounted 
for only 8% of sales) and DDDs (OTC accounted for 11%).
The largest group of prescription medicines in terms of sales is ATC 
group L (Antineoplastic and immunomodulating agents), accounting for 
27% of the total in 2018. This group includes cancer medicines and biological 
medicines (used, for example, in the treatment of rheumatoid arthritis and 
multiple sclerosis). The largest group of prescription medicines in terms of 
sales in DDDs is ATC group C, i.e. medicines for diseases of the cardiovas-
cular system. The cost of many medicines in this group has fallen over time 
due to the introduction of pricing/reimbursement regulations.
Norwegian, Swedish and Danish doctors are among those prescribing 
the fewest broad spectrum antibiotics, helping to reduce the emergence 
of antibiotic-resistant bacteria (OECD, 2017). Sales of antibiotics have 
decreased gradually since 2012 in line with the national action plan against 
antibiotic resistance in health care, which is intended to reduce the use of 
antibiotics by 30% from 2012 to the end of 2020 (Sakshaug et al., 2019).
COST-EFFECTIVE USE OF PHARMACEUTICALS
The Norwegian Medicines Agency (NoMA) assesses whether approved 
generic medicinal products should be placed on the substitution list. 
Pharmacists are obliged to inform patients if there is a cheaper generic alter-
native available. Physicians may decline the substitution for medical reasons, 
whereas patients may decline without reason. Patients must, however, cover 
the price difference between the two alternatives if they refuse the generic 
substitute. A step pricing system is in place to reduce prices wherever there 
is generic competition. This system has resulted in lower prices for medicinal 
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products that have generic competition and in a decline of generic substi-
tution (White Paper no. 28 (2014–2015) Legemiddelmeldingen (Report 
on Pharmaceuticals)). Information about generic substitution is available 
through the NoMA website, as well as via leaflets for patients, brochures 
to pharmacies, and presentations for the general media and at conferences 
and seminars.
ACCESS
Access to innovative pharmaceuticals is generally good compared to other 
European countries. A study assessing the economic impact of supple-
mentary protection certificates and pharmaceutical incentives and rewards 
in the EU concluded that the average time from the first international 
BOX 5.8 Evaluating efficiency in pharmaceutical care
Generic substitution was introduced to pharmacies in 2001 and has led to a 
reduction in the cost of pharmaceuticals financed through the NIS. The generics 
share of the pharmaceutical market rose steeply until 2008 and then stabilized 
between 2009 and 2014. Since then it has been rising again and in 2018 sales of 
generic medicinal products accounted for 52.2% of total sales, measured in terms 
of volume, compared to 23.6% in 2001 and 41.5% in 2011 (Norwegian Pharmacy 
Association, 2019). Nevertheless, this share remains about 10 percentage points 
below Denmark (OECD, 2017).
Uptake of low-cost statins has been increasing in Norway. Atorvastatin is 
the top-selling statin and its sales increased nearly threefold from 2009 to 2018. 
Norway has also been at the forefront of increasing biosimilars uptake, via for 
instance the NOR-SWITCH trial which aimed to test the safety of switching 
patients from the originator biological product with its biosimilars. The rationale 
behind the use of biosimilars is to increase price competition, thereby reducing 
pharmaceutical prices. Looking at the uptake of biosimilars – a biological medicine 
highly similar to another already approved biological medicine (‘reference med-
icine’) – OECD data reveal that Denmark and Norway have the highest uptake of 
anti-TNF biosimilars (developed for treating rheumatism) among OECD countries 
with respectively 90% and 82% of the market share (OECD, 2017). However, lower 
shares are observed for some other categories of pharmaceuticals. For example, 
the biosimilar market share for medicines used in the treatment of renal failure 
was close to the EU average of 45% (OECD, 2018a).
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launch until 25% of molecules (so-called ‘defining new molecules’) are 
available in Norway is 1 year compared to 1.6 years in the EU on average 
(Copenhagen Economics, 2018). The benefit of rapid access to new and/
or innovative pharmaceuticals is up for debate. A recent study has revealed 
that there is little or no evidence of added benefit for most of the new drugs 
introduced into the German market between 2011 and 2017. Evaluations of 
the effect upon regulatory approval are often rather limited for innovative 
pharmaceuticals, and post-marketing studies are less common (Wieseler, 
McGauran & Kaiser, 2019).
5.7 Rehabilitation/intermediate care
Provision of rehabilitation care has a long tradition in Norway. The approach 
to rehabilitation has evolved from a narrow (medical) focus on restoring lost 
functions to a more comprehensive approach incorporating non-medical 
(e.g. social, economic) factors and involving comprehensive cooperation 
between several sectors and areas of care. In May 2018 the amendment of the 
“Regulation for habilitation/rehabilitation, individual plan and co-ordinator” 
changed the definition of habilitation and rehabilitation and centred it more 
on the patient. According to this regulation, rehabilitation (and habilitation) 
should be based on the life situation and goals of the individual patient who 
has or is at risk of impaired physical, mental, cognitive or social ability and 
give them the opportunity to achieve optimal functional ability, sense of life 
achievement, independence and participation in education and work, on a 
personal and societal level. It should comprise targeted processes in a range 
of settings, with cooperation between patients, next-of-kin and service pro-
viders. Processes should be coordinated, continuous and knowledge-based.
Rehabilitation is provided at both primary (physiotherapy, occupational 
therapy, etc.) and secondary (specialized rehabilitation) levels. As in other 
countries, Norway has in the last two decades also developed some interme-
diate rehabilitation services based on shared care between specialized and 
primary health care.
Primary care rehabilitation is provided in the community – in patients’ 
homes, schools and institutions run by the municipalities (e.g. nursing 
homes). Services are provided by medical doctors, physiotherapists, nurses 
and midwives. Primary care rehabilitation is available for somatic as well as 
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psychiatric patients and can be accessed through a referral from a primary 
care physician.
Secondary rehabilitation services are provided in hospitals in dedicated 
rehabilitation departments or other units, such as rheumatology or neurology 
departments. Rehabilitation, especially postoperative rehabilitation, may also 
be provided in private rehabilitation institutions contracted by the RHAs; this 
is free of charge if the patient is referred by a GP or a hospital. Rehabilitation 
services for patients with specific conditions are also available in specialist 
hospitals (e.g. children’s hospitals treating pulmonary conditions, asthma and 
allergy) and competence centres (e.g. competence centres for rare diseases). 
Since 2017 patients have been able to choose to receive rehabilitation services 
outside their RHA, but most patients (97%) receive rehabilitation within 
their own RHA. The exception is the Northern Norway RHA, where the 
respective share is 92%.
Municipalities as well as RHAs are jointly responsible for coordinat-
ing rehabilitation services. This is done through designated ‘coordination 
units’. The units facilitate cooperation between health care providers and the 
Labour and Welfare Administration (NAV) and its local offices and user 
organizations. Coordination activities include registration of rehabilitation 
needs; designing and following individual holistic (ensuring interdisciplinary 
approaches) rehabilitation plans; and initiating, administering and moni-
toring multidisciplinary rehabilitation teams, which constitute the core of 
cooperation between different service providers.
In 2017, 54 000 patients received rehabilitation services from the special-
ist health service and 14 000 patients received rehabilitation in the municipal-
ities (Norwegian Directorate of Health, 2018d). Institutional rehabilitation 
within the municipalities is usually provided to older patients (85% of patients 
in 2017 were aged 70+) (Mørk et al., 2018). In 2017 over 27 870 patients 
received rehabilitation care in hospitals, nearly 50% of them as outpatients 
or day-care patients (Norwegian Directorate of Health, 2018d). Almost as 
many patients (27 393) received treatment in private institutions (mainly 
in an inpatient setting). The average length of stay was about three weeks.
According to the Action plan for habilitation and rehabilitation for 
2017–2019 there are several challenges within the rehabilitation sector 
(Norwegian Ministry of Health and Care Services, 2017b). The key chal-
lenges are: ensuring sufficient resources to allow the maintenance of an ade-
quate capacity of rehabilitation care; development of individual rehabilitation 
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programmes in a way that provides equitable access to services; ensuring 
sufficient cross-sectoral cooperation and coordination across administrative 
levels and professional groups; and eliciting the active participation of users.
5.8 Long-term care
The Patients’ Rights Act of 1999 was amended in 2016 to include a paragraph 
entitling patient access to care in long-term care facilities if it is deemed the 
only option to ensure necessary and justifiable care. The amendments also 
enforced municipalities to enact local criteria and waiting lists to safeguard 
the rights of patients.
In 2017 Norway spent over a quarter of current health spending on long-
term care, a proportion that is higher than in any EU country (Table 3.2; 
OECD, 2019). This reflects the government’s commitment to enabling family 
carers to stay in the labour market (Morgan, Gmeinder & Wilkens, 2017), 
as well as the possible overlaps between long-term care and social services. 
The organization and provision of long-term care is the sole responsibility of 
the municipalities and is often administratively integrated with other health 
and social services at the local level. In smaller municipalities these services 
are often organized within the same unit. Overall, municipalities have had a 
high degree of freedom in deciding how LTC services should be organized. 
The basic guiding principle for the provision of LTC is that services and 
individualized support should be arranged in a way that enables people to 
stay in their own homes for as long as possible.
LTC is provided in three types of settings: patients’ homes, nursing 
homes and sheltered housing run by the municipalities. Nursing homes 
are designed for residents who require a high degree of medical care (e.g. 
patients suffering from dementia or heart and lung diseases) and help with 
daily activities. There are also short-term rehabilitation departments within 
some nursing homes, where patients can stay, for instance, after a hospital 
discharge. Sheltered houses offer residents the same services as home care 
and are often located close to the municipalities’ long-term nursing homes. 
The distinction between nursing homes and sheltered houses is not always 
clear-cut. Some sheltered homes provide services resembling those provided 
in nursing homes; others are more like private homes. In addition, there are 
day-care centres for older people within nursing homes. The average resident 
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of a sheltered house will normally have fewer care needs than the average 
resident of a nursing home, as well as more private rooms/areas. The major-
ity of nursing and sheltered homes are owned by the municipalities. About 
5% of nursing homes are owned and managed by voluntary organizations, 
but may be staffed by health-care professionals and care is financed by the 
municipalities. There is also a small number of commercial nursing homes 
where patients pay full fee; these account for about 5% of all nursing homes 
beds (Statistics Norway, 2019a).
None of the LTC settings is specifically reserved for older people. 
Eligibility criteria are set by the municipalities. Decisions on eligibility are 
taken by the provider or by an independent unit within the municipality’s 
health care system and are based on an assessment of needs, irrespective of 
any potential help that may be forthcoming from the patient’s relatives. The 
assessment includes recommendations from the patient’s GP with regard 
to the appropriate level of care. Processing of applications and planning 
of LTC services is supported by two central information systems: IPLOS 
(providing a standardized set of information about any seeker or recipient 
of health or social help in the nursing and social care sector) and KOSTRA 
(Municipality-State-Reporting, a reporting system containing information 
on resources used in various areas of care, including LTC).
There has been an increase in the number of users of nursing and care 
services provided by the municipalities, especially of home care. The number 
of people receiving care at home grew from 162 000 in 2002 to nearly 
190 000 in 2017 (Statistics Norway, 2019a). The development of sheltered 
housing and nursing homes is encouraged by the state through the provision 
of earmarked funding. The number of places in nursing homes decreased 
slightly in the past two decades: in 2017 there were about 40 000 people 
living in nursing homes compared to almost 46 000 in 1992. This is partly the 
result of a deliberate process of increasing the number of single-occupancy 
accommodation to make nursing homes more home-like; in 2017 almost 
87% of rooms in nursing homes were for single occupancy with en-suite 
bathroom (Statistics Norway, 2019a).
In 2017 there were about 45 000 residents living in sheltered housing, of 
whom 20 000 were under 67 years of age (Statistics Norway, 2019a). The share 
of older people receiving care and practical support at home has declined 
in the last decade. It is not clear whether this decline is due to population 
ageing (see Section 1.4) and an inability on the part of the municipalities to 
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increase the volume of services or whether it is due to older people having 
better health and less need for support and services at home. In August 2019 
about 1300 people (3%) with a registered need for care were on a waiting 
list for nursing home/sheltered housing.
Quality regulations exist in the area of LTC, but there are no legal 
requirements for staff-to-patient ratios; the required qualifications of care 
workers are also not specified. The government has been exploring whether 
norms or guidelines for staffing and quality in the care services sector 
should be introduced (Norwegian Ministry of Health and Care Services, 
2015a). A study of LTC provision in 150 municipalities revealed variations 
in staff planning and differing viewpoints on the optimal staffing levels. 
The study did not recommend an optimal staff-to-patients ratio; however, 
it suggested that planning of replacement staffing to cover for sickness-
absence should be improved (Bratt & Gautun, 2015). The new Municipal 
Patient and User Registry (KPR) collects data on some quality aspects 
in nursing homes, which are included in the National Quality Indicator 
System (see Section 7.1).
5.9 Services for informal carers
The responsibility for supporting people with particularly comprehensive care 
needs lies with the municipalities. Municipalities also have a duty to offer 
guidance and measures, including financial support, to reduce the burden of 
care for next of kin with a particularly heavy care burden (Health and Care 
Services Act, 24 June 2011).
Informal carers are an important resource of LTC, with an estimated 
number of person-years equalling that provided by the municipal services. 
Informal carers looking after a close relative may be eligible for financial 
support from the municipality. The family caregiver scheme was introduced 
in 1988, initially as salary for care provided with an additional right to 
pension credits. In 2017 the terminology changed from salary/paid work to 
financial support for care provided, but caregivers continue to earn a right 
to pension credits.
Decisions to grant financial support are taken by the municipalities. In 
order to receive such support, the carer must commit to carry out care services 
at the patient’s home, and both the user and the municipality must agree 
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that this is the best solution for the person in need. Another precondition 
is that the person in need would otherwise be eligible for care provided by 
the municipality if informal care were not available. Decisions are taken on 
a case-by-case basis by the municipality.
The number of persons receiving monetary compensation for informal 
care work has been stable over the past decade, together with the number 
of people receiving care from paid informal carers (about 11 500 in 2017) 
(Statistics Norway, 2019a). On average, informal caregivers were compensated 
for 11 hours of work per week. The likelihood of being granted economic 
compensation for informal care varies according to the age of the user and 
is usually granted to persons caring for children and youngsters (Mørk et 
al., 2018).
As demographic and migration patterns change, this level of informal 
care might be difficult to uphold. The government’s ambition is to maintain 
the current level of involvement by developing a policy on informal care. This 
will include reforming payment in the family caregiver scheme and exploring 
the idea of establishing platforms where patients, users and family members 
can raise issues of common interests.
5.10 Palliative care
Since the early 1980s a number of official reports and national plans, closely 
linked to cancer care and the national cancer strategy, have promoted the 
gradual development of palliative care in Norway. Given the historical 
predominance of cancer patients among palliative care patients, oncology 
has been the most relevant postgraduate training in the area of palliative 
care. The Nordic Specialist Course in Palliative Medicine has been running 
since 2003 and palliative medicine was approved as a formal competence for 
physicians in 2011. Physicians specializing in oncology have a mandatory 
rotation in palliative care units in hospitals. Child palliative care has been 
offered as a nursing specialty since 2017.
The latest strategic policy documents in this area are an update of the 
National Action Programme for Cancer Palliative Care published in 2015 
and the child/youth-specific guidelines for palliative care from 2017. General 
guidelines for providers of palliative care were updated in 2018. An official 
report on palliation “On life and death; palliation for the ill and dying” 
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(Official Norwegian Report, 2017:16) is currently being processed by the 
MOHCS and the government has signalled stronger support for LTC and 
palliative care.
Palliative care services are provided at all levels of care. Palliative care 
for patients staying at home is provided by GPs and within municipal home 
care services. A comprehensive overview of how palliative care is organized 
across all the municipalities is lacking. The GPs and municipal home care 
services may be supported by hospital-based specialist palliative care teams 
who provide palliative care in hospital outpatient care departments and in 
the municipalities. Each team must have at least one consultant and one 
full-time nurse, and include a social worker, a physiotherapist and a pastoral 
worker. In order to be reimbursed, services provided by these teams must 
include a systematic symptoms assessment; follow-up of family members; 
and cooperation with primary care services. All main hospitals have multi-
disciplinary palliative care teams – in 2016 there were 40 teams or palliative 
wards across Norway. Specialist palliative care is also provided in inpatient 
settings such as designated inpatient units in municipal nursing homes (48 
units across Norway, of which 32 are located within the South-Eastern 
RHA), and specialist palliative care inpatient units in larger hospitals pro-
viding care to patients with the most complex needs (17 palliative hospital 
units across Norway).
Tertiary palliative care is provided in university hospitals. Each of the 
four university hospitals has a comprehensive palliative care programme 
comprising an ambulatory team, outpatient clinic and inpatient unit (only the 
university hospital in Tromsø does not have an inpatient unit). These are part 
of the regional competency centres for palliative care which are in charge of 
research and development activities. They are also responsible for establishing 
and developing local networks of cancer care and palliative care nurses who 
are mostly specially trained (i.e. resource nurses). In 2017 there were about 
2000 nurses participating in these networks. Resource nurses based in the 
communities work in cooperation with GPs and nursing home physicians 
and are the local link to the hospital-based specialist palliative care teams. 
In many municipalities nurses working in home care who are specialized in 
cancer care often also serve as resource nurses for palliative care.
According to a ranking (Quality of Death Index) published by The 
Economist magazine that assessed end-of-life care services across 80 countries 
(including 37 European countries), Norway was ranked in 12th place overall, 
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in 6th place in terms of capacity to deliver palliative care services, and in 7th 
place regarding human resources for palliative care. In terms of affordability 
and quality of care Norway achieved, respectively, 22nd and 16th places in the 
ranking (Economist Intelligence Unit, 2015).
5.11 Mental health care
As in most other countries in Europe, provision of mental health services 
in Norway has traditionally been linked to large inpatient institutions for 
long-term treatment. Over the last four decades there has been an increased 
emphasis on shifting provision to the municipalities, which has also been in 
line with developments observed in other countries in Western Europe. The 
goals of the current national strategy “Coping with life, 2017–2022” (Mestre 
hele livet, 2017–2022)* are to ensure that mental health is incorporated as an 
integral part of public health; ensure equity with regards to inclusion, belong-
ing and societal participation; provide patient-centred services; strengthen 
the knowledge base, quality and innovation; and promote mental health in 
children and youngsters. The strategy incorporates measures of improvement 
of housing for persons with mental health problems, inclusion in work life 
and prevention of discrimination, as well as improvement of mental health 
in children and teenagers, and prevention of bullying.
SUBSTANCE ABUSE PROBLEMS
Since 2004 the RHAs have had the overall responsibility for substance 
abuse treatment and rehabilitation services and they are part of specialized 
mental care services. These services are provided in close cooperation with 
the municipalities, which bear the overall responsibility for providing general 
and mental health care services. This includes outpatient services, services 
provided by community teams, low-threshold (i.e. before substance abuse 
becomes a serious problem) services, assessment and referral to treatment, 
* Inspired by the WHO Mental Health Action Plan 2013–2020, the European Mental Health 
Action Plan 2013–2020, as well as the European Action Plan for Strengthening Public Health 
Capacities and Services, Sustainable Development Goal 3: Ensure healthy lives and promote 
well-being for all ages, and the Norwegian Framework for Health 2020.
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and follow-up during and after treatment in a specialist health care setting 
or in prisons.
Opioid substitution treatment (OST) using methadone has been avail-
able through a nationwide programme since 1998. In 2010 new national 
guidelines for OST came into force. These guidelines aim to increase nation-
wide access to OST as part of a comprehensive treatment and rehabilitation 
process, reorienting OST services from being a limited high-threshold system 
to a widely available low-threshold system. At the end of 2016 a total of 
7554 clients were on OST, 38% on methadone and 60% on buprenorphine. 
New OST admissions have declined since 2011, and it is assumed the system 
is approaching saturation in terms of the number of current opioid users 
seeking treatment (EMCDDA, 2016).
OTHER MENTAL HEALTH PROBLEMS
Specialized mental health services are the responsibility of the RHAs. They 
are provided in the following settings: highly specialized mental hospitals 
(including high-security departments); community mental health centres; 
and in outpatient settings (treatment by privately practising psychiatrists 
and psychologists under contracts with the RHAs). Specialized services 
for children and adolescents (0–17 years old) have traditionally been pro-
vided in designated outpatient units. Mental health centres are vital for the 
decentralization of mental care services. They provide acute treatment (on 
an inpatient, outpatient and day-care basis) and rehabilitation services, and 
also supervision and support for other providers in primary care. According 
to annual national surveys of GPs, about 55% of GPs assess the overall 
professional competency at the community mental health centres as high 
or very high (Sjetne & Holmboe, 2014).
De-institutionalization of mental health care is reflected in the declining 
trend in the number of beds in mental health care institutions (see Section 
4.1). Fewer patients receive inpatient treatment and the average length of stay 
in inpatient mental health care institutions fell from 66 days in 1998 to 20 
days in 2017. At the same time the number of consultations at the community 
mental health centres has almost tripled. The number of consultations with 
privately practising specialists contracted by the RHAs decreased slightly 
between 2011 and 2017, but access to psychologists has improved in the 
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municipalities, from 130 contracted psychologists covering 95 municipali-
ties in 2013 to 377 contracted psychologists covering 265 municipalities in 
2017. From 2020 it has become mandatory for all municipalities to provide 
access to a contracted psychologist. At the same time emergency admissions 
remained fairly stable, suggesting the reduction in beds has not worsened 
access overall. However, emergency admissions were lowest in the two regions 
with the highest number of beds (Northern and Western RHAs), suggesting 
that there may be a link between the number of mental health care beds and 
access to care (Norwegian Directorate of Health, 2018b).
5.12 Dental care
Dental care for the adult population (20 years and older) is the area of care 
with the highest private participation, both in terms of provision and financ-
ing. Most dentists work in private practices (around 70% of all dentists) 
(Statistics Norway, 2019a) and most treatments are usually paid in full out-
of-pocket by the patient. Fees charged in the private sector are not regulated.
Provision of statutory dental care has traditionally been the responsibil-
ity of the counties, as regulated in the Dental Health Services Act (1983). 
However, by 2022 this responsibility may be transferred to the municipalities 
and dental care may then be regulated by the Municipal Health and Care 
Act (2011) (see Section 2.1). This, however, depends on a future parliamen-
tary decision.
Public dental care is carried out by salaried dentists in dental care clinics 
operated by the counties in cooperation with the municipalities. Except for 
orthodontic treatment, public dental care is free of charge for children and 
young people aged 0–18 years. Young people aged 19–20 years must pay 25% 
of the costs up to the cost-sharing ceiling (see Section 2.3).
Mentally disabled adults, older people and people with a long-term 
illness, who are either living in an institution or receiving home nursing 
care, pay reduced fees or may be eligible to receive public dental care free 
of charge. People outside these groups may also be able to access public 
dental care provided by the counties, but only after the needs of people in 
the prioritized groups have been met.
Standards in dental practice are monitored by the County Medical 
Officers, usually through designated dentists who supervise and assess 
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the observance of dental medical standards and quality assurance pro-
grammes. Six regional centres of competence for dental health care have 
been established during the last decade, in order to facilitate decentralized 
specialist education for dentists and educating more dental auxiliaries. A 
national action plan for research in oral health is in place for 2017–2027 
with goals including strengthening research in oral health, in the com-





  The key policy changes implemented in recent years have included 
the Coordination Reform (focusing on improving coordination 
of care between municipalities and hospitals); extending patient 
choice; reorganizing hospital care; strengthening primary care 
through the introduction of primary care teams (still in the piloting 
phase); and adapting the education and training of health profes-
sionals to meet future health needs.
  Although the evaluation of the Coordination Reform has so far 
shown mixed results, it has contributed to the decentralization of 
services and paved the way for subsequent primary care and public 
health reforms.
  Primary care teams are being piloted (2018–2021) with the goal 
of instituting multidisciplinary primary care teams. Related to this, 
and in line with the Health and Hospital Plan 2016–2019, there 
have been changes to the skill-mix and the competencies of health 
professionals to meet future health needs.
  Many proposals included in the political platform presented after 
the last parliamentary elections are a continuation of policies 
implemented under the previous government. Ongoing reforms 
focus on the following areas: public health (focus on children 
and youth and prevention of loneliness); primary care (evaluation 
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of the regular GP scheme); substance abuse (more emphasis on 
prevention and harm reduction); and long-term care (creating an 
age-friendly society).
6.1 Analysis of recent reforms
This section takes a closer look at reforms and policy initiatives introduced 
since 2012.* Table 6.1 provides an overview of recent health care reforms 
and policy initiatives and their implementation status.
LOCAL GOVERNMENT REFORM
A reform of local government has been under way since 2014. By 2020 
the number of counties is to be reduced from 19 to 11 and the number of 
municipalities from 429 to 356. The purpose of the reform is to achieve, 
via larger administrative entities, a more efficient planning and governance 
structure (Norwegian Ministry of Local Government and Modernisation, 
2017). In the area of health care, the intention is to transfer responsibility for 
dental care to the (larger) municipalities from 2023. The municipalities will 
also become more involved in the financing of all non-hospital health care 
services and social services. These changes are linked to the ongoing reform 
of primary care (see Box 6.1) and their exact scope and implementation dates 
were unknown at the time of writing.
CHANGES TO HEALTH CARE GOVERNANCE
In 2016 central health care governance was reorganized (Saunes & Lindahl, 
2015). Several agencies were merged with either the NIPH or the Directorate 
of Health, according to their functions. Smaller organizations dealing with 
complaints/grievances were merged into a new organization, the Norwegian 
Complaint Body for the Health Services. The Registration Authority for 
* Reforms implemented between 2000 and 2012 are described in the earlier editions of Health 
System in Transition reports for Norway ( Johnsen, 2006; Ringard et al., 2013).
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TABLE 6.1 Major reforms and policy initiatives between 2012 and 2019
YEAR REFORM/INITIATIVE
IMPLEMENTATION 




 • Goals: to improve coordination of care between municipalities and hospitals, 
and to strengthen public health
 • Key legislation: Municipal Health and Care Act (2011); Public Health Act (2011)
Implemented
2013
Strategy on Quality and Patient Safety
 • Goals: to provide a comprehensive approach to quality and patient safety
Implemented measures include:
 ∙ Quality improvement initiatives within the National Patient Safety Programme 2014–2018;
 ∙ Introduction of quality-based funding of hospitals (so far on a small scale);
 ∙ Increasing the number of collected quality and patient safety indicators;
 ∙ Establishment of the national registry for municipal health and care services (KOSTRA) 
in 2018 (see Box 5.4 and Table 7.1).
 ∙ Establishment of the National Commission for Health and Care Services in 2019 (see 
Section 2.1);
 ∙ Integration of patient safety initiatives in the Directorate of Health work on quality 
improvement from 2019;






 • Goals: to extend patient choice of treatments and providers
Implemented measures include:
 ∙ Since 2015 private providers without a tender agreement with the RHAs can apply to 
be included in the choice scheme;
 ∙ Since 2017 extending choice to cover rehabilitation treatment.
Implemented
2015
National Health and Hospital Plan 2016–2019
 • Goals: empowerment of patients; prioritizing mental health services and 
treatment of substance abuse; improving provision of health care; ensuring 
the right volume and skill-mix of human resources; improving quality and 
patient safety; improving coordination between hospitals and strengthening 
outpatient care.
Implemented and ongoing measures include:
 ∙ Decentralization of non-acute hospital care and introduction of hospital networks 
(ongoing) (see Section 4.1);
 ∙ Introduction of national quality requirements and standardization of treatments for 
stroke and cancer patients as well as for mental health services and substance abuse 
treatment (implemented);
 ∙ Implementation of a new model of specialist education of physicians (implemented) 
(see Section 4.2);
 ∙ Raising the age limit for withdrawal of authorizations for all health care personnel to 
80 years old (implemented);




Primary Care and Public Health Reform
 • Goals: Introduction of team-based intermediate care
Implemented measures include:









‘Live your whole life’ reform





 • Goal: to transfer responsibility over minor drug offences from the Ministry of 






Health Personnel was integrated in the Directorate of Health, and a new 
Directorate for e-Health was established. In January 2019 the Norwegian 
Health Care Investigation Board was established under the MOHCS to 
investigate adverse medical events.
IMPROVING COORDINATION OF CARE
Improving coordination of health care services was put on the political agenda 
in the early 2000s. A White Paper published in 2005 identified patient groups 
deemed particularly vulnerable to coordination problems and proposed 
a countrywide system of agreements between hospitals and their nearby 
municipalities to coordinate provision of care. In 2008 a proposal for “The 
Coordination Reform” was presented to the parliament (Norwegian Ministry 
of Health and Care Services, 2009). The proposed measures underwent 
extensive rounds of consultations with stakeholders and in parliament, before 
the final legislation was passed with broad parliamentary support in 2011.
The reform comprised two key pieces of legislation, the Municipal 
Health and Care Act (2011) and the Public Health Act (2011), and was 
further detailed in the National Health and Care Plan (White Paper no. 
16, 2010–2011). The Municipal Health and Care Act introduced two key 
changes. Firstly, the municipalities were given full responsibility for patients 
ready to be discharged from hospital treatment by providing local emergency 
care beds for patients with a need for pre- or post-hospital services. Secondly, 
municipalities were made responsible for co-financing of hospital care. The 
latter was abandoned one year later (effective from 2015) by the new gov-
ernment to reduce the municipalities’ financial risk. The Public Health Act 
established a new foundation for strengthening systematic public health 
work in the development of health and other policies and provided a broad 
basis for coordinating public health work across various sectors and actors, 
and between authorities at the local, regional and national levels.
In 2016 the Research Council of Norway published an evaluation of 
the Coordination Reform over the period 2012–2015 (Research Council 
of Norway, 2016). On the whole, municipal co-financing did not lead to a 
lower use of specialist health care and the number of hospital admissions 
has increased (although the number of readmissions did not). Units con-
taining emergency care beds with easy access to specialist services due to 
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their co-location with A&E services were the only ones that were associated 
with lower hospital admissions (by approximately 2.5%). At the time of the 
report it was not possible to assess the long-term effects as the evaluation 
was published shortly after the introduction of the emergency care beds. 
Yet the overall conclusion from the evaluation was that the Coordination 
Reform did contribute to decentralizing care according to the principle 
of delivering care at the lowest, effective level of care, and thus paved the 
foundation for the primary care and public health reforms of 2015 (see 
Box 6.1).
CHOICE REFORM
Free choice of hospitals was piloted in Norway in the 1990s and enacted in 
the Patients’ Rights Act (1999). Patients were then given the right to choose 
any hospital across the whole country. In 2014 amendments to the Patients’ 
Rights Act and the Specialist Health Services Act extended the choice of 
hospital from being limited to public hospitals, or hospitals with a tender 
agreement, to all public and private hospitals. The Directorate of Health 
became responsible for approving new institutions/hospitals eligible for 
choice. The amendments came into force in 2015, and have been extended 
to two vulnerable patients’ groups: mental health patients and patients with 
substance abuse problems. Private provision was well established in these two 
areas which has facilitated the establishment and inclusion of new providers 
in the scheme. The government-pronounced expectation was for the RHAs 
to buy more services from private contracted providers.
By including private non-contracted providers into the choice scheme 
and giving private providers under contract with the RHAs a more enhanced 
role, the reform has been an important driver of change for the supply 
side of the system. The 2015 reform adjusted existing demand-side policy 
with new supply-side policies, by enhancing patient choice and increas-
ing the supply of both public and private hospital services. About 8500 
patients used their right to choose in 2018 (92% of these patients were 
for somatic care, either for diagnostic purposes or day surgery), and 8% 
of the patients received treatment for substance abuse and received 82% 
of the funding connected with hospital choice (Norwegian Directorate 
of Health, 2019c).
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BOX 6.1 Piloting of primary care teams, 2018–2021
When the government presented the 2015 White Paper on primary health care, 
“Future primary care – localized and integrated”, it was the first comprehensive 
overview of primary health care services since 1973 (Norwegian Ministry of 
Health and Care Services, 2015c). The White Paper proposed a series of meas-
ures aimed at preparing primary health care for future population needs. These 
measures included the establishment of multidisciplinary primary care teams at 
the centre of primary care, development of new and tailored competencies and 
emphasis on management and leadership, strengthening of public health services, 
and organizational changes such as increasing the size of primary health care 
entities. The primary care reform coincides with the reform of local government 
currently being implemented.
The policy was not very detailed when it was presented in parliament (Helse- 
og omsorgskomiteen, 2015) and pilots with primary care teams are being tested 
in 2018–2021. Currently, multidisciplinary teams are GP-led and also include 
nurses and health secretaries. There are two types of team: teams that provide 
general primary care to the local populations and Complex Chronic Care Teams 
(CCC-teams) that support patients with comprehensive complex care needs. 
The teams will be responsible for working in a proactive manner to meet the 
needs of their patients. The goals are to achieve a more structured approach to 
various user groups based on their respective need for services, not necessarily 
based solely on the diagnosis, and to increase accessibility of primary care and 
achieve a more cost-efficient use of resources. The former will imply the use of 
coordinators, knowledge-based procedures and checklists, personalized plans 
formulated in consultation with the user, and systematic follow-up and evaluation 
of progress in achieving the objectives defined in the plan.
In addition, two new models for remuneration are planned to be tested out. The 
first model is essentially the same funding model as the one used currently for 
GPs and health secretaries, but it gives scope for introducing additional funding 
for nurses in the team. The second model envisages direct public funding of the 
team, with additional funding coming from OOP payments.
All municipalities were invited to participate in the pilot project. A total of 87 GPs 
from 13 GP practices, located in eight municipalities, have been included. While 
the GPs are administratively responsible for the teams, the pilots are led by the 
municipalities. The evaluation of the pilot project is led by the Research Council 
of Norway and three different research groups follow the project closely, pre-
senting evaluations along the way and at the end of the testing period (Norwegian 
Directorate of Health, 2018c). So far the evaluation results are mixed: physicians 
and nurses report positive experiences from having complementary roles, but 
the extent of cost-effectiveness is yet unclear, with some reports indicating that 
establishing team management at a GP practice is more time-consuming than 
anticipated. In the summer of 2019 it was decided to prolong the pilot to 2023 and 
include 3–5 more GP practices (Abelsen et al., 2019).
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CHANGES TO SKILL-MIX
In 2006 a long-term action plan in the area of health care human resources, 
“Competence Plan 2015” (K2015), was launched to ensure sufficient capacity 
and competencies in primary health care with the following five goals: (1) to 
increase the health labour workforce by an additional 12 000 person-years by 
2015; (2) to raise the formal level of education; (3) to secure access to skilled 
health care workers; (4) to establish a broader competency basis and wider 
professional scope; and (5) to strengthen internal counselling and training, 
as well as furthering education. The evaluation of K2015 concluded that 
most of the targets have been met (Helgesen et al., 2016).
In 2015 a new, more comprehensive action plan was approved by the 
parliament, setting goals for primary care services beyond 2020, with a com-
plementary action plan for competence building, “Competence Plan 2020” 
(K2020). The new Plan contains six goals: (1) to ensure recruitment and 
staffing for health and social care workers; (2) to ensure the quality of basic 
and further education programmes and their alignment with requirements 
regarding competencies; (3) to raise the level of professional expertise in care 
services; (4) to facilitate development of services, teamwork and innovation; 
(5) to support best practices, professional development, a broader profes-
sional base and sharing of knowledge; and (6) to strengthen managerial 
competencies in the health and care services sectors through provision of 
leadership training. Goals 4–6 aim to create a broader professional base with 
more professional groups and increased focus on interdisciplinary activity, 
thereby supporting the ongoing reform of primary care (see Box 6.1). K2020 
is also closely aligned with health workforce planning strategy included in 
the Health and Hospital Plan 2020–2023, which aims to ensure adequate 
supply of health personnel in all health sectors.
The Health and Hospital Plan seeks closer cooperation between the 
health care and education sectors through, among others, the introduction 
of a new model for specialist education of physicians, task-shifting from 
physicians to nurses, more efficient use of modern technologies, and a more 
efficient management of health personnel. Continuing education and extend-
ing the working age limit for health personnel are thought to encourage 
labour-force participation among senior workers. The new model for spe-
cialist education of physicians has been implemented (see Section 4.2), the 
age limit for withdrawal of authorizations for all health care personnel has 
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been raised from 75 to 80 years of age, while task-shifting from physicians 
to nurses is being piloted (see Box 6.1).
6.2 Future developments
Much of the policy effort in the years to come is likely to be consumed 
by the continued implementation of ongoing reforms, such as the pri-
mary care reform which is currently in the piloting phase (see Table 6.1 
and Box 6.1). Indeed, many proposals included in the political platform 
presented after the last parliamentary elections (in 2017) are a continua-
tion of policies implemented under the previous government. The slogan 
of the existing health policy is ‘The patient’s health service’. This motto 
reflects the government’s goal of providing high quality services that are 
characterized by shorter waiting times, patient engagement and patient 
choice. Below are the areas that are likely to see further changes in the 
near future.
  Public health: The latest Public Health Report, “Good lives in a safe 
society”, was published in April 2019 and signals a stronger emphasis 
on early interventions aimed at children and youths, and prevention of 
loneliness in society, as well as continued efforts to reduce social ine-
qualities in health. These aims are aligned with goal 3 of the Sustainable 
Development Goals of ensuring good health and well-being at all ages. 
The Report mentions the following strategies to meet these goals: the 
2019–2023 Strategy to Prevent Loneliness, the new tobacco strategy 
for 2019–2021 and the ‘Zero-vision’ strategy for 2019–2027 to reduce 
serious fall accidents at home.
  Primary care: In addition to the ongoing pilots of interdisciplinary pri-
mary care teams (Box 6.1) and the public health strategy above, planned 
efforts to strengthen primary care include an evaluation of the regular 
GP scheme, followed by an action plan on its future (planned for early 
2020). This plan is being developed by a tripartite collaboration between 
the state, the municipalities and the medical association, and appears to 
favour larger GP clinics and local community clinics providing GP services. 
However, this model may be challenging to implement in rural areas.
132 Health Systems in Transition
  Substance abuse treatment: The government’s policy on substance abuse 
emphasizes prevention and harm reduction. The use and possession of 
minor quantities of illicit drugs will not be decriminalized, but instead of 
punishment the focus shifts to treatment. Proposals include improving 
access to treatment by increasing the number of treatment places and 
integrating addiction and mental health services. Pathways for substance 
abuse treatment are envisaged to be developed, with treatment initiated 
immediately after detoxication. New pharmaceuticals are planned to be 
included in the treatment, including pilots of heroin-assisted treatment 
in opioid substitution treatment.
  Long-term care: The Strategy to ensure an age-friendly society, where 
people in need of help can live meaningful and dignified lives, was presented 
in 2018 (Norwegian Ministry of Health and Care Services, 2018b). The 
implementation starts from 2019, as municipalities need to decide how to 
align their activities with the best practices presented in the Strategy. The 
government encourages the municipalities to offer choice of long-term 
care providers for the elderly, improve access to information on quality 
of care services, establish quality of care indicators and measure user 
experiences. By increased use of technology and by introducing Complex 
Chronic Care teams (see Box 6.1) to support patients with comprehensive 
complex care needs, the ambition is to enable older patients to live longer 
in their own homes. The government also envisages provision of financial 
support to increase the number of available places in nursing- and care 
homes, as well as supporting investment in private and public housing 
with special security features for older people, nursing homes, hospices, 
dementia-villages and private community-houses.
  Specialist care: The Health and Hospital Plan 2020–2023 was launched 
in October 2019. The plan presented the newly established 19 “health 
communities” (Helsefelleskap), one for each hospital trust. Health com-
munities are a formalized cooperation between hospital trust and munic-
ipalities, where representatives from the hospitals, municipalities, GPs 
and patients/users work on the strategic development of services for four 
vulnerable patient groups: children and youngsters, persons with severe 
mental health and substance abuse problems, fragile elderly and patients 
with multiple chronic diseases.
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The plan also emphasizes digitalization, competency building, recruitment of 
health personnel and mental health. Activity-based funding will be further 
developed to include patient pathways. The Plan envisages the increased 
use of private specialists and the decentralization of specialist care with the 
goal of increasing access to care. It foresees an increased delegation and 
responsibility to hospitals.
7
Assessment of the health 
system
Chapter summary
  Transparency of the health care system has been a political priority 
over the past few decades. Public monitoring of performance indi-
cators and transparency in the policy process have both improved.
  The country scores well on health indicators and this can be in 
part attributed to prevention services and treatment offered in the 
health sector: the rates of both amenable and preventable mortality 
in Norway are among the lowest in Europe.
  The distribution of hospitals in Norway reflects the distribution of 
the population. Although Norway has one of the highest densities 
of health care personnel in Europe, the country struggles to ensure 
equal access to health care across its entire territory, particularly in 
rural and remote areas with scattered populations.
  The Norwegian health system offers a high level of social and 
financial protection, and the level of unmet medical need is low. 
Coverage is universal and public sources account for the majority 
(85%) of health expenditure. Various mechanisms, such as exemp-
tions and ceilings on OOP payments, limit the financial burden 
of care on individuals. However, the level of protection is poor for 
certain types of care such as home-based care and institutional care 
for older or disabled people and adult dental care.
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  Comparative price levels in the health and hospital sectors are 
higher in Norway than in most other countries. However, these 
high price levels appear to be in line with the country’s wealth and 
demographic structure. A shift to care outside the hospital setting, 
coordination reform and expansion of generic medicines and bio-
similars contributed to improved efficiency over the years, but there 
is further potential for improvement in these areas.
7.1 Health system governance
Transparency of the health care system has been a political priority over 
the past few decades and public monitoring of performance indicators has 
improved (see Section 2.6). Transparency in the policy processes has also 
improved.
The involvement of user representatives has a long tradition, not only 
in the development of policies, but also as board members in health trusts 
and institutions. Before any major political decision is taken within the area 
of health care, relevant knowledge base is often presented by a dedicated 
Royal Commission. Members of such commissions are usually experts 
from the relevant fields (from various research institutions or universi-
ties), user representatives and other stakeholders. The commissions’ work 
is then subject to a formal hearing process with all relevant stakeholders. 
This process is open to the public via the MOHCS website. Based on the 
Norwegian Official Report, the government then prepares a white paper 
for the parliament.
7.2 Accessibility
Access to health care for all who need it is considered to be a basic social 
right in Norway, and ensuring universal and equitable access to health care 
is an important health policy aim embedded in the Patients’ Rights Act of 
1999 and its later amendments (see Chapter 2).
The EU-SILC survey shows that unmet need for medical examinaton 
in Norway is relatively small: 1.1% of population (Fig. 7.1), of which 
0.7% report having unmet need due to waiting time and 0.4% due to 
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cost. There is a gap between the poorest and the richest households, 
with 2.4% of the poorest people being unable to access health services 
when they need them, mainly due to waiting time (1.3%) followed by 
cost (1%).
FIG. 7.1 Unmet need for a medical examination due to cost, waiting time or travel 
distance, by income quintile, EU/EEA countries, 2017
% of respondents




































































Source: European Commission (2019)
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Although Norway has one of the highest densities of health care per-
sonnel in Europe, geographical equity in access to health care may be an 
issue in rural and remote areas with scattered populations (see Box 4.2).
Ensuring access to health personnel with the right level of competence 
is the goal of the Action plan for Patient Safety and Quality Improvement. 
Norway is among the OECD countries with the highest number of doctors 
and nurses relative to the number of inhabitants. A recent analysis on the 
future demand for labour in the health and long-term care sector was pub-
lished at the beginning of 2019 (Statistics Norway, 2019b). The estimated 
demand was based upon assumptions on the following variables: the health 
status of older people; quality of services; productivity and unpaid care 
supplied by family members and friends. An increase in demand has been 
forecast and it is predicted that this may pose serious challenges for the health 
system: an increased need for educated health personnel and increased costs, 
which will have political implications for the financing of the health system.
Earlier analysis on the recruitment of health and care personnel projected 
an under-coverage of nurses and physicians by 2035 (Statistics Norway, 2012). 
While the educational capacity for nurses seems to be reasonable, the key 
challenge is the relatively high drop-out rate. Fewer than 60% complete their 
education on time, and fewer than 80% of students complete it within five 
years. A longitudinal study of nurses who graduated in 2004 revealed that 
20% of them left the health care sector within a decade of graduating. They 
either pursued a career in another sector or were out of work.
In spite of the high number of nurses, a shortage of nurses is a challenge 
within the care sector. Only a minority of newly educated nurses choose to 
work in nursing homes and home care, and about 50% of the nurses working 
within LTC consider a change of workplace. The reported reason is high 
time-pressure at work (Gautun, Martens & Veenstra, 2016).
The municipalities are responsible for regulating access to nursing homes 
or equivalent institutions. The local organization of waiting lists varies and 
so does the system for prioritizing patients. According to recent regulatory 
changes the municipalities were required, by July 2017, to develop regulations 
on access to care, and maintain waiting lists (Saunes & Lindahl, 2017).
Overall, there is an increasing amount of information on the accessibility 
of various types of care. There are geographical differences in access, with 
people living in rural and more remote areas having to travel longer distances 
to access care. Despite the high ratios of health care professionals to the size 
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of the population, waiting times for elective care are long and constitute a 
barrier to accessing care.
7.3 Financial protection
Public sources account for the vast majority (85%) of health expenditure, 
which is the highest among the European countries (see Section 3.1). 
Correspondingly, the share of out-of-pocket payments is relatively low. 
However, there are some exceptions: home-based care and institutional 
care for older or disabled people are based on needs assessment and imply 
a high degree of cost-sharing of up to 85 per cent of personal income. 
Although the cost covers housing, financial protection can be a challenge 
for households where one person is institutionalized and is not contribut-
ing to household expenses. Adult dental care is another area where private 
financing predominates.
A safety net mechanism is set up for most types of OOP expenditures 
(excluding dental care, long-term care and some prescription medicines), 
with annual caps above which fees are waived (see Table 3.3). There are also 
exemptions from user charges for certain population groups (e.g. children) 
and diseases (e.g. tuberculosis). In addition, certain basic services may be pro-
vided, upon application, to patients who regularly incur additional expenses 
because of chronic illness, injury or disability.
Only 2% of Norwegians above 65 years of age reported having prob-
lems paying for health care in an international survey among older adults 
(Commonwealth Fund, 2017). The share is well below the average of 6% for 
the other countries covered in the survey, but higher than in both Sweden 
and the United Kingdom. Another survey by the Commonwealth Fund 
conducted in 2016 showed that among the general population in Norway, 8% 
reported problems paying for health care, just below the average of 9% among 
countries included in the study (Norwegian Institute of Public Health, 2016).
A recent study covering Nordic countries by the Centre of Health 
Economics Research in Denmark concluded that in general the Nordic 
countries have accomplished good health for their populations and reached 
a high degree of socioeconomic equality in health (Christiansen et al., 2017). 
However, as explained above, the level of protection may differ for various 
types of care and various population groups.
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7.4 Health care quality
QUALITY OF PRIMARY AND HOSPITAL CARE
High levels of hospital admissions for certain conditions, such as asthma, 
COPD, congestive heart failure (CHF), hypertension and diabetes, may 
indicate inefficiencies and/or weaknesses in primary care. In 2017 in Norway 
the rate of avoidable hospital admissions from those diseases combined was 
higher than in the Netherlands, the UK or Sweden, but lower than in France, 
Denmark, Finland or Germany (Fig. 7.2).
In terms of effectiveness of specialist care, Norway has among the best 
outcomes in terms of mortality from acute myocardial infarction (AMI) 
and stroke within 30 days of hospitalization in Europe (Fig. 7.3). Despite 
already low mortality rates, further improvements were achieved over the 
past decade. During this time a patient care pathway for stroke has been 
developed, alongside initiatives to raise awareness around early symptoms 
and signs of stroke among the population. The survival gains seen for stroke 
are mainly attributable to more rapid and timely access to care (OECD/
European Observatory on Health Systems and Policies, 2019). The National 
Strategy on Brain Health (2018–2024) aims to further improve stroke care 
and reduce geographical variations in access to post-stroke rehabilitation 
services.
BOX 7.1 Universal health coverage
Norway has universal health coverage and residents are entitled to essential 
medical and care services. Publicly funded health care covers planned and acute 
primary, hospital and ambulatory care, rehabilitation and outpatient prescrip-
tion drugs, although cost-sharing exists for most services. Financial protection 
mechanisms are in place for most services. Key among them are annual caps on 
out-of-pocket expenditures (see Section 3.4).
Coverage for non-residents depends on their citizenship: in principle, EEA 
and EU residents are entitled to the same health services as Norwegians, while 
citizens of other countries normally must pay the full cost of services received 
(unless there is a bilateral agreement). Children of undocumented migrants 
have the right to receive certain basic services (such as vaccinations and 
examinations).
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FIG. 7.3 In-hospital mortality rates for admissions following acute myocardial infarc-
tion and stroke
2007 (or nearest year) 2017 (or nearest year)























































































































































Notes: Figures are based on patient data and have been age-sex standardized to the 
2010 OECD population aged 45+ admitted to hospital for AMI and stroke.
Source: OECD Statistics (2019) in OECD/European Observatory on Health Systems and Policies (2019)
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Norway’s five-year survival rates for treatable cancers are higher than 
the EU average and many comparable countries (Fig. 7.4). This is due to 
effective screening programmes, timely diagnosis and access to quality 
treatment. The Norwegian Breast Cancer Screening Programme started 
as a pilot in 1995 and became nationwide in 2005. It targets all women 
aged 50 to 69 for mammographic screening every other year (Cancer 
Registry of Norway, 2017). According to an independent evaluation, the 
Programme contributed to reducing breast cancer mortality by 20–30% 
among invited women (Research Council of Norway, 2015). A recent study 
of physicians’ recommendations of cancer screening according to national 
guidelines revealed that close to or over 90% of doctors recommended 
breast and cervical cancer screening to their patients, while only 42% of 
doctors recommended colorectal cancer screening (Bringedal et al., 2019). 
In addition, cancer patient pathways were introduced in 2015 for 28 dif-
ferent types of cancer to reduce unnecessary waiting times and improve 
coordination of care (OECD/European Observatory on Health Systems 
and Policies, 2019). Each cancer patient now has a dedicated pathway 
coordinator who is responsible for continuity of care during treatment 
and follow-up.
























































Notes: Age-standardized five-year net survival (%): adults (15–99 years) diagnosed with 
breast and colon cancers and children (0–14) diagnosed with leukaemia
Sources: Allemani et al. (2018)
142 Health Systems in Transition
INITIATIVES TO IMPROVE QUALITY AND SAFETY
Regulation of health care quality and safety has changed markedly in recent 
years. In 2017 regulation of internal control for health services was replaced 
with “Regulation for leadership and quality improvement in the health 
services”. A distinct change between the previous regulations for internal 
control and the new regulations is the explicit duty to “work systematically 
with quality-improvement and patient- and clients- safety in all services”, and 
to ensure proper documentation of the planning, implementation, evaluation 
and corrections taken to improve quality and patient safety.
The new Action plan for Patient Safety and Quality Improvement 
2019–2023 (Norwegian Directorate of Health, 2019a) was launched in 
April 2019. The overall goal of the plan is to improve quality and safety by 
supporting the new regulations from 2017. Four broad areas are identified: 
leadership and culture, competence, national initiatives for quality and safety, 
and system and structures. The plan builds on measures from the previous 
Patient Safety Programme (2014–2018) and the patient safety campaign 
“In Safe Hands” (2011–2013).
Since 2013 the government has presented a yearly white paper on 
“Quality and Patient Safety” to the parliament, highlighting status and 
efforts in quality improvement and patient safety. In 2017 the emphasis was 
on managing responsibility regarding internal control and development of 
ICT for the health care sector, alongside the new Health and Hospital Plan 
and the 2014–2018 Patient Safety programme. In 2018 leadership, a patient 
safety culture and systems approach were identified as the preconditions of 
patient safety. In the white paper on quality and patient safety the continuous 
work on quality improvement and patient safety were linked to leadership, 
measurement of patient safety culture and the work of the new Norwegian 
Health Care Investigation Board (UKOM). The white paper also presents 
an overview of Norway’s ranking on indicators reported in the OECD 
Health at a Glance database each year. The indicators are chosen to reflect 
the health system, primary care, emergency care, patient safety, treatment of 
cancer and handling of contagious diseases (see Table 7.1). Norway scores 
relatively well in most areas, although there are some challenges, such as 
patient experiences with physicians and excess mortality in patients with 
mental health problems.
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TABLE 7.1 Selected quality indicators, 2018




Life expectancy X New
Primary care
Hospital admission asthma and COPD X
Hospital admissions Congestive heart failure X New
Hospital admission Diabetes X
Major lower extremity amputation X
Overall volume of antibiotics prescribed Primary care X Up
Volume of 2nd line antibiotics prescribed in Primary care X
Chronic Benzodiazepine Use: Long time > 1 year X
Patient experiences with physicians X Down
Emergency care
Mortality following acute myocardial infarction (AMI) X
Mortality following ischaemic stroke X
Patient safety
Postoperative pulmonary embolism (PE) or deep vein thrombosis (DVT) X Up
Postoperative sepsis in abdominal surgeries X Down
Foreign body left in during procedure X Down
Obstetric trauma, vaginal delivery with instrument X Up
Obstetric trauma, vaginal delivery without instrument X
Mental health: Excess mortality X New
Treatment of cancer
Mammography screening in women aged 50–69 X
Breast cancer five-year net survival X
Colon cancer five-year net survival X
Leukaemia mortality in children X New
Contagious disease
Childhood vaccination measles X
Influenza vaccination 65 years + X New
Source: Selected OECD (2018a)
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7.5 Health system outcomes
The health status of the Norwegian population is very good by international 
standards and has improved considerably over the last decades (see Section 1.4).
Mortality amenable to medical intervention is used as an indication of 
the contribution that health care makes to improve population health. It is 
defined as “premature deaths from causes that should not occur in the pres-
ence of timely and effective health care” (Nolte & McKee, 2011). In addition, 
preventable mortality is deaths from causes that could be avoided through 
public health policies, such as chronic liver disease, road traffic injuries and 
lung cancer. Fig. 7.5 shows amenable and preventable deaths across the EU 
and EEA in 2000 and the latest year for which data is available.
In terms of both amenable and preventable mortality Norway ranks 
among the countries with the lowest rates in Europe. Between 2000 and 2016 
amenable mortality in Norway has almost halved, from 117 to 60 deaths per 
100 000 inhabitants. Over the same period preventable mortality decreased 
from 50 to 35 deaths per 100 000. Part of Norway’s low levels of amenable 
mortality may be attributed to a large reduction in mortality from ischemic 
heart disease and increased rates of survival from some of the treatable can-
cers. The overall positive trend in survival of treatable cancers reflects both 
screening and improved diagnostics, as well as improved treatment (Cancer 
Registry of Norway, 2017).
Mortality from ischemic heart disease decreased by 73% between 1990 
and 2015 (OECD, 2017). For many types of cancers, such as colorectal and 
breast cancer, Norway is among the countries with the highest percentage 
of patients surviving five years after diagnosis (see Section 7.4).
EQUITY OF OUTCOMES
Health outcomes differ across different population groups in Norway, point-
ing towards the existence of socioeconomic inequalities in health outcomes, 
and these inequalities seem to persist over time (see Section 1.4). As for health 
care-related outcomes, the data point towards comparatively high levels of 
equity (Box 7.2). For example, in 2014, 85% of women aged 50–69 reported 
having attended breast screening in the past three years, and this proportion 
is consistent across all educational levels (European Commission, 2019). 
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FIG. 7.5 Amenable and preventable mortality per 100 000 population in Norway and 
selected countries, 2000 and 2016 (or latest available)
2000 2016 or latest
Amenable mortalityPreventable mortality
































































Notes: 2000–2016 unless stated otherwise (2000–2015 for BE, DE, DK, EL, FI, FR, IE, IT, LU, LV, MT, PL, SI, EU28; 
2000–2014 for BG, SK; 2001–2015 for the UK; 2004–2016 for CY). Age-standardized death rates for all persons 
calculated by European Observatory for Health Systems and Policies; contact: marina.karanikolos@lshtm.ac.uk.
Sources: Population data from WHO detailed mortality files (released December 
2018). Amenable causes as per list by Nolte and McKee (2004)
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The equity gap, however, is larger for cervical screening in women aged 20–69: 
66% of women reported having had screening in the past three years, but 
among women with lower education this share is 61%, compared to 73% in 
women with higher education. Still, this gap is among the narrowest in the 
EU/EEA countries.
7.6 Health system efficiency
7.6.1 Allocative efficiency
A number of different actors at both central and local levels influence alloc-
ative efficiency in the health sector in Norway. At the central level, the 
amounts allocated from the MOHCS to the lower levels takes into account 
population needs including the number of inhabitants living in the region, 
as well as their age and income, and the levels of service use (in the case of 
allocation to the RHAs).
Between 2002 and 2017 the National Council for Priority Setting 
in Health Care, which served as an advisory body for the government on 
health care-related issues, contributed to the establishment of a National 
System for the Managed Introduction of New Health Technologies (‘New 
Methods’) within the Specialist Health Service in Norway. This has led to 
a more systematic use of HTAs as a basis for prioritization in the health 
sector (see also Section 2.4 and Box 3.3).
Traditionally, Norway, together with Sweden and the Netherlands, 
are the countries with the highest share of health spending devoted to 
BOX 7.2 Assessing inequalities in health
In 2019 Norway ranks among the top countries in the world in terms of income 
equality (see Section 1.2). Nevertheless, there are some inequalities related to 
health. Income-related inequalities have been shown to be associated with ine-
qualities in preventable and also amenable mortality in Norway and this income-
related gap remained fairly constant throughout the late 1990s and 2000s (Kinge, 
Vallejo-Torres & Morris, 2015). A recent study indicates that income appears to 
be a stronger marker for inequalities in health service utilization than education 
(Lunde, Otnes, & Ramm, 2017).
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long-term care (over 25%) (OECD, 2018a). More recently, there has been 
a focus on increasing the amount of resources allocated to psychiatric care 
for children and adolescents and to treatment of substance abuse, and it 
is a stated political goal to reallocate resources between different areas of 
specialist care. This still continues to be seen as a priority, with mental health 
and substance abuse budgets in 2018 seeing higher increases than somatic 
care (Høie, 2018).
7.6.2 Technical efficiency
Norway is among the top spenders on health measured in terms of spend-
ing per capita, while the share of GDP spent on health is closer to the 
OECD-average. There has been a continuing debate whether this level 
of spending is not excessive. As a result, a special report from the OECD 
Health Division was commissioned in 2016 by the MOHCS to examine 
how health spending in Norway compares with other relevant high-income 
OECD countries. The report found that costs in the Norwegian health 
sector in general and in the hospital sector in particular are much higher 
than in other comparable countries, with the exception of Switzerland. A 
comparison of price level indices (PLIs) related to GDP revealed that for 
the same basket of goods the prices in Norway were 44% higher than the 
EU-average. At the same time PLIs for health goods were 88% higher, while 
PLIs for comparable hospital services were 131% higher for Norway com-
pared to the EU average. This, however, is not surprising as higher income 
levels are associated with higher price levels. The report concludes that high 
spending in Norway is in line with the country’s wealth and demographic 
structure. Further discussions on allocation of resources, new technology 
and human resources have been sought in the debate on priority setting in 
health care (Ottersen et al., 2016).
As in many European countries, inpatient care in Norway saw a shift 
towards outpatient settings, leading to a decreasing number of hospital beds, 
shorter length of stay and wider use of day surgery. Nevertheless, there are 
more curative hospital beds in Norway than in Sweden, Denmark or Finland 
(Fig. 4.1). A recent Health Profile for Norway 2019 (OECD/European 
Observatory on Health Systems and Policies, 2019) suggests that important 
steps towards further efficiency have been made in Norway in recent years, 
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and identifies potential for further gains from the strengthening of care 
coordination between hospitals and municipalities. Until 2016 there was 
an increasing number of readmissions to hospitals, due to lack of capac-
ity in some municipalities to provide follow-up care after discharge. This 
trend has been reversed in more recent years, alongside the requirement for 
municipalities to provide emergency care beds for pre- and post-operative 
care (see Section 5.2).
Another area of concentrated effort to date, as well as further potential 
for improvement, is pharmaceuticals. In 2017 generics constituted just under 
50% of the pharmaceutical market, which is similar to the EU average, and 
below the share in Denmark (60%). In late 2018 Norway and Denmark 
established a joint initiative to further promote the use of generics and 
increase the market share of biosimilars.
8
Conclusions
Norway has one of the highest per capita GDPs in the world, with a high 
share of spending on health, which provides for a broad scope of benefits 
and ensures a relatively low level of private financing. This, however, makes 
the system relatively expensive, as Norwegians spend two-thirds more on 
health than the EU average. When adjusting for the country’s economic 
development, Norway’s health spending is in line with other high-income 
countries; however, the debates persist on whether the cost of health care 
justifies the level of outcomes.
Overall, Norway has a well-performing health system, and the level of 
self-reported unmet medical need is very low. Norwegians live longer and 
healthier lives than most Europeans, with the gains over recent decades 
partly attributable to effective and high-quality prevention measures and 
treatment. There are visible efforts to make the health system (and society 
in general) age-friendly and address mental health problems.
Norway also has a well-developed system of long-term care compared 
to other countries in Europe. Long-term care receives about a quarter of the 
total public spending on health. Home-based nursing care is entirely publicly 
financed but other types of long-term care, including nursing homes, require 
substantial cost-sharing.
Population ageing may put further pressures on the health and social 
care systems and, although much of long-term care is provided outside 
hospitals, continued efforts are needed to further strengthen primary and 
community care. Norway is facing these challenges by reforming primary 
and hospital care, further strengthening coordination between various types 
of care, and adapting medical education to future health needs. If successful, 
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the multidisciplinary primary care teams that are currently being piloted are 
expected to be rolled out nationwide.
The relationship between the municipalities and specialist care is also 
changing, with more efforts being put into coordination between primary 
and specialist care services. Further efficiencies are being sought through the 
ongoing administrative reform, which is expected to reduce the number of 
municipalities and counties.
The accountability and broader governance relationships between the 
central government, the RHAs and the municipalities have become more 
transparent and formalized, with more monitoring and publication of per-
formance measures. The use of e-health solutions has increased and is fur-
ther strengthened alongside efforts to make better use of the various health 
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Norwegian System of Patient Injury Compensation: https://www.npe.no/en/
Norwegian Association of Local and Regional Authorities: http://www.ks.no/news-in-english/
english-articles/
The Employers’ Association Spekter: http://www.spekter.no/Stottemeny/Om-Spekter/Om-
Spekter/Information-in-English/
Norwegian Medical Association: http://legeforeningen.no/english/
Norwegian Nurses Organization: https://www.nsf.no/om-nsf/english
Norwegian Dental Association: http://www.tannlegeforeningen.no/english/
Norwegian Psychological Association: https://www.psykologforeningen.no/foreningen/english
Norwegian Patient Organization: https://www.pasient.no/
Norwegian Cancer Society: https://kreftforeningen.no/en/about-us/
Norwegian Health Network: https://www.nhn.no/
Association of the Pharmaceutical Industry in Norway: https://www.lmi.no/
The Norwegian Universities and Colleges Admission Service: https://www.samordnaopptak.
no/info/english/
Regional Health Authorities:
 Northern Norway RHA: https://helse-nord.no/work-with-helse-nord
 Central Norway RHA: https://helse-midt.no/
 South-Eastern Norway RHA: https://www.helse-sorost.no/south-eastern- norway-regional-
health-authority
 Western Norway RHA: https://helse-vest.no/seksjon-engelsk
Norwegian Electronic Health Library: http://www.helsebiblioteket.no/om-oss/english
Statistics Norway: https://www.ssb.no/en/
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9.3 HiT methodology and production process
HiTs are produced by country experts in collaboration with the Observatory’s 
research directors and staff. They are based on a template that, revised peri-
odically, provides detailed guidelines and specific questions, definitions, 
suggestions for data sources and examples needed to compile reviews. While 
the template offers a comprehensive set of questions, it is intended to be used 
in a flexible way to allow authors and editors to adapt it to their particular 
national context. The most recent template is available online at: http://www.
euro.who.int/en/home/projects/observatory/publications/health-system-
profiles-hits/ hit-template-2010.
Authors draw on multiple data sources for the compilation of HiTs, 
ranging from national statistics, national and regional policy documents to 
published literature. Furthermore, international data sources may be incorpo-
rated, such as those of the OECD and the World Bank. The OECD Health 
Data contain over 1200 indicators for the 34 OECD countries. Data are 
drawn from information collected by national statistical bureaux and health 
ministries. The World Bank provides World Development Indicators, which 
also rely on official sources.
In addition to the information and data provided by the country experts, 
the Observatory supplies quantitative data in the form of a set of standard 
comparative figures for each country, drawing on the European Health for 
All database. The Health for All database contains more than 600 indicators 
defined by the WHO Regional Office for Europe for the purpose of moni-
toring Health in All Policies in Europe. It is updated for distribution twice 
a year from various sources, relying largely upon official figures provided by 
governments, as well as health statistics collected by the technical units of the 
WHO Regional Office for Europe. The standard Health for All data have 
been officially approved by national governments. With its summer 2007 
edition, the Health for All database started to take account of the enlarged 
EU of 27 Member States. HiT authors are encouraged to discuss the data in 
the text in detail, including the standard figures prepared by the Observatory 
staff, especially if there are concerns about discrepancies between the data 
available from different sources.
A typical HiT consists of nine chapters.
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1. Introduction: outlines the broader context of the health system, 
including geography and sociodemography, economic and political 
context, and population health.
2. Organization and governance: provides an overview of how the 
health system in the country is organized, governed, planned 
and regulated, as well as the historical background of the system; 
outlines the main actors and their decision-making powers; and 
describes the level of patient empowerment in the areas of infor-
mation, choice, rights, complaints procedures, public participation 
and cross-border health care.
3. Financing: provides information on the level of expenditure and 
the distribution of health spending across different service areas, 
sources of revenue, how resources are pooled and allocated, who is 
covered, what benefits are covered, the extent of user charges and 
other OOP payments, VHI and how providers are paid.
4. Physical and human resources: deals with the planning and distri-
bution of capital stock and investments, infrastructure and medical 
equipment; the context in which IT systems operate; and human 
resource input into the health system, including information on 
workforce trends, professional mobility, training and career paths.
5. Provision of services: concentrates on the organization and delivery 
of services and patient flows, addressing public health, primary care, 
secondary and tertiary care, day care, emergency care, pharmaceuti-
cal care, rehabilitation, long-term care, services for informal carers, 
palliative care, mental health care, dental care, complementary and 
alternative medicine, and health services for specific populations.
6. Principal health reforms: reviews reforms, policies and organiza-
tional changes; and provides an overview of future developments.
7. Assessment of the health system: provides an assessment based on 
the stated objectives of the health system, financial protection and 
equity in financing; user experience and equity of access to health 
care; health outcomes, health service outcomes and quality of care; 
health system efficiency; and transparency and accountability.
8. Conclusions: identifies key findings, highlights the lessons learnt 
from health system changes; and summarizes remaining challenges 
and future prospects.
9. Appendices: includes references, useful web sites and legislation.
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The quality of HiTs is of real importance since they inform policy-making 
and meta-analysis. HiTs are the subject of wide consultation throughout 
the writing and editing process, which involves multiple iterations. They are 
then subject to the following:
  A rigorous review process (see the following section).
  There are further efforts to ensure quality while the report is final-
ized that focus on copy-editing and proofreading.
  HiTs are disseminated (hard copies, electronic publication, trans-
lations and launches). The editor supports the authors throughout 
the production process and in close consultation with the authors 
ensures that all stages of the process are taken forward as effectively 
as possible.
One of the authors is also a member of the Observatory staff team and they 
are responsible for supporting the other authors throughout the writing and 
production process. They consult closely with each other to ensure that all 
stages of the process are as effective as possible and that HiTs meet the series 
standard and can support both national decision-making and comparisons 
across countries.
9.4 The review process
This consists of three stages. Initially the text of the HiT is checked, reviewed 
and approved by the series editors of the European Observatory. It is then 
sent for review to two independent academic experts, and their comments 
and amendments are incorporated into the text, and modifications are made 
accordingly. The text is then submitted to the relevant ministry of health, or 
appropriate authority, and policy-makers within those bodies are restricted 
to checking for factual errors within the HiT.
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